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ABSTRACT 
This dissertation describes 1) the synthesis of disaccharide standards for mass 
spectrometry-based carbohydrate sequencing and 2) the automated iterative solution-
phase synthesis of beta-glucans.  Two libraries of mass-identical disaccharides were 
synthesized.  Varying in linkage position and the identity of the non-reducing end 
monosaccharide residue, these compounds served as synthetic standards for systematic 
study by tandem mass spectrometry.  These disaccharides were analyzed by mass 
spectrometry in the laboratories of Professors Edward Yeung and Young-Jin Lee.  The 
varying degrees of fragmentation observed in the MS-MS spectra of several of these 
disaccharides were used to produce classification functions that were capable of correctly 
classifying the linkage position and identity of the non-reducing end monosaccharide 
residue.  These results provide insight that will ultimately contribute to the development 
of faster carbohydrate sequencing methods. 
The second portion of this dissertation describes the automated solution-phase 
syntheses of branched and linear beta-glucans.  A fluorocarbon-based tag on the growing 
sugar chain allows for facile purification of intermediates by automated fluorous solid-
phase extraction (FSPE), and also provides a means of noncovalent attachment to a 
fluorinated glass slide for the direct formation of carbohydrate microarrays.  Our 
synthetic approach allows for traditional solution-phase kinetics, reaction monitoring, and 
chromatographic purification, techniques that are not possible with solid-phase 
oligosaccharide synthesis.  Several new glucosyl trichloroacetimidate building blocks 
were synthesized and subsequently utilized for the automated synthesis of branched and 
linear beta-glucan fragments.  Finally, conditions were developed to fully deprotect our 
vi 
synthetic glucans, rendering them suitable for NMR binding studies and biological 
assays.  These studies established automation protocols that can be used for the synthesis 
of larger, more complex beta-glucan structures. 
 1 
CHAPTER 1 
General Introduction 
1. Dissertation Organization 
 This dissertation is composed of five chapters.  Chapter 1 is a general introduction 
to the chemistry discussed in Chapters 2-4.  Chapter 2 discusses the synthesis of a library 
of mass-identical disaccharides varying in linkage and monosaccharide composition.  A 
select number of these compounds were analyzed by MALDI mass spectrometry by Hui 
Zhang and Ning Fang in the labs of Prof. Edward Yeung, and preliminary results were 
published in Rapid Communications in Mass Spectrometry in 2008.1  Chapter 3 discusses 
the development of methodology for the automated fluorous solution-phase synthesis of 
beta-glucan fragments, culminating in the synthesis of a 3,6-branched glucose 
tetrasaccharide.  This work demonstrates the ability to assemble branched 
oligosaccharides by automated iterative solution-phase synthesis.  Chapter 4 discusses the 
automated solution-phase synthesis of other branched and linear beta-glucan fragments.  
Chapter 5 provides general conclusions and future directions for the entire dissertation. 
 
2. Introduction to Carbohydrates 
 Carbohydrates are the most widely abundant class of organic compounds found 
on Earth.2 All cells have oligosaccharides, or glycans, covalently linked to their surfaces.  
These glycans mediate cell-cell, cell-matrix, and cell-molecule interactions in 
multicellular organisms.3  Carbohydrates also mediate interactions between host 
organisms and parasites.4  The recognition of bacterial, fungal, and viral oligosaccharides 
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by specific immune system receptors is a key step in the immune system’s process by 
which pathogens can be targeted and destroyed, as well as in the development of 
protective immunity.5  A number of carbohydrate-based therapeutic agents and vaccine 
formulations have been developed and commercialized.6  The difficulty in obtaining 
sufficient quantities of pure oligosaccharides, combined with the lack of technology for 
the rapid determination of oligosaccharide structure, have limited efforts toward the 
development of other carbohydrate-based therapeutic agents. 
 
3. Carbohydrate Structure Analysis by Mass Spectrometry 
 Carbohydrates represent one of the three major classes of biopolymers, the other 
two being peptides and nucleotides.  The field of proteomics was revolutionized during 
the 1990s when the development of rapid mass spectrometry-based methods for peptide 
sequencing displaced the more laborious and time-intensive Edman degradation.7  
Similarly, the pioneering work of Maxam and Gilbert8 and Sanger and Coulson9 led to 
methods for the sequencing of DNA.  The sequencing of DNA and proteins has been 
automated,10 and automated DNA and protein sequencing instruments are commercially 
available from companies such as Applied Biosystems.  However, automated sequencing 
technology for carbohydrates has yet to be developed.  Several factors have contributed 
to the lag in development of carbohydrate sequencing methods.  Unlike DNA and 
polypeptides, which are primarily linear polymeric chains, oligosaccharides often contain 
branches.  Oligosaccharide linkages can be formed through one of several hydroxyl 
groups found on each monosaccharide residue.  Additionally, each linkage contains 
stereochemical information, with each linkage being either ! or ".  Clearly, the structural 
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complexity of carbohydrates presents a significant challenge for the development of 
sequencing methods. 
 Many techniques have been used for carbohydrate structure determination.  
Among these, mass spectrometry has emerged as one of the most valuable.11  Soft 
ionization techniques, such as MALDI, can be used to generate high-mass molecular 
ions, which can then be fragmented using techniques such as collision-induced 
dissociation.12  The fragmentation patterns observed can provide valuable information 
about the structure of carbohydrates.  Ideally, technology could be developed for the 
automated structural determination of underivatized carbohydrates. However, the 
robustness and scope of any such technologies will depend on the ability to obtain and 
test a wide variety of well-defined carbohydrate structures not commercially available. 
 
4. Iterative Chemical Synthesis of Oligosaccharides 
 The iterative approach to the synthesis of oligosaccharides relies on two key 
steps.  First, a suitably protected glycosyl donor must be activated in the presence of a 
suitable nucleophile to generate a new glycosidic linkage of the desired stereochemical 
configuration.  Second, a temporary protecting group must be selectively cleaved to 
generate a reactive hydroxyl group for further extension of the growing sugar chain 
(Figure 1.1).  This process of glycosylation and deprotection steps can be repeated until 
the desired sugar chain length is achieved. 
O
LG
PO
ROH
Activating 
Agent
O
OR
PO
Deblocking
Agent O
OR
HO
Figure 1.1. General strategy for iterative oligosaccharide synthesis.  P = protecting group;
LG = leaving group  
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The challenge of carbohydrate synthesis is thus two-fold.  First, an orthogonal protecting 
group strategy must be developed that allows for the selective unmasking of reactive 
hydroxyl groups for chain elongation.  Second, the choice of the anomeric leaving group 
in the glycosyl donor and conditions for its activation must be compatible with the 
protecting groups chosen.  Fortunately, several types of synthetically useful glycosylating 
agents exist, as will be discussed below. 
 
4.1 Glycosyl Donors 
 Several anomeric leaving groups have been developed for use in glycosylation 
reactions.  Glycosyl halides were first introduced by Koenigs and Knorr.13  Glycosyl 
halides, typically the chlorides and bromides, are activated by a halophilic promoter, such 
as Ag2O or AgOTf.  Many variations of the classical Koenigs-Knorr method, including 
the use of glycosyl fluorides14 and iodides,15 have been developed.  Thioglycosides can 
also act as glycosyl donors, and are typically activated by a Lewis acid, such as 
BF3
.OEt2,
16 or iodonium systems such as NIS/AgOTf.17  One drawback to the 
thioglycosides, however, is the requirement of substantial quantities of highly reactive 
reagents needed for their activation.  The 1,2-orthoesters of aldose sugars have also 
gained utility as glycosyl donors, especially the n-pentenyl orthoesters developed by 
Fraser-Reid and coworkers.18 
Activated by various Lewis acid/NIS combinations, these donors result in the formation 
of 1,2-trans glycosidic linkages.  The n-pentenyl orthoesters can be converted to n-
pentenyl glycosides, another useful type of glycosyl donor.19  Perhaps the most popular 
glycosyl donor developed to date is the glycosyl trichloroacetimidate, introduced by 
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Schmidt in 1980.20  Glycosyl trichloroacetimidates are readily obtained by the addition of 
trichloroacetonitrile (Cl3CCN) to a free anomeric hydroxyl group in the presence of a 
base, typically NaH, 1,8-diazabicyclo[5.4.0]-undec-7-ene (DBU), or Cs2CO3.  The ease 
of formation of glycosyl trichloroacetimidates, as well as their reactivity and broad 
applicability, have contributed to their widespread use in synthetic carbohydrate 
chemistry.  Glycosyl trichloroacetimidates are generally activated by catalytic amounts of 
Lewis acids, such as BF3
.OEt2 or TMSOTf.  Trivalent lanthanide triflates have also been 
used.21-22  More recently, the use of glycosyl trifluoroacetimidates as glycosyl donors has 
been explored.23-24 Many other types of glycosyl donors have been developed in recent 
years, providing chemists with a number of tools for the synthesis of complex 
oligosaccharides. 
 
4.2 Automated Synthesis of Oligosaccharides 
 The development of solid-phase synthetic methodologies has led to the 
commercialization of automated peptide and nucleic acid synthesizers.  Researchers in 
need of a specific nucleic acid or peptide sequence can purchase a custom-made molecule 
from a number of online vendors.  Unfortunately, commercial custom oligosaccharide 
synthesis is not yet a reality. 
 Bruce Merrifield’s development of solid-phase peptide synthesis25 in the 1960s 
provided a means for the rapid synthesis of peptides.  Other researchers began to apply 
solid-phase approaches to carbohydrate synthesis.   The first report of solid-phase 
carbohydrate synthesis was made by Frechet and Schuerch in 1971.26  Three decades 
later, a modified automated peptide synthesizer was used to synthesize 
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oligosaccharides.27  However, solid-phase synthesis presents a number of challenges to 
carbohydrate synthesis.  To overcome the kinetic limitations of a biphasic reaction 
system, large excesses of sugar building blocks (10-20 equivalents per coupling cycle) 
must be used to ensure high coupling efficiencies.  Since these building blocks may 
require four or as many as fourteen or more steps to prepare, this represents a very 
significant cost in terms of both time and money.  Additionally, the difficulty in 
monitoring reaction progress on the solid phase is another limitation of solid-phase 
synthesis.  Clearly, further efforts must be undertaken to develop a robust, efficient 
method for the automated synthesis of oligosaccharides. 
 
5. Beta-Glucans 
 Glucose and its polymers constitute the largest percentage of carbohydrates on 
Earth and therefore are important targets for the development of any automated synthesis 
protocols. For example, glucans are naturally occurring polysaccharides composed of 
repeating D-glucopyranose units connected by "-glycosidic linkages.  These compounds 
can be obtained from a number of natural sources, including cereal grains, plants, algae, 
yeasts, and fungi.  "-Glucans consist of linear (1#3)-"-linked backbones with (1#6) or 
(1#4)-linked side chains. The "-glucans vary considerably in terms of primary structure, 
degree of branching, molecular weight, and solution conformation, all of which play a 
role in determining the biological activity associated with these compounds. 
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5.1. Sources and Structures of Naturally Occurring Beta-Glucans 
 "-Glucans can be found in a wide variety of organisms.  A number of "-glucans 
have been discovered in prokaryotes, including the capsular glucans from Streptococcus 
pneumoniae
28 and the (1#3)-"-linked glucan called curdlan, produced by fermentation 
of Agrobacterium.29  Algae are also rich sources of "-glucans.  Laminarans, obtained 
from Laminaria species of brown algae, are low-molecular weight storage 
polysaccharides comprised of (1#3)-"-D-glucopyranose chains with some (1#6)-
branching.  The laminarans can be likened to starch found in plants.  The (1#3, 1#6)-"-
glucans are major components of the cell walls of yeasts and fungi.  These cell surface 
oligosaccharides play important roles in the formation of symbiotic and pathogenic 
relationships with plants and animals, and are important targets for the immune system.30  
Fungal and yeast glucans all share a similar structure: a (1#3)-linked "-D-glucopyranose 
backbone with some side chains of "-D-glucopyranosyl residues connected to the 
backbone by "-(1#6) linkages. For example, a "-glucan called HEP3, isolated from the 
fruiting bodies of the fungus Hericium erinaceus, was reported to be composed of   a 
(1#3)-linked "-D-glucopyranose backbone, with one "-D-glucopyranosyl substituent at 
O-6 for, on average, every three backbone residues.31 Linear "-glucans containing both 
(1#3)- and (1#4)-"-glucosidic linkages can be found in the endosperm walls of barley, 
wheat, and other cereal grains. "-Glucans can form complex tertiary structures stabilized 
by interchain hydrogen bonds, ranging from random coils to highly organized triple 
helices.32  Clearly, the "-glucans are a structurally diverse family of oligosaccharides. 
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Figure 1.2. Examples of naturally occuring !-glucans  
5.2 The Immune Response to Beta-Glucans 
 The "-glucans have been shown to exhibit a wide range of medicinal and 
bioactive properties, including anti-inflammatory, antimicrobial, anti-tumoral, 
cholesterol-lowering, and immunomodulatory activity.32  However, the precise activity of 
"-glucan preparations can vary considerably based on the source of the glucan, and its 
method of isolation, structure, and purity.  Hot water extracts from mushrooms and tree 
fungi have been used as folk remedies in Asia and Russia for centuries.32  Currently, 
these preparations are used for both general health-stimulating effects and for specific 
therapeutic purposes.33  The protective effects of "-glucans are thought to arise from non-
specific immune stimulation via a number of immune pathways, including macrophage 
activation, activation of natural killer cells, activation of complement pathways, and 
increased antibody production.32 
The "-glucans have emerged as a major target for the recognition of pathogens by 
the innate immune system.  Recognition of fungal "-glucan structures by a number of 
immune system receptors triggers responses that protect the host from the pathogen.  
Several "-glucan receptors have been identified in vertebrates, including scavenger 
receptors, complement receptor 3, lactosylceramide, and Dectin-1.34  In particular, the "-
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glucan receptor Dectin-1 has been studied extensively over the past decade.  Dectin-1 is a 
type II transmembrane receptor comprised of four main portions: a lectin-like 
carbohydrate recognition domain, a stalk region, a transmembrane domain, and an 
immunoreceptor tyrosine-based activation motif (ITAM) (Figure 1.3).35,36 
Dectin-1 recognizes particulate and soluble glucans from fungi, bacteria, and plants, and 
serves as the primary receptor for these carbohydrates on white blood cells.37   
Dectin-1 can induce a number of cellular responses to fungal pathogens, including 
phagocytosis and killing and the induction of cytokines and chemokines.  The ITAM 
motif of Dectin-1 induces the intracellular signaling pathways that result in these 
responses.36  Studies carried out in vivo have demonstrated the protective effects of 
Dectin-1.  For example, the blockage of Dectin-1 function using a soluble inhibitor 
resulted in a reduced inflammatory response and increased fungal burdens in the lungs of 
mice infected with A. fumigatus.38   
 
plasma membrane
extracellular
cytoplasm
CRD
stalk
transmembrane domain
ITAM
Figure 1.3. Schematic illustration of the structure of Dectin-1.
Dectin-1 is composed of a carbohydrate-recognition domain (CRD),
a stalk region, transmembrane domain, and a cytoplasmic region 
containing the immunoreceptor tyrosine-based activation motif (ITAM)  
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The discovery and characterization of the "-glucan receptor Dectin-1 has 
provided a wealth of information regarding the innate immune response to pathogens.  
Research has also shown that Dectin-1 plays a significant role in antifungal immunity.  
However, further efforts must be taken to continue to elucidate the molecular 
mechanisms involved in the action of Dectin-1.  Access to pure, structurally defined "-
glucans would allow researchers to study in detail the ligand specificity of Dectin-1 as a 
function of chain length and branching pattern in the carbohydrate ligand. 
 
6. Research Aims 
 The aims of this research can be divided into two main areas: 1) the synthesis of a 
small library of mass-identical disaccharides, varying in monosaccharide composition 
and linkage position, for systematic structural analysis by mass spectrometry, and 2) the 
development of methods for the automated solution-phase synthesis of branched and 
linear "-glucan fragments. 
 
6.1. Synthesis of Disaccharides for Mass Spectrometry Studies 
 The goal of this work was to synthesize a number of disaccharides with different 
monosaccharide residues and linkage positions, but with identical masses.  These 
compounds could then be systematically studied by tandem mass spectrometry to obtain 
structural information based on fragmentation patterns.  Initially, disaccharides bearing a 
propyl group at the reducing end were synthesized to avoid the presence of anomeric 
mixtures.  Later, a second library of reducing disaccharides was prepared.  In both cases, 
appropriately protected glucosyl acceptors were synthesized to facilitate the formation of 
 11 
1,2-, 1,3-, 1,4-, and 1,6-glycosidic linkages.  The acceptors were then glycosylated with 
the well-known peracetylated glycosyl donors derived from D-glucose, D-galactose, and 
D-mannose.  Following global deprotection, the disaccharides could then be screened by 
mass spectrometry. 
 
6.2. Automated Solution-Phase Synthesis of Beta-Glucan Fragments 
 The goal of this project was to develop a strategy for the synthesis of both linear 
and branched "-glucan fragments using an automated solution-phase approach.  Several 
key challenges were met in the course of this work.  First, a number of glucose-based 
trichloroacetimidate building blocks were synthesized to allow for the selective formation 
of various glycosidic linkages.  In particular, building blocks were developed for the 
introduction of branch point glucose residues that would allow for either simultaneous or 
independent chain extension from the branch point.  Second, protocols were established 
to transfer the many tasks involved in benchtop oligosaccharide synthesis to a new 
automated solution-phase synthesis platform.  Finally, these new automation protocols 
were applied to the synthesis of a number of "-glucan fragments. 
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CHAPTER 2 
Synthesis of Disaccharides for Linkage and Residue Determination by 
Tandem Mass Spectrometry and Linear Discriminant Analysis* 
*Portions of the work in this chapter were published in Zhang, H.; Brokman, S.M.; Fang, 
N.; Pohl, N.L.; Yeung, E.S. Rapid Communications in Mass Spectrometry 2008, 22, 
1579-1586. 
 
Abstract 
 The development of rapid mass spectrometry-based techniques for the sequencing 
of nucleic acids and peptides sparked growth in the fields of genomics and proteomics.  
Unfortunately, no such technology currently exists for the sequencing of carbohydrates. 
The structural complexity of carbohydrates presents a considerable challenge to 
researchers seeking to develop oligosaccharide-sequencing tools.  Mass spectrometry is 
perhaps the most powerful technique for determining the structure of oligosaccharides.  
The lack of access to a diverse library of well-defined oligosaccharides has limited the 
development of carbohydrate sequencing technologies.  In this research, two small 
libraries of mass-identical disaccharides varying in linkage position and identity of the 
non-reducing end monosaccharide residue were synthesized.  A number of these 
synthetic standards were subjected to tandem mass spectrometry in the laboratory of Prof. 
Edward Yeung.  Preliminary results showed that differences in the MS-MS spectra of the 
synthetic disaccharides could be used to generate classification functions that were able 
to predict the linkage type as well as the identity of the non-reducing end monosaccharide 
residue present in each disaccharide. 
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Introduction 
 Carbohydrates represent one of the three major classes of biopolymers, the other 
two being nucleotides and proteins.  Carbohydrates play a number of important roles in 
living systems, including structural roles, mediating cell-cell and cell-pathogen 
interactions, and acting as regulatory switches for cellular processes.1 The structural 
complexity of carbohydrates represents a significant challenge for the development of 
carbohydrate sequencing methods.  Unlike proteins and nucleotides, which are almost 
exclusively linear polymers, oligosaccharides often possess branched structures.  
Additionally, glycosidic linkages contain stereochemical information- each linkage may 
be either ! or ".  Since each monosaccharide is a polyfunctional molecule, multiple 
linkage types are possible for each monosaccharide residue. Despite their biological 
significance, development of technology for the structural determination of carbohydrates 
has not kept pace with that of nucleotides and proteins.   
 Of the many techniques explored for the structural characterization of 
carbohydrates, mass spectrometry has emerged as a dominant technique.2  Soft ionization 
techniques such as MALDI allow the generation of high-mass molecular ions, making 
them well suited for carbohydrate analysis.  Collision-induced dissociation (CID) of 
molecular ions generated by MALDI has been used to analyze underivatized 
oligosaccharides.3  Electrospray ionization (ESI) has been used to analyze carbohydrates, 
but best results are achieved with permethylated oligosaccharides.4  The ability to analyze 
underivatized oligosaccharides, without the need for permethylation of other forms of 
derivatization, would be a significant advancement in the area of oligosaccharide 
sequencing. 
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In order to develop a systematic approach to the determination of oligosaccharide 
sequence by mass spectrometry, we must explore the ability of mass spectrometry to 
differentiate between various linkage types and the identities of individual 
monosaccharide residues, even when those residues share identical masses.  A library of 
disaccharides with various linkage types and differing but mass-identical monosaccharide 
residues could be systematically explored by mass spectrometry, in order to observe the 
influence of structure on the fragmentation patterns that are observed.  Molecules 
containing the monosaccharides glucose, galactose, and mannose are ideal test cases as 
all three residues are commonly found in natural structures and all share the same mass. 
Unfortunately, only a limited number of disaccharides containing these monomeric 
sugars are available from commercial sources.  Fortunately, chemical synthesis can 
provide ready access to a wide variety of disaccharides for mass spectrometry studies. 
 
Results and Discussion 
 In order to supplement the commercially available disaccharides, we synthesized 
two small libraries of disaccharides bearing a glucose residue at the reducing end and 
either glucose, galactose, or mannose at the nonreducing end.  One library of 
disaccharides would bear a propyl group at the reducing end to limit the complications 
provided by mutarotation of free anomers in solutions, and the other a free hydroxyl 
group.  First, the library of propyl-tagged disaccharides was constructed.  The known 
glycosyl acceptors 15, 26, 57, and 68, were selected.  Acceptors 1 and 2 were synthesized 
from D-glucose following published procedures.5,6  Acceptors 5 and 6 were synthesized 
from the known diol 39(Scheme 1).  Diol 3 was benzylated to provide the known 2,3-di-
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O-benzyl derivative 4.8  Cleavage of the benzylidene acetal from 4 gave the 4,6-diol 5.  
Regioselective reductive benzylidene ring opening10 of 4 gave only the 6-O-benzyl 
derivative 6. 
 With the glycosyl acceptors in hand, the known peracetylated glycosyl donors 711, 
8
12, and 911 were synthesized in three steps from D-glucose, D-galactose, and D-mannose, 
respectively, via peracetylation, selective anomeric deacetylation, and 
trichloroacetimidate formation (Scheme 2). The very reactive trichloroacetimidate-
activated glycosyl donors13 were expected to readily provide disaccharides with not only 
the less hindered primary alcohol nucleophiles, but also the various secondary alcohol 
nucleophiles. Additionally, through neighboring group participation of the 2-O-acetyl 
group, these donors can provide the 1,2-trans glycosides as the sole product. 
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Scheme 1. Synthesis of acceptors 3 and 4. a) BnBr, NaH, Bu4NI, DMF, rt, 2.5 h, 87%;
b) 60% TFA (aq.), CH2Cl2,  rt, 45 min, 89%; c) Et3SiH, TfOH, 4 A MS, CH2Cl2, -78 
oC,
130 min, 67%.  
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a) Ac2O, I2, rt, 3 h; b) H2NNH2
.HOAc, DMF, 60 oC, 1h; c) Cl3CCN, Cs2CO3, CH2Cl2, rt.  
 With the requisite donors and acceptors in hand, the assembly of disaccharides 
was commenced.  Glycosylation of the 2-hydroxyl glucose acceptor 1 with each of the 
three donors gave the desired disaccharides in excellent yields (Scheme 3).  In a similar 
fashion, the 1,3-linked disaccharides 13, 14, and 15 were prepared by the glycosylation of 
acceptor 2 with the aforementioned donors 7, 8, and 9, respectively (Scheme 4). The 
somewhat lower yields in these cases are likely a result of deactivation of the glycosyl 
acceptors by the sterically large and electron-withdrawing pivaloate14 at the neighboring 
hydroxyl. 
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 Next, the 1,4-linked disaccharides were synthesized.  The commercially available 
disaccharides cellobiose and lactose were used to prepare their known peracetylated 
trichloroacetimidate derivatives 1615 and 18.16  Condensation of 16 and 18 with n-
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propanol gave the desired propyl glycosides 17 and 19 in modest yields.  To prepare the 
mannosyl analog, acceptor 6 was glycosylated with mannose donor 9 to furnish 
disaccharide 20 (Scheme 5).  Finally, the 1,6-linked disaccharides 21, 22, and 23 were 
prepared by selective glycosylation at the O-6 position of diol 5.  By using limiting 
amounts (0.5 – 1.0 equiv.) of donors 7, 8, and 9, the desired disaccharides could be 
obtained (Scheme 6).  The structures of 21, 22, and 23 were confirmed by 1H-1H COSY 
NMR experiments, which for each compound showed coupling of H-4 on the reducing-
end glucose residue ($ 3.44 ppm) to the hydroxyl proton on O-4 ($ 2.3 ppm). 
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 Having obtained each of the desired disaccharides, global deprotection was 
carried out to unmask the hydroxyl groups and yield the disaccharides as the propyl 
glycosides.  The 1,2-linked disaccharides 10, 11, and 12 were subjected to catalytic 
hydrogenation to cleave the benzyl ethers and reduce the double bond in the allyl group, 
followed by deacetylation17 under Zemplen conditions.  The galactosyl and mannosyl 
analogs 11 and 12 were then purified as the corresponding peracetylated derivatives 25 
and 27 prior to final deacetylation to give compounds 26 and 28.  The 1,3-linked 
disaccharides 13, 14, and 15 were subjected to acid-catalyzed debenzylation, catalytic 
hydrogenation, and Zemplen deacetylation to furnish the fully deprotected derivatives 29, 
30, and 31 (Scheme 7). 
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Scheme 7. Deprotection of 1,2- and 1,3-linked disaccharides. a) H2, 10% Pd/C,
MeOH or EtOH, rt; then NaOMe, MeOH, rt, 95%; b) H2, 10% Pd/C, MeOH, rt; 
then NaOMe, MeOH, rt; then Ac2O, pyr, DMAP, rt, 77% for 25, 58% for 27;
c) NaOMe, MeOH, rt, 96% for 26, 99% for 28; d) 60% TFA (aq.), CH2Cl2, rt;
then H2, 10% Pd/C, MeOH or EtOH, rt; then NaOMe, MeOH, rt, 90% for 29,
96% for 30, 94% for 31.
b
 
The cellobiose derivative 17 and lactose derivative 19 were deacetylated to furnish the 
propyl glycosides 32 and 33 in 90 and 98% yields, respectively.  The allyl glycosides 20, 
21, 22, and 23 were hydrogenated and deacetylated to furnish the corresponding propyl 
glycosides 34, 35, 36, and 37 (Scheme 8). 
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Scheme 8. Deprotection of 1,4- and 1,6-linked disaccharides. a) NaOMe,
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 Having successfully prepared a number of propyl-tagged disaccharides, our 
efforts then focused on the synthesis of disaccharides bearing a free reducing end.  To 
this end, we chose to prepare glucose acceptors protected only by benzyl ethers and 
couple them with the aforementioned peracetylated glycosyl trichloroacetimidates 7, 8, 
and 9.  The resulting disaccharides would then be fully deprotected through a 
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straightforward two-step sequence consisting of catalytic hydrogenation followed by 
Zemplen deacetylation to furnish the desired reducing disaccharides.   
First, the four necessary acceptor molecules were synthesized, each bearing a 
single free hydroxyl group (Scheme 9).  The synthesis of 2-OH acceptor 3918 was 
accomplished by treating the known 1,2-orthoester 3819 with benzyl alcohol and catalytic 
TMSOTf.  Following cleavage of the 2-O-acetyl group from the crude product, a 
considerable amount of benzyl alcohol remained.  The benzyl alcohol was converted to 
its trityl ether to facilitate the purification of benzyl glucoside 39.  The synthesis of 3-OH 
acceptor 4420 commenced from diacetone-D-glucose 40.21  The 3-OH group was 
protected as the allyl ether 41.22  Acidic hydrolysis of the ketal groups gave pyranose 
42,23 which was benzylated to give the fully protected compound 43.  The allyl ether in 
43 was cleaved to give the 3-OH acceptor 44.24 
For the production of acceptor 49,25 known glucosyl bromide 4526 was treated 
with benzyl alcohol and silver oxide to furnish benzyl glucoside 46.25 Formation of the 
4,6-O-benzylidene acetal and benzylation of the two remaining hydroxyl groups yielded 
48.25  Selective benzylidene ring opening of 48 furnished the 4-OH acceptor 49.  To 
construct the 6-OH acceptor, the procedure of Lu and coworkers27 was followed.  
Perbenzylation of D-glucose yielded compound 50.27  Selective acetolysis of the 6-O-
benzyl group in 50, followed by deacetylation of the crude product, afforded the 6-OH 
acceptor 51.27,28 
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Scheme 9.  Synthesis of benzylated glucosyl acceptors.  a) BnOH, TMSOTf, 0 oC, 20
min, then NaOMe, MeOH, rt, 18 h, then TrCl, DMAP, DMF, 70 oC, 40 min, 54%; 
b) Allyl bromide, NaH, Bu4NI, THF, rt, 2 h, 54%; c) Dowex 50 (H
+), H2O, 70 
oC, 4 h, 46%;
d) BnBr, NaH, DMF, rt (44% for 43, 94% for 48, 50% for 50); 
e) [Ir(COD)(PMePh2)2]PF6, H2, THF, rt, 16 h, then HgCl2, HgO, acetone, H2O, rt, 1 h,
86%; f) BnOH, Ag2O, CH2Cl2, rt, 4 h, then NaOMe, MeOH, rt, 3 h, 66%; g) PhCH(OMe)2,
CH3CN, CSA, reflux, 75 min, 72%; h) Et3SiH, TfOH, 4A MS, CH2Cl2, -78 
oC, 1 h, 53%;
i) ZnCl2, Ac2O, AcOH, 0 
oC to rt, 1 h, then NaOMe, MeOH, rt, 2 h, 37%  
 
 Acceptors 39 and 44 were successfully glycosylated with donors 8 and 9 to 
generate disaccharides 52, 53, 54, and 55 (Scheme 10).  Similarly, acceptor 49 was 
glycosylated with donor 9 to give disaccharide 56, and acceptor 51 was glycosylated with 
donors 8 and 9 to give disaccharides 57 and 58, respectively (Scheme 11). 
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Scheme 11.  Synthesis of 1,4- and 1,6-linked disaccharides. a) TMSOTf, CH2Cl2, rt,
30 min (85% for 56, 51% for 57, 75% for 58).  
 The deprotection sequences for disaccharides 52-58 were then carried out 
(Schemes 12 and 13).  Each disaccharide was subjected to debenzylation followed by 
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deacetylation to yield the corresponding deprotected reducing disaccharide.  In the case 
of the deprotection reactions for compounds 54 and 55, the debenzylated intermediates 
were purified as the peracetylated derivatives 61 and 63 prior to final deprotection. 
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Scheme 12.  Deprotection of 1,2- and 1,3-linked disaccharides. a) H2, 10%
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 The synthetic disaccharides 24, 26, 28, 29, 30, 31, 32, 33, and 34 served as 
standards for preliminary mass spectrometry studies carried out in the laboratory of Prof. 
Edward Yeung.  The compounds were analyzed using MALDI mass spectrometry using 
an acidic fullerene matrix.  The relative intensities of the fragments observed in the 
MS/MS spectra of each synthetic disaccharide were used as input for linear discriminant 
analysis (LDA).  Following linear discriminant analysis, classification functions were 
produced.  These functions were used to successfully determine not only the saccharide 
linkage type (1,2-, 1,3- or 1,4-) but also the identity of the non-reducing end 
monosaccharide residue (glucose, galactose, or mannose).29  MALDI MS/MS analyses of 
the remaining synthetic disaccharides prepared in this work are in progress in the labs of 
Prof. Young-Jin Lee to determine the generality of this new approach to sequencing 
carbohydrates using mass spectrometry. 
. 
 32 
 
Conclusion 
 A library of synthetic disaccharides was prepared by coupling suitably protected 
glucosyl acceptors with peracetylated glycosyl trichloroacetimidate donors.  After 
chromatographic purification, the protecting groups were removed to furnish the 
deprotected disaccharides, either as propyl glycosides or as free reducing sugars.  
Preliminary studies showed that the synthetic disaccharides exhibited differences in the 
fragmentation observed in their MS/MS spectra, and that these results could be used to 
classify each disaccharide by its linkage position as well as the identity of the 
nonreducing end monosaccharide residue.  The results of this study will likely improve 
our ability to determine the structure of oligosaccharides and provide insight that will 
ultimately contribute to the development of faster carbohydrate sequencing methods. 
 
Experimental Section 
 
General Materials and Methods 
Reaction solvent dichloromethane was obtained from a commercial solvent purification 
tower or distilled from calcium hydride.  Dowex 50W X-8 (H+) resin was washed 
repeatedly with MeOH prior to use.  Powdered 4Å molecular sieves were purchased from 
Aldrich Chemical Company and were activated by heating in a furnace at 250 °C 
overnight prior to use.  All other reagents were used as received without further 
purification.  Reactions were monitored and the Rf values determined using analytical 
TLC with Sorbent Technologies silica gel plates (60F-254).  Developed TLC plates were 
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visualized by immersion in 10% ethanolic sulfuric acid solution, or in acidic p-
anisaldehyde solution, followed by heating on a hot plate.  Moisture-sensitive reactions 
were run in flame- or oven-dried glassware under a nitrogen atmosphere.  Bath 
temperatures were used to record the reaction temperature for reactions performed at 
elevated or sub-ambient temperatures.  All reactions were stirred magnetically at ambient 
temperature unless otherwise indicated.  Manual flash chromatography was performed 
using Sorbent Technologies silica gel (60F-254), and the solvent systems outlined in the 
experimental procedures.  Automated flash chromatography was carried out on a Biotage 
SP-1 chromatography workstation fitted with either a Biotage 12M or 25M silica gel 
cartridge, using ethyl acetate/hexane gradients as outlined in the experimental procedures. 
1H NMR and 13C NMR spectra were obtained with a Bruker DRX400 at 400 MHz and 
101 MHz, respectively.  1H NMR spectra were reported in parts per million ($) relative to 
CDCl3, CD3OD, D2O, or TMS (7.27 ppm, 4.84 ppm, 4.81 ppm, and 0.00 ppm, 
respectively) as internal references.  13C NMR spectra were reported in parts per million 
($) relative to CDCl3 or CD3OD (77.23 ppm or 49.15 ppm, respectively).  For 
13C NMR 
spectra obtained in D2O, chemical shifts are reported relative to acetone as an internal 
standard (215.94 and 30.89 ppm). 
 
Synthetic Procedures 
O
HO
HO
O
O
Ph
OAll
O
BnO
BnO
O
O
Ph
OAll  
   3      4 
Allyl 2,3-di-O-benzyl-4,6-O-benzylidene-!-D-glucopyranoside (4). Allyl 4,6-O-
benzylidene-!-D-glucopyranoside (39) (778 mg, 2.52 mmol), benzyl bromide (0.66 mL, 
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5.5 mmol), and tetrabutylammonium iodide (20 mg) were dissolved in DMF (20 mL).  
To this solution, sodium hydride [60% (w/w) dispersion in mineral oil, 300 mg, 7.57 
mmol] was added portionwise over 15 minutes.  The mixture was stirred at ambient 
temperature for 2.5 hours, then quenched with water (20 mL).  The mixture was extracted 
with dichloromethane (50 mL).  The organic extract was washed with 2N aqueous HCl 
(2%40 mL) and brine (40 mL), and dried over Na2SO4.  The solvent was removed under 
reduced pressure, and the residue purified by flash chromatography on silica gel using 
10% ethyl acetate in hexanes as the eluant.  The product 4 was obtained as a white 
crystalline solid (1.07 g, 2.18 mmol, 87%).  The 1H NMR spectrum was consistent with 
the reported data.8  Full proton assignments are presented here. 
 
Rf: 0.90 (30% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.51-7.25 (m, 15H, Ar-H), 5.99-5.88 (m, 1H, 
OCH2CH=CH2), 5.55 (s, 1H, benzylidene CH), 5.36-5.30 (m, 1H, OCH2CH=CHaHb), 
5.25-5.22 (m, 1H, OCH2CH=CHaHb), 4.92 (d, 1H, J = 11 Hz, PhCH), 4.86-4.82 (m, 2H, 
2%PhCH), 4.80 (d, 1H, J1,2 = 3.6 Hz, H-1), 4.68 (s, 1H, J = 12 Hz,  PhCH) 4.28-4.24 (dd, 
1H, J5,6 = 4.8 Hz,  J6,6’ = 10 Hz, H-6), 4.22-4.16 (m, 1H, OCHaHbCH=CH2), 4.08 (t, 1H, 
J2,3= J3,4 =  9.2 Hz, H-3), 4.08-4.01 (m, 1H, OCHaHbCH=CH2), 3.93-3.85 (m, 1H, H-5), 
3.70 (t, 1H, J5,6 = J6,6’ =  10 Hz, H-6’), 3.61 (t, 1H, J3,4 = J4,5 =  9.6 Hz, H-4), 3.59-3.55 
(dd, 1H, J1,2 = 4 Hz,  J2,3 = 9.2 Hz, H-2). 
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   4      5 
Allyl 2,3-di-O-benzyl-!-D-glucopyranoside (5). Allyl 2,3-di-O-benzyl-4,6-O-
benzylidene-!-D-glucopyranoside (4) (323 mg, 0.66 mmol), was dissolved in 
dichloromethane (4 mL).  To this solution trifluoroacetic acid (60% v/v in water, 1 mL) 
was added, and the mixture stirred at ambient temperature.  After 45 minutes, the mixture 
was diluted with dichloromethane (40 mL), washed with saturated NaHCO3 solution (2 % 
25 mL), and dried over Na2SO4.  The solvent was evaporated under reduced pressure.  
Purification of the residue by flash chromatography on silica gel, using 10% ethyl acetate 
in hexanes as the eluant, provided the product 5 as a syrup (237 mg, 0.59 mmol, 89%).  
The 1H NMR spectrum was in agreement with the reported data.7   Full proton 
assignments are presented here. 
 
Rf: 0.26 (30% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.36-7.26 (m, 10H, Ar-H), 5.99-5.88 (m, 1H, 
OCH2CH=CH2), 5.36-5.29 (m, 1H, OCH2CH=CHaHb), 5.24-5.22 (m, 1H, 
OCH2CH=CHaHb), 5.02 (d, 1H, J = 12 Hz, PhCH), 4.80 (d, 1H, J1,2 = 3.6 Hz, H-1), 4.74-
4.69 (m, 2H,  2%PhCH), 4.62 (d, 1H, J = 12 Hz, PhCH), 4.17-4.12 (m, 1H, 
OCHaHbCH=CH2), 4.02-3.96 (m, 1H, OCHaHbCH=CH2), 3.82 (t, 1H, J2,3= J3,4  = 9.6 Hz, 
H-3), 3.78-3.72 (m, 2H, H-6. H-6’), 3.68-3.64 (m, 1H, H-5), 3.53 (apparent t, 1H, J1,2 = 
J2,3  = 9 Hz, H-2), 3.51-3.47 (dd, 1H, J1,2 = 3.6 Hz,  J2,3  = 9.6 Hz, H-2), 2.65 (br s, 1H, -
OH), 2.16 (br s, 1H, -OH). 
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   4      6 
Allyl-2,3,6-tri-O-benzyl-!-D-glucopyranoside (6).   Allyl 2,3-di-O-benzyl-4,6-O-
benzylidene-!-D-glucopyranoside (4) (449 mg, 0.92 mmol) was dissolved in 
dichloromethane (10 mL).  Powdered activated 4Å molecular sieves (1 g) were added, 
and the mixture cooled to -78 °C.  To this mixture, triethylsilane (0.44 mL, 2.8 mmol) 
and TfOH (0.28 mL, 3.1 mmol) were added.  The mixture was stirred at -78 °C for 70 
minutes, then additional TfOH ( 0.10 mL, 1.1 mmol) was added.  After 60 additional 
minutes at -78 °C, the mixture was poured into a separatory funnel containing saturated 
NaHCO3 solution and dichloromethane.  The organic layer was washed with water and 
brine, dried over Na2SO4, and filtered through Celite.  The solvent was removed under 
reduced pressure.  The residue was purified by flash chromatography on silica gel, using 
a gradient of 10#30% ethyl acetate in hexanes.  First, unreacted starting material (59 
mg, 0.12 mmol, 13%) was eluted, followed by the product 6 as a colorless oil (302 mg, 
0.62 mmol, 67%).  The 1H NMR spectrum was in agreement with the literature data.8   
 
Rf: 0.58 (30% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.37-7.25 (m, 15H, Ar-H), 5.94-5.89 (m, 1H, 
OCH2CH=CH2), 5.36-5.29 (m, 1H, OCH2CH=CHaHb), 5.23-5.19 (m, 1H, 
OCH2CH=CHaHb), 5.00 (d, 1H, J = 11.6 Hz, PhCH), 4.83 (d, 1H, J1,2 = 4.0 Hz, H-1), 
4.74 (d, 2H, 2PhCH) 4.64, 4.59, 4.53 (3 d, each 1H, 3 PhCH),  4.19-4.13 (m, 1H, 
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OCHaHbCH=CH2), 4.04-3.98 (m, 1H, OCHaHbCH=CH2), 3.82 (t, 1H, J2,3 = J3,4 = 9.2 Hz, 
H-3), 3.79-3.74 (m, 1H, H-5), 3.70-3.59 (m, 3H, H-4, H-6, H-6’) 3.56-3.52 (dd, 1H, J2,3 = 
9.6Hz, J1,2 = 3.6 Hz, H-2), 2.40-2.30 (br s, 1H, -OH). 
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 1   7      10 
Allyl 3,4,6-tri-O-benzyl-2-O-(2,3,4,6-tetra-O-acetyl-"-D-glucopyranosyl)-"-D-
glucopyranoside (10).  Allyl 3,4,6-tri-O-benzyl-"-D-glucopyranoside (15) (85 mg, 0.18 
mmol) and 2,3,4,6-tetra-O-acetyl-!-D-glucopyranosyl trichloroacetimidate (711) (175 mg, 
0.35 mmol) were combined in a 25 mL round bottom flask. Toluene (3 x 3 mL) was 
added to the sugars and the solvent was removed under reduced pressure after each 
addition.  The flask was dried under high vacuum (10-4 torr) for 1 h.  The reactants were 
dissolved in dichloromethane (1.5 mL) and cooled to 0 °C.  TMSOTf (60 µL of a 
solution of 100 µL TMSOTf in 1 mL dichloromethane) was added, and the mixture 
stirred at 0 °C.  After 20 minutes, the reaction was quenched by the addition of 
triethylamine (0.1 mL) and the solvent removed under reduced pressure.  The residue was 
subjected to flash chromatography on silica gel (3:7 EtOAc/hexanes) to give the product 
10 as a colorless syrup (131 mg, 0.16 mmol, 92%). 
 
Rf: 0.77 (50% EtOAc/hexanes) 
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1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.37-7.07 (m, 15H, Ar-H), 5.90-5.88 (m, 1H), 5.33 
(m, 1H), 5.20-5.11 (m, 3H), 5.03-4.98 (m, 2H), 4.82-4.76 (m, 3H), 4.63-4.52 (m, 3H), 
4.47-4.42 (m, 2H), 4.24-4.22 (dd, 1H), 4.12-4.06 (m, 2H), 3.74-3.60 (m, 6H), 3.46-3.39 
(m, 1H), 2.08 (s, 3H), 2.01 (s, 3H), 1.98 (s, 3H), 1.78 (s, 3H). 
 13
C NMR (CDCl3, 101 MHz) $ (ppm) 170.9, 170.5, 169.7, 169.5, 138.6, 138.2, 138.0, 
128.6, 128.5, 128.0, 128.0, 127.9, 127.7, 116.9, 101.6, 100.4, 84.3, 81.6, 78.1, 75.8, 75.2, 
74.9, 73.7, 73.5, 72.3, 71.9, 70.2, 68.8, 68.2, 62.1, 21.0, 20.8, 20.6. 
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 1   8      11 
Allyl 3,4,6-tri-O-benzyl-2-O-(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-"-D-
glucopyranoside (11). Allyl 3,4,6-tri-O-benzyl-"-D-glucopyranoside (15) (72 mg, 0.15 
mmol) and 2,3,4,6-tetra-O-acetyl-!-D-galactopyranosyl trichloroacetimidate (812) (139 
mg, 0.28 mmol) were combined in a 25 mL round bottom flask.  Toluene (3 x 3 mL) was 
added to the sugars and the solvent was removed under reduced pressure after each 
addition.  The reactants were dried under high vacuum (10-4 torr) for 1 h.  
Dichloromethane (1.5 mL) was added, and the solution cooled to 0 °C.  TMSOTf (50 µL 
of a solution of 100 µL TMSOTf in 1 mL dichloromethane) was added, and the mixture 
stirred at 0 °C.  After 20 minutes, the reaction was neutralized with triethylamine (0.1 
mL) and the solvent evaporated.  The residue was subjected to flash chromatography on 
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silica gel (3:7 EtOAc/hexanes) to give the product 11 as a pale yellow syrup (113 mg, 
0.14 mmol, 94%). 
 
Rf: 0.81 (50% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.37-7.07 (m, 15H, Ar-H), 6.02-5.92 (m, 1H), 
5.37-5.33 (m, 2H), 5.26-5.19 (m, 2H), 5.01-4.95 (m, 2H), 4.85-4.75 (m, 3H), 4.63-4.43 
(m, 5H), 4.19-4.08 (m, 3H), 3.88 (t, 1H), 3,72-3.63 (m, 5H), 3.57-3.49 (m, 1H), 2.16 (s, 
3H), 2.03 (s, 3H), 1.96 (s, 3H), 1.76 (s, 3H). 
 13
C NMR (CDCl3, 101 MHz) $ (ppm) 170.49, 170.46, 170.4, 170.0, 138.7, 138.2, 138.0, 
134.2, 128.6, 128.4, 128.1, 128.0, 127.9, 127.64, 127.60, 117.0, 101.8, 100.8, 84.3, 82.0, 
78.1, 75.9, 75.2, 74.8, 73.7, 71.6, 70.9, 70.4, 70.0, 68.8, 67.3, 61.5, 20.91, 20.86, 20.80, 
20.7. 
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 1   9      12 
Allyl 3,4,6-tri-O-benzyl-2-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-"-D-
glucopyranoside (12). Allyl 3,4,6-tri-O-benzyl-"-D-glucopyranoside (15) (77 mg, 0.16 
mmol) and 2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl trichloroacetimidate (911) (147 
mg, 0.30 mmol) were combined in a 25 mL round-bottom flask. Toluene (3 x 3 mL) was 
added to the sugars and the solvent was removed under reduced pressure after each 
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addition.  The flask was dried under high vacuum (10-4 torr) for 1 h.  Dichloromethane 
(1.5 mL) was added, and the solution cooled to 0 °C.  TMSOTf (50 µL of a solution of 
100 µL TMSOTf in 1 mL dichloromethane) was added, and the mixture stirred at 0 °C.  
After 20 minutes, the reaction was quenched with triethylamine (0.1 mL) and the solvent 
removed under reduced pressure.  Flash chromatography on silica gel (3:7 
EtOAc/hexanes) gave the product 12 as a pale yellow syrup (126 mg, 0.15 mmol, 98%). 
 
Rf: 0.76 (50% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.35-7.09 (m, 15H), 5.92-5.84 (m, 1H), 5.46 (s, 
1H), 5.29-5.16 (m, 5H), 5.0-4.52 (m, 6H), 4.42 (d, 1H), 4.37-4.32 (m, 1H), 4.16-4.06, (m, 
2H), 3.83-3.58 (m, 7H), 3.47-3.42 (m, 1H), 2.14 (s, 3H), 2.04 (s, 3H), 1.99 (s, 3H), 1.84 
(s, 3H). 
 13C NMR (CDCl3, 101 MHz) $ (ppm) 170.9, 170.2, 170.1, 169.7, 138.3, 138.1, 137.9, 
133.8, 128.61, 128.58, 128.5, 128.12, 128.07, 127.9, 127.7, 127.0, 118.1, 102.2, 96.9, 
83.2, 78.6, 76.2, 75.6, 75.2, 75.1, 73.7, 70.5, 69.5, 68.6, 68.3, 65.6, 61.9, 21.1, 20.95 (2), 
20.8. 
 
O
PivO
HO
OAll
O
AcO
AcO
AcO
AcO
O CCl3
NH
+ O
AcO
AcO
AcO
AcO
O
O
Ph
O
PivO
O
OAll
O
O
Ph
 
 2   7      13 
Allyl 4,6-O-benzylidene-2-O-pivaloyl-3-O-(2,3,4,6-tetra-O-acetyl-"-D-
glucopyranosyl)-!-D-glucopyranoside (13). Allyl 4,6-O-benzylidene-2-O-pivaloyl-!-
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D-glucopyranoside (26) (50mg, 0.13 mmol)  and 2,3,4,6-tetra-O-acetyl-!-D-
glucopyranosyl trichloroacetimidate (711) (82 mg, 0.17 mmol) were combined in a 25 mL 
round-bottom flask.  Toluene (3 x 3 mL) was added to the sugars and the solvent was 
removed under reduced pressure after each addition.  The reactants were dried under high 
vacuum (10-4 torr) for 1 h.  The reactants were dissolved in dichloromethane (3 mL) and 
cooled to -15 °C.  TMSOTf (20µL) was added, and the mixture stirred at -15 °C.  After 
30 min, the reaction was quenched by the addition of triethylamine (0.1 mL) and the 
solvent removed under reduced pressure.  The residue was purified by flash 
chromatography on silica gel (20#50% ethyl acetate in hexanes) to give the disaccharide 
product 13 as a syrup (53 mg, 0.073 mmol, 58%). 
 
Rf: 0.75 (50% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.50-7.32 (m, 5H), 5.91-5.81 (m, 1H), 5.57 (s, 
1H), 5.32-5.27 (m, 1H), 5.24-5.20 (m, 1H), 5.11-5.01 (m, 4H), 4.83 (dd, 1H), 4.76 (d, 
1H), 4.32-4.20 (m, 3H), 4.19-4.14 (m, 1H), 4.09-4.05 (dd, 1H), 3.96-3.87 (m, 2H), 3.77 
(dd as t, 1H), 3.67 (dd as t, 1H), 3.62-3.57 (m, 1H), 2.00 (s, 3H), 1.99 (s, 3H), 1.98 (s, 
3H), 1.97 (s, 3H), 1.28 (s, 9H). 
 
 13
C NMR (CDCl3, 101 MHz) $ (ppm) 177.8, 171.0, 170.5, 169.5, 169.4, 137.5, 133.3, 
129.1, 128.3, 126.2, 118.8, 101.2, 100.4, 95.5, 79.0, 75.7, 73.5, 73.1, 71.8, 71.3, 69.2, 
68.9, 68.5, 62.7, 62.3, 39.0, 27.4, 20.9, 20.8 (3). 
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 2   8      14 
Allyl 4,6-O-benzylidene-2-O-pivaloyl-3-O-(2,3,4,6-tetra-O-acetyl-"-D-
galactopyranosyl)-!-D-glucopyranoside (14). Allyl 4,6-O-benzylidene-2-O-pivaloyl-
!-D-glucopyranoside (26) (55 mg, 0.14 mmol) and 2,3,4,6-tetra-O-acetyl-!-D-
galactopyranosyl trichloroacetimidate (812) (105 mg, 0.21 mmol) were combined in a 25 
mL round-bottom flask. Toluene (3 x 3 mL) was added to the sugars and the solvent was 
removed under reduced pressure after each addition.  The flask was dried under high 
vacuum (10-4 torr) for 1 h.  The reactants were dissolved in dichloromethane (2 mL) and 
cooled to -15 °C.  TMSOTf (15 µL) was added, and the mixture stirred at -15 °C.  After 
30 minutes, the reaction was quenched with triethylamine (0.1 mL) and the solvent 
removed under reduced pressure.  The residue was purified by flash chromatography on 
silica gel (15#35% ethyl acetate in hexanes) to give the 14 as a syrup (60 mg, 0.083 
mmol, 60%). 
 
Rf: 0.74 (50% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.52-7.32 (m, 5H), 5.90-5.82 (m, 1H), 5.58 (s, 
1H), 5.35-5.20 (m, 4H), 5.04 (d, 1H), 4.92 (dd, 1H), 4.83 (dd, 1H), 4.73 (d, 1H), 4.32-
4.23 (m, 2H), 4.18-4.09 (m, 3H), 3.96-3.74 (m, 4H), 3.67 (dd as t, 1H), 2.12 (s, 3H), 2.00 
(s, 3H), 1.98 (s, 3H), 1.97 (s, 3H), 1.27 (s, 9H). 
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 13
C NMR (CDCl3, 101 MHz) $ (ppm) 177.8, 170.6, 170.5, 170.4, 169.6, 137.5, 133.3, 
129.1, 128.3, 126.2, 118.7, 101.0, 100.9, 95.5, 79.0, 75.7, 73.5, 71.2, 70.6, 69.2, 69.1, 
68.9, 67.1, 62.7, 61.3, 39.0, 27.4, 21.0, 20.9 (2), 20.8. 
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 2    9     15 
Allyl 4,6-O-benzylidene-2-O-pivaloyl-3-O-(2,3,4,6-tetra-O-acetyl-!-D-
mannopyranosyl)-!-D-glucopyranoside (15). Allyl 4,6-O-benzylidene-2-O-pivaloyl-!-
D-glucopyranoside (26 ) (50 mg, 0.13 mmol)  and 2,3,4,6-tetra-O-acetyl-!-D-
mannopyranosyl trichloroacetimidate (911) (125 mg, 0.26 mmol) were combined in a 25 
mL round-bottom flask.  Toluene (3 x 3 mL) was added to the sugars and the solvent was 
removed under reduced pressure after each addition.  The flask was dried under high 
vacuum (10-4 torr) for 1 h.  The mixture was dissolved in dichloromethane (2 mL) and 
cooled to -15 °C.  TMSOTf (15 µL) was added, and the mixture stirred at -15 °C.  After 
30 minutes, the reaction was quenched with triethylamine (0.1 mL).  The solvent was 
removed under reduced pressure, and the residue purified by flash chromatography on 
silica gel (15#35% ethyl acetate in hexanes) to give provide 15 as a syrup (57 mg, 0.079 
mmol, 62%). 
 
Rf: 0.73 (50% EtOAc/hexanes) 
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1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.41-7.30 (m, 5H), 5.88-5.79 (m, 1H), 5.56 (s, 
1H), 5.44 (d, 1H), 5.33-5.30 (m, 2H), 5.27-5.25 (m, 2H), 5.23-5.19 (m, 1H), 5.14 (d, 1H), 
4.80 (dd, 1H), 4.39 (dd as t, 1H), 4.31-4.15 (m, 4H), 4.07 (dd, 1H), 3.96-3.88 (m, 2H), 
3.80-3.74 (m, 2H), 2.10 (s, 3H), 2.05 (s, 3H), 1.99 (s, 3H), 1.94 (s, 3H), 1.24 (s, 9H).   
 13
C NMR (CDCl3, 101 MHz) $ (ppm) 178.0, 170.9, 170.0, 169.9, 169.7, 136.9, 133.4, 
129.2, 128.3, 126.3, 118.4, 101.5, 97.4, 95.5, 82.6, 72.3, 71.6, 69.4, 69.1, 69.0, 68.9, 68.6, 
66.1, 62.3, 62.2, 38.9, 27.3, 21.0 (2), 20.9, 20.8. 
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  16        17 
Propyl 2,3,6-tri-O-acetyl-4-O-(2,3,4,6-tetra-O-acetyl-"-D-glucopyranosyl)-  
"-D-glucopyranoside (17).   The glycosyl donor 2,3,6-tri-O-acetyl-4-O-(2,3,4,6-tetra-O-
acetyl-"-D-glucopyranosyl)-!-D-glucopyranosyl trichloroacetimidate (1613) (156 mg, 
0.20 mmol) was placed in a 25 mL round-bottom flask.  Toluene (3 x 3 mL) was added 
and the solvent was removed under reduced pressure after each addition.  The flask was 
dried under high vacuum (10-4 torr) for 1 h.  The donor was dissolved in dichloromethane 
(3 mL) and cooled to 0 °C.  To this solution, n-propanol (44 µL, 0.60 mmol) was added, 
followed by TMSOTf (11 µL, 0.06 mmol).  The reaction was stirred at 0 °C for 15 
minutes, then quenched by the addition of triethylamine (0.2 mL).  The solvents were 
removed under reduced pressure.  The residue was purified by flash column 
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chromatography on silica gel (20#60% ethyl acetate in hexanes) to afford propyl 
glycoside 17 as a white solid (72 mg, 0.11 mmol, 53%). 
 
Rf: 0.79 (70% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 5.18-5.03 (m, 3H), 4.94-4.87 (m, 2H), 4.52 (m, 
2H), 4.44 (d, 1H), 4.36 (dd, 1H), 4.11-4.02 (m, 2H), 3.82-3.74 (m, 2H), 3.67-3.64 (m, 
1H), 3.61-3.56 (m, 1H) 3.54-3.47 (m, 1H), 2.12 (s, 3H), 2.08 (s, 3H), 2.02 (s, 6H), 2.01 
(s, 3H), 2.00 (s, 3H), 1.98 (s, 3H), 1.62-1.54 (m, 2H), 0.88 (t, 3H). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 170.6, 170.5, 170.4, 170.0, 169.8, 169.5, 169.2, 
100.9, 100.8, 76.7, 73.1, 72.8, 72.7, 72.1, 72.0, 71.8, 68.0, 62.1, 61.7, 22.8, 21.0, 20.8, 
20.7, 10.4. 
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Propyl 2,3,6-tri-O-acetyl-4-O-(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-  
"-D-glucopyranoside (19). The glycosyl donor 2,3,6-tri-O-acetyl-4-O-(2,3,4,6-tetra-O-
acetyl-"-D-glalactopyranosyl)-!-D-glucopyranosyl trichloroacetimidate (1814) (153 mg, 
0.19 mmol) was placed in a 25 mL round-bottom flask.  Toluene (3 x 3 mL) was added 
and the solvent was removed under reduced pressure after each addition.  The flask was 
dried under high vacuum (10-4 torr) for 1 h.  The donor was dissolved in dichloromethane 
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(3 mL).  The solution was cooled to 0 °C.  To this solution, n-propanol (43 µL, 0.58 
mmol) was added, followed by TMSOTf (10 µL, 0.06 mmol).  The reaction was stirred at 
0 °C for 20 minutes, then quenched by the addition of triethylamine (0.2 mL).  The 
solvents were removed under vacuum, and the residue purified by flash column 
chromatography on silica gel (40#50% ethyl acetate in hexanes) to afford propyl 
glycoside 19 as a colorless syrup (30 mg, 0.040 mmol, 23%). 
 
Rf: 0.80 (70% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 5.35 (d, 1H), 5.20 (t, 1H), 5.13-5.08 (dd, 1H), 
4.97-4.94 (dd, 1H), 4.89 t, 1H), 4.49-4.45 (m, 3H), 4.16-4.05 (m, 3H), 3.87 (t, 1H), 3.83-
3.77 (m, 2H), 3.62-3.58 (m, 1H), 3.45-3.38 (m, 1H), 2.16 (s, 3H), 2.12 (s, 3H), 2.06 (s, 
3H), 2.05 (s, 6H), 2.04 (s, 3H), 1.97 (s, 3H), 1.61-1.55 (m, 2H), 0.89 (t, 3H). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 170.6 (2), 170.4, 170.3, 170.0, 169.8, 169.3, 
101.3, 100.8, 76.5, 73.0, 72.7, 72.0, 71.9, 71.2, 70.8, 69.3, 66.8, 62.2, 61.0, 22.9, 21.1, 
21.0, 20.9, 20.8, 20.7, 10.5. 
 
O
OAc
AcO
AcO
AcO
O CCl3
NH
+
O
BnO
BnO
OBn
HO
OAll
O
BnO
BnO
OBn
O
OAll
O
OAc
AcO
AcO
AcO
 
 6   9      20 
Allyl 2,3,6-tri-O-benzyl-4-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-!-D-
glucopyranoside (20).  A solution of allyl-2,3,6-tri-O-benzyl-!-D-glucopyranoside (68) 
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(105 mg, 0.21 mmol) in dichloromethane (3 mL) was added to 2,3,4,6-tetra-O-acetyl-!-
D-mannopyranosyl trichloroacetimidate (911) (211 mg, 0.43 mmol).  The solution was 
cooled to 0 °C.  TMSOTf (11 µL, 0.064 mmol) was added.  The reaction mixture was 
stirred at 0 °C for 30 minutes, then quenched by the addition of triethylamine (0.1 mL).  
The solvent was removed under reduced pressure.  The residue was subjected to 
purification using a Biotage SP-1 flash chromatography system fitted with a Biotage 12M 
cartridge.  Gradient elution from 6%-60% EtOAc/hexanes over 12 column volumes gave 
the desired product (Rf = 0.59, 1:1 EtOAc/hexanes) along with a small amount of an 
impurity of slightly lower Rf..  Fractions containing the desired product were 
concentrated and subjected to careful flash chromatography on silica gel using 30% 
EtOAc/hexanes as eluant to give 20 as a colorless syrup (107 mg, 0.013 mmol, 61%). 
 
Rf: 0.59 (50% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.35-7.20 (m, 15H), 6.00-5.90 (m, 1H), 5.41-5.18 
(m, 6H), 5.05 (d, 1H, J = 11.2 Hz), 4.80 (d, 1H, J = 3.2 Hz), 4.70-4.52 (m, 5H), 4.21-4.11 
(m, 2H), 4.03-3.63 (m, 8H), 3.56-3.52 (dd, 1H), 2.02 (2s, 2%3H), 1.95 (s, 3H), 1.94 (s, 
3H). 
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 5   7      21 
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Allyl 2,3-di-O-benzyl-6-O-(2,3,4,6-tetra-O-acetyl-"-D-glucopyranosyl)-!-D-
glucopyranoside (21).  A mixture of allyl 2,3-di-O-benzyl-!-D-glucopyranoside (57) (98 
mg, 0.24 mmol) and 2,3,4,6-tetra-O-acetyl-!-D-glucopyranosyl trichloroacetimidate (711) 
(65 mg, 0.13 mmol) was placed in a 25 mL round-bottom flask.  Toluene (3 x 3 mL) was 
added to the sugars and the solvent was removed under reduced pressure after each 
addition.  The flask was dried under high vacuum (10-4 torr) for 1 h.   The mixture was 
dissolved in dichloromethane (2 mL), and the solution was cooled to 0 °C.  TMSOTf (13 
µL, 0.07 mmol) was added.  The reaction mixture was stirred at 0 °C for 15 minutes, then 
quenched by the addition of triethylamine (0.1 mL).  The solvent was removed under 
reduced pressure.  The residue was purified using a Biotage SP-1 flash chromatography 
system (Biotage 12M cartridge, gradient elution from 30#50% ethyl acetate in hexanes, 
to furnish the product 21 as a syrup (27 mg, 37 µmol, 28% based on donor).  The 
remaining unconsumed 5 was also recovered. 
 
Rf: 0.40 (50% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.36-7.28 (m, 10H), 5.94-5.87 (m, 1H), 5.36-5.31 
(m, 1H), 5.25-5.16 (m, 2H), 5.10-4.99 (m, 3H), 4.80 (d, 1H, J = 3.2 Hz), 4.73-4.70 (m, 
2H), 4.65-4.62 (d, 1H), 4.59 (d, 1H, J = 8.0 Hz), 4.26-4.22 (dd, 1H), 4.17-4.11 (m, 2H), 
4.05-3.95 (m, 2H), 3.79 (t, 1H), 3.74-3.66 (m, 3H), 3.52-3.42 (m, 2H), 2.30 (br d, J = 2.4 
Hz, -OH), 2.06 (s, 3H), 2.02 (s, 3H), 2.00 (2s, each 3H). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 171.0, 170.5, 169.6, 169.5, 139.0, 138.2, 133.8, 
128.8, 128.7, 128.3, 128.1(2), 128.0, 118.7, 101.2, 95.6, 81.4, 79.7, 75.5, 73.1, 72.8, 72.0, 
71.3, 70.4, 70.0, 68.6, 68.5, 68.2,  62.0, 20.9, 20.8(3).   
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Allyl 2,3-di-O-benzyl-6-O-(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-!-D-
glucopyranoside (22).  A mixture of allyl 2,3-di-O-benzyl-!-D-glucopyranoside (57) (85 
mg, 0.21 mmol) and 2,3,4,6-tetra-O-acetyl-!-D-galactopyranosyl trichloroacetimidate 
(812) (50 mg, 0.10 mmol) was placed in a 25 mL round-bottom flask.  Toluene (3 x 3 mL) 
was added to the sugars and the solvent was removed under reduced pressure after each 
addition.  The flask was dried under high vacuum (10-4 torr) for 1 h.  The mixture was 
dissolved in dichloromethane (2 mL), and the solution was cooled to 0 °C.  TMSOTf (12 
µL, 0.06 mmol) was added.  The reaction mixture was stirred at 0 °C for 15 minutes, then 
quenched by the addition of triethylamine (0.1 mL).  The solvent was removed under 
reduced pressure.  The residue was purified by flash chromatography on silica gel, using 
40#50% ethyl acetate in hexanes as eluant, to furnish the product 22 as a syrup (23 mg, 
31 µmol, 30% based on donor).  The remaining unconsumed acceptor 5 (45 mg, 0.11 
mmol) was also recovered. 
 
Rf: 0.61 (50% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.36-7.28 (m, 10H), 5.94-5.88 (m, 1H), 5.38-5.32 
(m, 2H), 5.26-5.21 (m, 2H), 5.05-4.99 (m, 2H), 4.81 (d, 1H, J = 3.6 Hz, H-1I), 4.75-4.71 
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(m, 2H), 4.64 (d, 1H, J = 12 Hz), 4.54 (d, 1H, J = 8.0 Hz, H-1II), 4.10-4.03 (m, 4H), 4.01-
3.96 (m, 1H), 3.90 (t, 1H), 3.80 (t, 1H), 3.78-3.71 (m, 2H), 3.53-3.44 (m, 2H), 2.27 (br d, 
1H, J = 1.2 Hz, -OH), 2.14 (s, 3H), 2.03 (s, 3H), 2.02 (s, 3H), 1.99 (s, 3H). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 170.5, 170.3, 170.2, 169.4, 138.9, 138.0, 133.7, 
128.6, 128.5, 128.1, 128.0, 127.9(2), 118.4, 101.5, 95.4, 81.3, 79.6, 75.3, 73.0, 71.0, 70.8, 
70.2, 70.0, 68.8, 68.6, 68.1, 67.0, 61.3, 20.8, 20.7(2), 20.6. 
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 5   9      23 
Allyl 2,3-di-O-benzyl-6-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-!-D-
glucopyranoside (23).  A mixture of allyl 2,3-di-O-benzyl-!-D-glucopyranoside (57) (86 
mg, 0.21 mmol) and 2,3,4,6-tetra-O-acetyl-!-D-mannoopyranosyl trichloroacetimidate 
(911) (106 mg, 0.21 mmol) was placed in a 25 mL round-bottom flask.  Toluene (3 x 3 
mL) was added to the sugars and the solvent was removed under reduced pressure after 
each addition.  The flask was dried under high vacuum (10-4 torr) for 1 h.  The mixture 
was dissolved in dichloromethane (2 mL), and the solution cooled to 0 °C.  TMSOTf (40 
µL of a 10% (v/v) solution in dichloromethane) was added.  The reaction mixture was 
stirred at 0 °C for 15 minutes, then quenched by the addition of triethylamine (0.1 mL).  
The solvent was removed under reduced pressure.  Purification of the residue by flash 
chromatography on silica gel, using 40% ethyl acetate in hexanes as eluant, furnished the 
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6-O-glycosylated product 23 as a syrup (40 mg, 55 µmol, 26%).  The unconsumed 
acceptor 5 was also recovered. 
 
Rf: 0.60 (50% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.39-7.28 (m, 10H), 6.00-5.89 (m, 1H), 5.38-5.23 
(m, 5H), 5.05 (d, 1H, J = 11.6 Hz), 4.86 (d, 1H, J = 3.6 Hz, H-1I), 4.84 (2, 1H, J = 0.8 
Hz, H-1II), 4.76-4.66 (m, 3H), 4.25-4.12 (m, 3H), 4.09-4.00 (m, 2H), 3.92-3.88 (dd, 1H), 
3.83-3.76 (m, 2H), 3.69-3.66 (dd, 1H), 3.60-3.57 (dd, 1H), 3.52 (t, 1H), 2.34 (br s, 1H, -
OH), 2.15 (s, 3H), 2.06 (s, 3H), 2.05 (s, 3H), 1.99 (s, 3H). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 171.0, 170.1, 170.0, 169.9, 138.8, 138.2, 133.8, 
128.9, 128.7, 128.3(2), 128.2(2), 118.7, 97.6, 95.6, 81.6, 80.1, 75.7, 73.1, 70.1, 69.7(2), 
69.2, 68.5, 66.5, 66.4, 62.7, 21.1, 20.9(3).   
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Propyl 2-O-("-D-glucopyranosyl)-"-D-glucopyranoside (24). Allyl 3,4,6-tri-O-benzyl-
2-O-(2,3,4,6-tetra-O-acetyl-"-D-glucopyranosyl)-"-D-glucopyranose (10) (47 mg, 57 
µmol) was dissolved in EtOH (2 mL).  To this solution, 10% palladium on carbon (5 mg) 
was added.  The mixture was stirred at ambient temperature under an atmosphere of 
hydrogen for 2 days, and filtered on Celite.  The solvent was evaporated under reduced 
pressure.  The residue was dissolved in MeOH (2 mL).  Sodium metal (~5 mg) was 
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added.  The mixture was allowed to stir overnight at ambient temperature.  The solution 
was neutralized with Dowex 50W X-8 (H+) resin and filtered.  The solvent was removed 
under reduced pressure to give 24 as a white solid (21 mg, 55 µmol, 95%). 
 
Rf: 0.22 (1:2:7 H2O/MeOH/EtOAc) 
1
H NMR (CD3OD, 400 MHz) $ (ppm) 4.60 (d, 1H, J = 7.6 Hz, H-1
II), 4.40 (d, 1H, J = 
7.6 Hz, H-1I), 3.88-3.80 (m, 3H), 3.68-3.63 (m, 2H), 3.58-3.52 (m, 2H), 3.45-3.30 (m, 
3H), 3.28-3.19 (m, 4H), 1.66-1.60 (m, 2H), 0.95 (t, 3H). 
13
C NMR (CD3OD, 101 MHz) $ (ppm) 105.1, 103.1, 83.0, 78.4, 78.0, 77.9, 77.8, 76.1, 
72.7, 71.6, 62.8, 24.1, 11.0. 
 
O
O
BnO
BnO
BnO
OAll
O
AcO
AcO
OAc
AcO
O
O
AcO
AcO
AcO
OPr
O
AcO
AcO
OAc
AcO
 
   11      25 
Propyl 3,4,6-tri-O-acetyl-2-O-(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-"-D-
glucopyranoside (25).   Allyl 3,4,6-tri-O-benzyl-2-O-(2,3,4,6-tetra-O-acetyl-"-D-
galactopyranosyl)-"-D-glucopyranoside (11) (22 mg, 0.027 mmol) was dissolved in 
MeOH (2 mL). To this solution, 10% palladium on carbon (10 mg) was added.  The 
mixture was stirred at ambient temperature under an atmosphere of hydrogen for 5.5 h.  
The palladium catalyst was removed by filtration on Celite.  The solvent was evaporated 
under reduced pressure.  The residue was dissolved in MeOH (2 mL).  Sodium metal (~5 
mg) was added.  The mixture was stirred overnight at ambient temperature.  The solution 
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was neutralized with Dowex 50W X-8 (H+) resin and filtered.  The solvent was removed 
under reduced pressure.  As proton NMR showed the presence of small amount of 
impurities at this stage, the crude product was dissolved in pyridine (0.5 mL) and acetic 
anhydride (0.5 mL).  4-dimethylaminopyridine (1 mg) was added, and the mixture stirred 
for 12 hours at ambient temperature.  The solvent was removed under reduced pressure, 
and the residue dissolved in dichloromethane (10 mL).  The organic solution was washed 
with water and brine, and dried over Na2SO4.  The solvent was removed under reduced 
pressure, and the residue subjected to flash chromatography on silica gel (1:1 
EtOAc/hexane) to give the peracetylated product 25 as a colorless syrup (14 mg, 0.021 
mmol, 77% over 3 steps). 
 
Rf: 0.35 (50% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 5.35 (d, 1H), 5.21-5.12 (m, 2H), 5.00-4.93 (m, 
2H), 4.76 (d, 1H, J = 8.0 Hz, H-1II), 4.46 (d, 1H, J = 7.6 Hz, H-1I), 4.29-4.25 (dd, 1H), 
4.14-4.08 (m, 3H), 3.89-3.84 (m, 2H), 3.73-3.64 (m, 2H), 3.55-3.51 (m, 1H), 2.14 (s, 
3H), 2.08 (s, 3H), 2.07 (s, 3H), 2.06 (s, 3H), 2.05 (s, 3H), 2.00 (s, 3H), 1.98 (s, 3H), 1.68-
1.60 (m, 2H), 0.98 (t, 3H). 
 13C NMR (CDCl3, 101 MHz) $ (ppm) 170.9, 170.6, 170.5, 170.4, 170.2, 170.0, 169.7, 
102.0, 101.0, 78.1, 74.3, 72.1, 71.6, 71.3, 70.9, 69.6, 68.9, 67.1, 62.3, 61.4, 23.2, 21.0, 
20.95, 20.90 (2), 20.84, 20.83, 20.79, 10.7. 
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Propyl 2-O-("-D-galactopyranosyl)-"-D-glucopyranoside (26). Propyl 3,4,6-tri-O-
acetyl-2-O-(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-"-D-glucopyranoside (25) 
(12.0 mg, 18 µmol) was dissolved in MeOH (1 mL).  Sodium metal (5 mg) was added 
and the mixture stirred at ambient temperature for 2 hours.  The mixture was neutralized 
with Dowex 50W X-8 (H+) resin and filtered.  The filtrate was concentrated to give the 
disaccharide 26 as a white solid (6.5 mg, 0.017 µmol, 96%). 
 
Rf: 0.24 (1:2:7 H2O/MeOH/EtOAc) 
1
H NMR (D2O, 400 MHz) $ (ppm) 4.71 (d, 1H, J = 7.6 Hz, H-1
II), 4.56 (d, 1H, J = 7.6 
Hz, H-1I), 3.91-3.32 (m, 14H), 1.62 (m, 2H), 0.90 (t, 3H). 
13
C NMR (D2O, 101 MHz) $ (ppm) 103.9, 101.5, 81.1, 76.6, 76.4, 75.9, 73.2, 72.8, 72.2, 
70.1, 69.2, 61.5, 61.3, 22.9, 10.3. 
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Propyl 3,4,6-tri-O-acetyl-2-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-"-D-
glucopyranoside (27).   Allyl 3,4,6-tri-O-benzyl-2-O-(2,3,4,6-tetra-O-acetyl-!-D-
mannopyranosyl)-"-D-glucopyranoside (12) (23.5 mg, 0.0286 mmol) was dissolved in 
MeOH (3 mL).  10% palladium on carbon (10 mg) was added.  The mixture was stirred 
at ambient temperature under an atmosphere of hydrogen for 19 h, then filtered on Celite.  
The solvent was evaporated under reduced pressure.  The residue was dissolved in 
pyridine (0.5 mL) and acetic anhydride (0.5 mL).  The mixture was stirred for 18 h at 
ambient temperature.  The solvent was removed under reduced pressure, then dissolved 
in dichloromethane.  The organic solution was washed successively with water, NaHCO3 
solution, and brine, then dried over Na2SO4.  The solvent was removed under reduced 
pressure, and the residue subjected to flash chromatography on silica gel (1:1 
EtOAc/hexane) to give the peracetylated product 27 as a colorless syrup (11.4 mg, 0.0168 
mmol, 58% over 2 steps). 
 
Rf: 0.33 (50% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 5.30-5.15 (m, 5H), 5.00 (t, 1H), 4.47 (d, 1H, J = 
7.6 Hz, H-1I), 4.31-4.24 (m, 2H), 4.14-4.08 (dd, 2H), 3.98-3.94 (m, 1H), 3.87-3.81 (m, 
1H), 3.73-3.65 (m, 2H), 3.53-3.45 (m, 1H), 2,14, (s, 3H), 2.13 (s, 3H), 2.08 (s, 3H), 2.06 
(s, 3H), 2.03 (s, 6H), 1.98 (s, 3H), 1.64-1.55 (m, 2H), 0.87 (t, 3H). 
13
C NMR (CDCl3, 101 MHz) $ (ppm)  170.88 (2), 170.0 (2), 169.97, 169.91, 169.8, 
103.0, 97.6, 75.7, 73.3, 72.3, 71.8, 69.3, 69.2, 69.1, 69.0, 65.9, 62.4, 62.2, 22.9, 21.0(3), 
20.9(4), 10.6. 
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Propyl 2-O-(!-D-mannopyranosyl)-"-D-glucopyranose (28). Propyl 3,4,6-tri-O-
acetyl-2-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-"-D-glucopyranose (27) (10.5 
mg, 0.015 mmol) was dissolved in MeOH (1mL). Sodium metal (5 mg) was added and 
the mixture stirred at ambient temperature for 12 hours.  The mixture was neutralized 
with Dowex 50W X-8 (H+) resin and filtered.  The filtrate was concentrated to give 28 as 
a white solid (6.0 mg, 0.015 mmol, 99%). 
 
Rf: 0.30 (1:2:7 H2O/MeOH/EtOAc) 
1
H NMR (D2O, 400 MHz) $ (ppm) 5.28 (s, 1H, H-1
II), 4.57 (d, 1H, J = 8.0 Hz, H-1I), 
3.99-3.40 (m, 14H), 1.64 (m, 2H), 0.93 (t, 3H). 
13
C NMR (D2O, 101 MHz) $ (ppm) 103.3, 100.4, 78.3, 76.5, 75.1, 73.4, 73.1, 71.1, 70.8, 
70.5, 67.2, 61.5 (2), 23.0, 10.6. 
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Propyl 3-O-("-D-glucopyranosyl)-!-D-glucopyranose (29). Allyl 4,6-O-benzylidene-
2-O-pivaloyl-3-O-(2,3,4,6-tetra-O-acetyl-"-D-glucopyranosyl)-!-D-glucopyranoside 
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(13) (25 mg, 35 µmol) was dissolved in dichloromethane (1 mL).  To this solution, 60% 
aqueous TFA (0.2 mL) was added.  The mixture was stirred at ambient temperature for 
20 minutes, then diluted with dichloromethane (10 mL) and washed with NaHCO3 
solution, water, and brine.  The organic layer was dried over Na2SO4 and concentrated 
under reduced pressure.  The residue was then dissolved in MeOH (2 mL).  Palladium 
(10 wt.% on activated carbon, 10 mg) was added to the solution.  The mixture was placed 
under an atmosphere of hydrogen and stirred overnight at ambient temperature.  The 
mixture was filtered and the solvent removed under reduced pressure.  The residue was 
then dissolved in MeOH (2 mL).  Sodium metal (5 mg) was added to the solution.  The 
mixture was stirred for 24 hours at ambient temperature.  The mixture was neutralized 
with Dowex 50W X-8 (H+) resin and filtered.  The filtrate was concentrated under 
reduced pressure to give the product 29 as a white solid (12 mg, 31 µmol, 90%). 
 
 Rf: 0.83 (19:1 MeOH/H2O) 
1
H NMR (CD3OD, 400 MHz) $ (ppm) 4.80 (d, 1H, J = 3.6 Hz, H-1
I), 4.51 (d, 1H, J = 
7.6 Hz, H-1II), 3.87 (dd, 1H), 3.82-3.75 (m, 2H), 3.71-3.57 (m, 5H), 3.45-3.33 (m, 4H), 
3.29-3.24 (m, 2H), 1.69-1.63 (m, 2H), 0.96 (t, 3H). 
13
C NMR (CD3OD, 101 MHz) $ (ppm) 105.3, 99.9, 85.8, 78.3, 78.0, 75.6, 73.6, 72.9, 
71.7, 70.9, 70.3, 62.7, 23.9, 11.2. 
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   14      30 
Propyl 3-O-("-D-galactopyranosyl)-!-D-galactopyranose (30). Allyl 4,6-O-
benzylidene-2-O-pivaloyl-3-O-(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-!-D-
glucopyranoside (14) (27 mg, 37 µmol) was dissolved in dichloromethane (1 mL).  To 
this solution, 60% aqueous TFA (0.2 mL) was added.  After stirring at ambient 
temperature for 30 minutes, the solution was diluted with dichloromethane (10 mL) and 
washed with NaHCO3 solution, water, and brine.  The organic layer was dried over 
Na2SO4 and concentrated under reduced pressure to give the debenzylidenated product 
(21 mg, 33 µmol, 89%).  A portion of the 4,6-diol (11 mg, 17 µmol) was dissolved in 
EtOH (1 mL).  Palladium (10 wt.% on activated carbon, 5 mg) was added to the solution.  
The mixture was stirred overnight at ambient temperature under an atmosphere of 
hydrogen, and filtered.  The solvent was removed under reduced pressure.  The residue 
was then dissolved in MeOH (0.7 mL).  Sodium metal (11 mg) was added to the solution.  
The mixture was stirred for 48 hours at ambient temperature.  The mixture was 
neutralized with Dowex 50W X-8 (H+) resin and filtered.  The filtrate was concentrated 
under reduced pressure to yield the deprotected disaccharide 30 as a white solid (6.4 mg, 
17 µmol, 96%). 
 
Rf: 0.80 (19:1 MeOH/H2O) 
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1
H NMR (CD3OD, 400 MHz) $ (ppm) 4.80 (d, 1H, J = 3.6Hz, H-1
I), 4.47 (d, 1H, J = 7.6 
Hz, H-1II), 3.82-3.39 (m, 14H), 1.70-1.61 (m, 2H), 0.97 (t, 3H). 
13
C NMR (CD3OD, 101 MHz) $ (ppm) 105.8, 100.0, 85.7, 77.2, 74.9, 73.6, 73.2, 72.9, 
70.8, 70.4, 70.3, 62.7, 23.9, 11.2. 
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   15      31 
Propyl 3-O-(!-D-mannopyranosyl)-!-D-glucopyranose (31). Allyl 4,6-O-
benzylidene-2-O-pivaloyl-3-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-!-D-
glucopyranoside (15) (28 mg, 39 µmol) was dissolved in dichloromethane (1 mL).  A 
solution of TFA (0.2 mL, 60% (v/v) in water) was added.  After stirring at ambient 
temperature for 40 minutes, the solution was diluted with dichloromethane (10 mL) and 
washed with NaHCO3 solution, water, and brine.  The organic layer was dried over 
Na2SO4 and concentrated under reduced pressure.  The residue was dissolved in MeOH 
(1 mL).  Palladium (10 wt.% on activated carbon, 10 mg) was added to the solution, and 
the mixture stirred overnight at ambient temperature under an atmosphere of hydrogen.  
The reaction mixture was filtered on Celite, and the solvent removed under reduced 
pressure.  The residue was then dissolved in MeOH (1 mL), and sodium metal (5 mg) 
added.  The mixture was stirred for 4 days at ambient temperature.  The mixture was 
neutralized with Amberlyst 15 (H+) resin and filtered.  The filtrate was concentrated 
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under reduced pressure to furnish the deprotected disaccharide 31 as a white solid (14 
mg, 36 µmol, 94%). 
 
Rf: 0.82 (19:1 MeOH/H2O) 
1
H NMR (CD3OD, 400 MHz) $ (ppm) 5.20 (s, 1H, H-1
II), 4.77 (d, 1H, J = 3.6 Hz, H-1I), 
3.99-3.55 (m, 11H), 3.44-3.38 (m, 3H), 1.70-1.62 (m, 2H), 0.96 (t, 3H). 
13
C NMR (CD3OD, 101 MHz) $ (ppm) 102.8, 100.2, 82.2, 74.6, 73.7, 72.6, 72.5, 72.2, 
70.9, 68.9, 63.1, 62.6, 23.9, 11.2. 
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  17       32 
Propyl 4-O-("-D-glucopyranosyl)-"-D-glucopyranoside (32). Propyl 2,3,6-tri-O-
acetyl-4-O-(2,3,4,6-tetra-O-acetyl-"-D-glucopyranosyl)-"-D-glucopyranoside (17) (40 
mg, 59 µmol) was dissolved in MeOH (2 mL).  Sodium metal (5 mg) was added to the 
solution.  The mixture was stirred for 72 hours at ambient temperature.  The mixture was 
neutralized with Dowex 50W X-8 (H+) resin and filtered.  The filtrate was concentrated 
under reduced pressure to give the product 32 as a syrup (20.5 mg, 53 µmol, 90%). 
 
 Rf: 0.40 (1:2:7 H20/MeOH/EtOAc) 
1
H NMR (D2O, 400 MHz) $ (ppm) 4.53-4.48 (apparent t, 2H, J = 8.0 Hz, overlapping H-
1I and H-2II), 4.00-3.29 (m, 14H), 1.66-1.60 (m, 2H), 0.92 (t, 3H). 
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13
C NMR (D2O, 101 MHz) $ (ppm) 103.3, 102.6, 79.4, 76.7, 76.2, 75.4, 75.0, 73.8, 73.6, 
73.0, 70.1, 61.2, 60.7, 22.9, 10.3. 
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  19       33 
Propyl 4-O-("-D-galactopyranosyl)-"-D-glucopyranoside (33). Propyl 2,3,6-tri-O-
acetyl-4-O-(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-"-D-glucopyranoside (19) (18 
mg, 27 µmol) was dissolved in MeOH (1 mL).  Sodium metal (2 mg) was added, and the 
mixture stirred for 19 hours at ambient temperature.  The mixture was neutralized with 
Dowex 50W X-8 (H+) resin and filtered.  The solvent was evaporated under reduced 
pressure to furnish disaccharide 33 as a syrup (10 mg, 26 µmol, 98%). 
 
 Rf: 0.24 (1:2:7 H20/MeOH/EtOAc) 
1
H NMR (D2O, 400 MHz) $ (ppm) 4.50 (d, 1H, J = 7.6 Hz, H-1
II), 4.45 (d, 1H, J = 7.6 
Hz, H-1I), 4.00-3.51 (m, 13H), 3.34-3.28 (m, 1H), 1.68-1.58 (m, 2H), 0.92 (t, 3H). 
13
C NMR (D2O, 101 MHz) $ (ppm) 104.2, 103.3, 79.7, 76.7, 76.1, 75.8, 74.2, 73.8, 73.6, 
72.3, 69.9, 62.3, 61.4, 23.5, 10.9. 
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  20       34 
Propyl 4-O-(!-D-mannopyranosyl)-!-D-glucopyranoside (34). Propyl 2,3,6-tri-O-
acetyl-4-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-!-D-glucopyranoside (20) (41 
mg, 50 µmol) was dissolved in MeOH (2 mL).  Palladium (10 wt.% on carbon, 2 mg) 
was added, and the mixture stirred at ambient temperature under a hydrogen atmosphere 
for 20 hours.  The mixture was filtered on Celite and the solvent evaporated.  The residue 
was dissolved in MeOH (2 mL), and sodium metal (2 mg) was added.  The mixture was 
stirred for 6 hours at ambient temperature, then neutralized with Dowex 50W X-8 (H+) 
resin and filtered.  The solvent was removed under reduced pressure to furnish 
disaccharide 34 as a pale yellow syrup (14 mg, 37 µmol, 75%). 
 
 Rf: 0.17 (1:2:7 H20/MeOH/EtOAc) 
1
H NMR (D2O, 400 MHz) $ (ppm) 5.29 (d, 1H, J = 2.0 Hz, H-1
II), 4.92 (2, 1H, J = 3.6 
Hz, H-1I), 4.06-4.03 (m, 1H), 3.90-3.43 (m, 13H), 1.68-1.58 (m, 2H), 0.92 (t, 3H). 
13
C NMR (D2O, 101 MHz) $ (ppm) 102.7, 99.0, 77.6, 75.0, 74.9, 72.6, 71.6(3), 71.2, 
67.8, 62.2, 61.9, 23.3, 11.2. 
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   21      35 
Propyl 6-O-("-D-glucopyranosyl)-!-D-glucopyranoside (35) Allyl 2,3-di-O-benzyl-6-
O-(2,3,4,6-tetra-O-acetyl-"-D-glucopyranosyl)-!-D-glucopyranoside (21) (20 mg, 27 
µmol) was dissolved in MeOH (2 mL).  Palladium (10 wt.% on carbon, 10 mg) was 
added.  The mixture was stirred at ambient temperature under an atmosphere of hydrogen 
for 19 hours, then filtered on Celite.  The solvent was evaporated under reduced pressure, 
and the residue dissolved in MeOH (1.5mL).  Sodium metal (5 mg) was added to the 
solution.  The mixture was stirred for 4.5 hours at ambient temperature, then neutralized 
with Dowex 50W X-8 (H+) resin and filtered.  The filtrate was concentrated under 
reduced pressure to give the disaccharide 35 as a syrup (10 mg, 26 µmol, 96%). 
 
 Rf: 0.23 (1:2:7 H20/MeOH/EtOAc) 
1
H NMR (D2O, 400 MHz) $ (ppm) 4.92 (d, 1H, J = 3.6 Hz, H-1
I), 4.50 (d, 1H, J = 7.6 
Hz, H-1II), 4.18-4.13 (d, 1H), 3.95-3.82 (m, 3H), 3.76-3.64 (m, 3H), 3.58-3.29 (m, 7H), 
1.70-1.60 (m, 2H), 0.93 (t, 3H). 
13
C NMR (D2O, 101 MHz) $ (ppm) 103.3, 98.7, 76.5, 76.3, 73.8, 73.7, 72.0, 71.3, 70.7, 
70.3, 70.0, 68.9, 61.4, 22.7, 10.6. 
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   22      36 
Propyl 6-O-("-D-galactopyranosyl)-!-D-glucopyranoside (36). Allyl 2,3-di-O-benzyl-
6-O-(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-!-D-glucopyranoside (22) (5.5 mg, 
7.5 µmol) was dissolved in MeOH (1 mL).  Palladium (10 wt.% on carbon, 1 mg) was 
added.  The mixture was stirred at ambient temperature under an atmosphere of hydrogen 
for 4.5 hours, then filtered on Celite.  The filtrate was concentrated under reduced 
pressure, and the residue dissolved in MeOH (1 mL).  Sodium metal (1 mg) was added to 
the solution.  The mixture was stirred for 30.5 hours at ambient temperature, then 
neutralized with Dowex 50W X-8 (H+) resin and filtered.  The filtrate was concentrated 
under reduced pressure to give the disaccharide 36 as a white solid (2.8 mg, 7.3 µmol, 
97%). 
 
 Rf: 0.18 (1:2:7 H20/MeOH/EtOAc) 
1
H NMR (D2O, 400 MHz) $ (ppm) 4.92 (d, 1H, J = 3.6 Hz, H-1
I), 4.43 (d, 1H, J  = 7.6 
Hz, H-1II), 4.20-4.16 (dd, 1H), 3.95-3.43 (m, 13H), 1.70-1.60 (m, 2H), 0.93 (t, 3H). 
13
C NMR (D2O, 101 MHz) $ (ppm) 103.9, 98.7, 75.8, 73.7, 73.4, 71.9, 71.4, 71.3, 70.7, 
69.9, 69.3, 68.8, 61.7, 22.7, 10.6. 
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  23       37 
Propyl 6-O-(!-D-mannopyranosyl)-!-D-glucopyranoside (37). Allyl 2,3-di-O-benzyl-
6-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-!-D-glucopyranoside (23) (9.2 mg, 13 
µmol) was dissolved in MeOH (1 mL).  Palladium (10 wt.% on carbon, 1 mg) was added.  
The mixture was stirred at ambient temperature under an atmosphere of hydrogen for 4.5 
hours, and filtered on Celite.  The filtrate was concentrated under reduced pressure, and 
the residue dissolved in MeOH (1 mL).  Sodium metal (1 mg) was added to the solution.  
The mixture was stirred for 30.5 hours at ambient temperature, then neutralized with 
Dowex 50W X-8 (H+) resin and filtered.  The filtrate was concentrated under reduced 
pressure to give the disaccharide 37 as a white solid (4.8 mg, 12.5 µmol, 99%).  
 
Rf: 0.17 (1:2:7 H20/MeOH/EtOAc) 
1
H NMR (D2O, 400 MHz) $ (ppm) 4.92 (d, 1H, J = 3.6 Hz, H-1
I), 4.89 (d, 1H, J = 2.4 
Hz, H-1II), 3.99-3.46 (m 14H), 1.70-1.60 (m,2H), 0.94 (t, 3H). 
13
C NMR (D2O, 101 MHz) $ (ppm)  
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   38      39 
Benzyl 3,4,6-tri-O-benzyl-"-D-glucopyranoside (39). 1,2-O-(1-ethoxyethylidene)-
3,4,6-tri-O-benzyl-!-D-glucopyranose (3819) (1.27 g, 2.43 mmol) was dissolved in 
benzyl alcohol (3 mL).  The solution was cooled to 0 °C, and TMSOTf (90 µL, 0.49 
mmol) was added.  The mixture was stirred for 20 minutes at 0 °C, then quenched with 
triethylamine (1 mL).  The reaction mixture was diluted with dichloromethane (100 mL), 
washed with water (2%20 mL) and brine (50 mL), and dried over Na2SO4.  The solvent 
was removed under reduced pressure to give a mixture of the 2-OH and 2-OAc 
derivatives and residual benzyl alcohol.  The crude product was dissolved in MeOH (10 
mL).  Sodium metal (50 mg) was added, and the mixture stirred for 18 hours at ambient 
temperature.  TLC showed that the 2-OAc derivative had been consumed.  The reaction 
was neutralized by the addition of Dowex 50W X-8 (H+) resin and filtered.  The solvent 
was removed under reduced pressure.  The excess benzyl alcohol from the first step was 
difficult remove by evaporation at this stage.  To facilitate purification of the desired 
product, the benzyl alcohol was converted to its trityl ether.  The crude product was 
dissolved in DMF (30 mL).  Trityl chloride (8.9 g, 31.9 mmol) and DMAP (3.53 g) were 
added.  The mixture was heated to 70 °C in a CEM Discover microwave reactor for 40 
minutes.  TLC showed the disappearance of benzyl alcohol (Rf 0.40, 2:8 EtOAc/hexanes) 
and the appearance of benzyl trityl ether (Rf 0.80, 2:8 EtOAc/hexanes).  The reaction 
mixture was poured into water and extracted with dichloromethane (2%80 mL).  The 
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organic layer was washed successively with saturated NaHCO3 solution and brine, dried 
over Na2SO4, and concentrated under reduced pressure.  The residue was purified by 
flash chromatography using a Biotage SP-1 chromatography worksation (Biotage 25M 
cartridge,  gradient of 7#60% ethyl acetate in hexanes, to provide the product 39 as a 
white solid (716 mg, 1.32 mmol, 54%).  An analytical sample was prepared by 
recrystallization from CHCl3/hexanes.  The 
13C NMR spectrum was consistent with that 
reported in the literature.18   
 
Rf: 0.25 (20% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.40-7.24 (m, 18H, Ar-H), 7.19-7.15 (m, 2H, Ar-
H), 4.96-4.90 (2 overlapping d, 2H, 2%PhCH), 4.85-4.80 (2 overlapping d, 2H, 2%PhCH), 
4.65-4.60 (2d, 2H, 2%PhCH), 4.57-4.52 (2d, 2H, 2%PhCH), 4.35 (d, 1H, J1,2 = 7.2 Hz, H-
1), 3.78-3.74 (dd, 1H, J5,6 = 2.4 Hz, J6,6’= 10.8 Hz, H-6), 3.73-3.69 (dd, 1H, J5,6’ = 4.8 Hz, 
J6,6’= 10.8 Hz, H-6’),  3.65-3.55 (m, 3H, H-2, H-3, H-4), 3.50-3.45 (ddd, 1H, J5,6 = 2.4 
Hz, J5,6’ = 4.8 Hz, J6,6’= 10.8 Hz, H-5), 2.37 (d, J = 0.8 Hz, -OH). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 138.8, 138.3(2), 137.3, 128.7, 128.6(2), 128.3, 
128.1(2), 128.0(2), 127.9, 127.8, 101.9, 84.7, 77.7, 75.4, 75.3, 75.2, 74.9, 73.7, 71.2, 
69.0. 
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   40      41 
3-O-Allyl-1,2-5,6-di-O-isopropylidene-D-glucofuranose (41).  Diacetone-D-glucose 
(40) was prepared according to the literature procedure.21  To a solution of diacetone-D-
glucose (3.00 g, 11.5 mmol) in THF (15 mL) was added sodium hydride [60% (w/w) 
dispersion in mineral oil, 552 mg, 13.8 mmol] and tetrabutylammonium iodide (425 mg, 
1.15 mmol).  To this mixture, allyl bromide (1.09 mL, 12.65 mmol) was added, and the 
mixture stirred under a nitrogen atmosphere for two hours at ambient temperature.  The 
mixture was poured into water and extracted with ethyl acetate (2% 100 mL).  The 
organic extract was washed with brine, dried over Na2SO4, and concentrated under 
reduced pressure.  The residue was purified by flash chromatography on silica gel, using 
a gradient of 10#20% ethyl acetate in hexanes, to provide the product 41 as a colorless 
oil (3.46 g, 11.5 mmol, 99%).  The 1H NMR spectrum was consistent with the data 
reported in the literature.22  
 
Rf: 0.61 (30% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 5.96-5.84 (m, 2H), 5.34-5.28 (m, 1H), 5.22-5.18 
(m, 1H), 4.55 (d, 1H, J = 3.6 Hz), 4.34-4.29 (dt, 1H, J = 7.6Hz, 6.0 Hz), 4.18-4.07 (m, 
4H), 4.02-3.98 (dd, 1H, J = 8.4 Hz, 5.6 Hz), 3.94 (d, 1H, J = 3.2 Hz), 1.50 (s, 3H), 1.43 
(s, 3H), 1.36 (s, 3H), 1.32 (s, 3H). 
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   41      42 
3-O-Allyl-"-D-glucopyranose (42). A modification of the procedure of Takeo and 
coworkers23 was followed.  3-O-allyl-1,2-5,6-di-O-isopropylidene-D-glucofuranose (41) 
(3.43 g, 11.4 mmol) and Dowex 50W X-8 (H+) resin (7.0 g) were suspended in water (25 
mL).  The mixture was stirred for 4 hours at 70°C.  The resin was filtered off and washed 
with water.  The solvent was evaporated under reduced pressure, and the solid residue 
recrystallized from ethanol and hexanes to afford 42 as a white powdery solid (1.17 g, 
5.31 mmol, 46%). 
 
Rf: 0.34 (10% MeOH/EtOAc) 
1
H NMR (D2O, 400 MHz) $ (ppm) 6.05-5.95 (m, 1H, OCH2CH=CH2), 5.38-5.32 (m, 
1H, OCH2CH=CHaHb), 5.27-5.23 (m, 1H, OCH2CH=CHaHb), 4.64 (d, 1H, J1,2 = 8.0 Hz, 
H-1), 4.34 (d, 2H, OCH2CH=CH2), 3.91-3.86 (d, 1H, J6,6’ = 12.0 Hz, H-6), 3.73-3.69 (dd, 
1H, J5,6’ = 4.8 Hz, J6,6’= 12.0 Hz, H-6’), 3.51-3.39 (m, 3H), 3.29 (t, 1H, J  = 8.8 Hz). 
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   42      43 
Benzyl 3-O-allyl-2,4,6-tri-O-benzyl-"-D-glucopyranoside (43). 3-O-allyl-"-D-
glucopyranose (42) (500 mg, 2.27 mmol) was dissolved in DMF (10 mL).  To this 
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solution, sodium hydride [60% (w/w) dispersion in mineral oil, 363 mg, 9.1 mmol] and 
benzyl bromide (1.08 mL, 9.1 mmol) were added, and the mixture stirred for 20 hours at 
ambient temperature.  Additional sodium hydride (363 mg) and benzyl bromide (1.08 
mL) were added, and the mixture stirred for an additional 22 hours at ambient 
temperature.  The reaction mixture was then poured into water, and extracted with 
dichloromethane (2 % 75 mL).  The combined organic extracts were washed with water 
and brine, dried over Na2SO4, and concentrated under reduced pressure.  The residue was 
purified by flash chromatography on silica gel, using a gradient of 0#20% ethyl acetate 
in hexanes, to provide a white solid. The solid was recrystallized from ethyl acetate and 
hexanes to furnish 43 as fine white needles (583 mg, 1.0 mmol, 44%). 
 
Rf:  0.70 (3:7 EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.39-7.20 (m, 20H, Ar-H), 5.99-5.89 (m, 1H, 
OCH2CH=CH2), 5.28-5.23 (m, 1H, OCH2CH=CHaHb), 5.16-5.13 (m, 1H, 
OCH2CH=CHaHb), 4.98-4.53 (m, 8H, 4%PhCH2), 4.47 (d, 1H, J1,2 = 7.2 Hz, H-1), 4.41-
4.36 (m, 1H, OCHaHbCH=CH2), 4.29-4.24 (m, 1H, OCHaHbCH=CH2), 3.77-3.74 (dd, 
1H, J5,6 = 1.6 Hz, J6,6’ = 10.8 Hz, H-6), 3.71-3.67 (dd, 1H, J5,6’ = 4.8 Hz, J6,6’ = 10.8 Hz, 
H-6’), 3.58-3.41 (m, 4H, H-2, H-3, H-4, H-5). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 138.7, 138.5, 138.4, 137.8, 135.4, 128.6(2), 128.5, 
128.4, 128.3, 128.1, 128.0, 127.9, 127.8(2), 116.9, 102.8, 84.6, 82.4, 78.0, 75.2, 75.1, 
74.7, 73.7, 71.4, 69.2. 
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   43      44 
Benzyl 2,4,6-tri-O-benzyl-"-D-glucopyranoside (44). Benzyl 3-O-allyl-2,4,6-tri-O-
benzyl-"-D-glucopyranoside (43) (309 mg, 0.53 mmol) was dissolved in THF (8 mL). To 
this solution, (1,5-cyclooctadiene)bis(methyldiphenylphosphine)iridium(I) (4.5 mg, 5.3 
µmol) was added.  The resulting red suspension was degassed by brief exposure of the 
reaction flask to vacuum.  The mixture was then stirred under a balloon of hydrogen until 
the red suspension became a colorless solution (approximately 30 seconds).  The mixture 
was degassed and the flask flushed with nitrogen.  The resulting mixture was stirred for 
16 hours at ambient temperature.  Proton NMR analysis of a small aliquot (~50 µL) of 
the reaction mixture indicated that conversion to the 1-propenyl ether was complete.  The 
solvent was removed under reduced pressure.  The crude 1-propenyl ether was dissolved 
in 10:1 acetone/water (5 mL).  To this solution, red mercuric oxide (173 mg, 0.80 mmol) 
was added, followed by the dropwise addition of a mercuric chloride solution (216 mg, 
0.80 mmol, in 10:1 acetone/water, 3 mL).  The reaction was complete after 1 hour at 
ambient temperature.  The reaction mixture was filtered through a pad of Celite to 
remove the mercuric oxide.  The solvent was partially evaporated under reduced pressure, 
and diethyl ether (75 mL) added.  The organic layer was washed with a potassium iodide 
solution (2%30 mL), water (30 mL), and brine.  After drying over Na2SO4, the solvent 
was evaporated.  The residue was purified by flash chromatography on silica gel, using a 
gradient of 15#20% ethyl acetate in hexanes, to provide 44 as a colorless syrup (246 mg, 
0.46 mmol, 86%). 
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Rf: 0.39 (20% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.39-7.21 (m, 20H, Ar-H), 5.00-4.95 (d, 2H, 
2%PhCH), 4.84 (d, 1H, J = 11.2 Hz, PhCH), 4.68-4.61 (m, 3H, 3%PhCH), 4.59-4.54 (m, 
2H, 2%PhCH), 4.49 (d, 1H, J1,2 = 7.6 Hz, H-1), 3.80-3.68 (m, 3H, H-3, H-6, H-6’), 3.52 
(t, 1H, J2,3 = J3,4 = 9.2 Hz, H-4), 3.49-3.44 (m, 1H, H-5), 3.37-3.32 (dd, 1H, J1,2 = 8.0 Hz, 
J2,3 = 8.8 Hz, H-2), 2,43 (d, 1H, J = 2.0 Hz, -OH). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 138.5, 138.4, 137.6, 128.7, 128.6(2), 128.4, 128.2, 
128.0, 127.9, 127.8, 102.4, 81.5, 77.6, 75.0, 74.7, 74.6, 73.7, 71.2, 69.1. 
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   45      46 
Benzyl "-D-glucopyranoside (46).  Commercial silver(II) oxide (Alfa Aesar, 1.72 g, 7.4 
mmol) was added to a solution of 2,3,4,6-tetra-O-acetyl-!-D-glucopyranosyl bromide 
(4526) (2.04 g, 5.0 mmol) and benzyl alcohol (1.54 mL, 14.9 mmol) in dichloromethane 
(20 mL).  The mixture was stirred for 4 hours at ambient temperature, then filtered 
through a pad of Celite.  The filtrate was concentrated under reduced pressure, and the 
residue dissolved in MeOH (20 mL).  Sodium metal (50 mg) was added to the solution.  
The mixture was stirred at ambient temperature for 3 hours, neutralized with Dowex 50W 
X-8 (H+) resin, filtered, and concentrated.  The residue was purified by flash 
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chromatography on silica gel, using a gradient of 10#20% methanol in dichloromethane, 
to provide the product 46 as a white crystalline solid (890 mg, 3.3 mmol, 66%). 
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  46       47 
Benzyl 4,6-O-benzylidene-"-D-glucopyranoside (47). Benzyl "-D-glucopyranoside 
(46) (880 mg, 3.26 mmol) was dissolved in acetonitrile (10 mL).  Benzaldehyde dimethyl 
acetal (0.98 mL, 6.51 mmol) and 10-camphorsulfonic acid (38 mg, 0.16 mmol) were 
added, and the mixture heated to reflux for 75 minutes.  The mixture was neutralized by 
the addition of triethylamine (0.5 mL), and the solvent evaporated.  The residue was 
dissolved in dichloromethane (75 mL), washed successively with saturated NaHCO3 
solution, water, and brine, dried over Na2SO4, and concentrated.  The solid residue was 
recrystallized from ethanol to afford 47 as a white solid (844 mg, 2.35 mmol, 72%).  The 
1H NMR was in agreement with the literature.25 
 
Rf: 0.42 (50% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.56-7.27 (m, 10H, Ar-H), 5.49 (s, 1H, 
benzylidene Ph-CH), 5.02-3.22 (m, 10H), 2.44 (bs, 2H, -OH). 
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   47      48 
Benzyl 2,3-di-O-benzyl-4,6-O-benzylidene-"-D-glucopyranoside (48). Benzyl 4,6-O-
benzylidene-"-D-glucopyranoside (47) (844 mg, 2.35 mmol) was dissolved in DMF (10 
mL).  To this solution, benzyl bromide (0.62 mL, 5.17 mmol) and sodium hydride [60% 
(w/w) dispersion in mineral oil, 280 mg, 7.0 mmol] were added, and the mixture stirred at 
ambient temperature.  After 60 minutes at ambient temperature, the reaction was 
quenched by the addition of methanol (1 mL), and diluted with dichloromethane.  The 
organic solution was washed with water and brine, dried over Na2SO4, and concentrated.  
The residue was purified by flash chromatography on silica gel, using a gradient of 
0#20% ethyl acetate in hexanes, to provide the product 48 as a white solid (1.19 g, 2.21 
mmol, 94%).  The 1H NMR spectrum was consistent with the partial assignments 
reported in the literature.25  Full proton assignments are given below. 
 
Rf: 0.74 (30% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.50-7.23 (m, 20H, Ar-H), 5.57 (s, 1H, 
benzylidene CH), 4.95-4.87 (m, 3H, 3%PhCH), 4.79-4.74 (m, 2H, 2%PhCH), 4.66 (d, 1H, 
J = 11.6 Hz, PhCH), 4.62 (d, 1H, J1,2 = 7.6 Hz, H-1), 4.39-4.35 (dd, 1H, J5,6  = 5.2 Hz, 
J6,6’ = 10.2 Hz, H-6), 3.80 (t, 1H, J5,6’ = J6,6’ = 10.0 Hz, H-6’), 3.74 (t, 1H, J2,3 = J3,4 = 9.2 
Hz, H-3), 3.69 (t, 1H, J3,4 = J4,5 = 9.2 Hz, H-4), 3.52 (t, 1H, J1,2 = J2,3 = 8.0 Hz, H-2), 3.44-
3.37 (m, 1H, H-5). 
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   48      49 
Benzyl 2,3,6-tri-O-benzyl-"-D-glucopyranoside (49).  Benzyl 2,3-di-O-benzyl-4,6-O-
benzylidene-"-D-glucopyranoside (48) (508 mg, 1.07 mmol) was dissolved in 
dichloromethane (10 mL).  Activated powdered 4Å molecular sieves (1.0 g) were added, 
and the mixture stirred at ambient temperature for 1 hour.  The mixture was cooled to 
-78 °C. Triethylsilane (0.51 mL, 3.2 mmol) and TfOH (0.32 mL, 3.7 mmol) were added.  
After stirring for 90 minutes at -78 °C, the reaction mixture was poured into a mixture of 
saturated aqueous NaHCO3 solution and dichloromethane.  The mixture was filtered 
through a pad of Celite to remove the molecular sieves.  The filtrate was poured into a 
separatory funnel and the layers separated.  The organic layer was washed with brine, 
dried over Na2SO4, and concentrated.  The residue was purified by flash chromatography 
on silica gel, using a gradient of 0#20% ethyl acetate in hexanes, to give 49 as an oil 
(308 g, 0.57 mmol, 53%).  The 1H NMR spectrum was consistent with the partial 
assignments reported in the literature.25  Full proton assignments are given below. 
 
Rf: 0.43 (30% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.38-7.22 (m, 20H, Ar-H), 4.97-4.91 (apparent t, 
3H, 3%PhCH), 4.73-4.64 (m, 3H, 3%PhCH), 4.62 (d, 1H, J = 12 Hz, PhCH), 4.58 (d, 1H, 
J = 12 Hz, PhCH), 4.52 (d, 1H, J1,2 = 7.2 Hz, H-1), 3.81-3.77 (dd, 1H, J5,6  = 4.0 Hz, J6,6’ 
= 10.2 Hz, H-6), 3.74-3.70 (dd, 1H, J5,6’  = 5.2 Hz, J6,6’ = 10.2 Hz, H-6’), 3.61 (t, 1H, J2,3  
= J3,4 = 9.2 Hz, H-3), 3.52-3.42 (m, 3H, H-2, H-4, H-5), 2.50 (br s, 1H, -OH). 
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Benzyl 2,3,4,6-tetra-O-benzyl-"-D-glucopyranoside (50). Benzyl 2,3,4,6-tetra-O-
benzyl-"-D-glucopyranoside (50) was prepared from D-glucose according to the 
procedure of Lu and coworkers.27  D-glucose (2.00 g, 11.1 mmol) was suspended in DMF 
(50 mL).  Sodium hydride [60% (w/w) dispersion in mineral oil, 1.33 g, 33.3 mmol] was 
added, and the mixture stirred for 30 minutes at 0 °C.  To this mixture, benzyl bromide 
(4.6 mL, 38.9 mmol) was added.  After 10 minutes, the ice bath was removed and the 
mixture stirred for 3 hours at ambient temperature.  The procedure of additions of sodium 
hydride and benzyl bromide was repeated, using the same quantities as the first addition.  
After 12 hours at ambient temperature, additional sodium hydride (60% (w/w) in mineral 
oil, 891 mg) and benzyl bromide (3,1 mL, 26.0 mmol) were added, and the mixture 
stirred for 90 minutes at ambient temperature.  The excess sodium hydride was destroyed 
by the addition of methanol (1 mL).  The reaction mixture was diluted with water (75 
mL) and extracted with dichloromethane (3%75 mL).  The combined organic extracts 
were washed with water and brine, dried over Na2SO4, and concentrated.  The residue 
was purified by flash chromatography on silica gel, using 10% ethyl acetate in hexanes as 
the eluant, to afford the product 50 as a white solid (3.52 g, 5.6 mmol, 50%).  The 1H and 
13C NMR spectra were consistent with the reported data.27 
 
Rf: 0.64 (20% EtOAc/hexanes) 
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1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.40-7.14 (m, 25H, Ar-H), 5.00-4.50 (m, 11H, 
10%PhCH, H-1), 3.78-3.75 (dd, 1H, J5,6  = 2.0 Hz, J6,6’ = 10.2 Hz, H-6), 3.72-3.68 (dd, 
1H, J5,6’  = 4.8 Hz, J6,6’ = 10.2 Hz, H-6’), 3.67-3.59 (m, 2H, H-3, H-4), 3.53 (t, 1H, J2,3  = 
J3,4 = 8.4 Hz, H-2), 3.48-3.44 (m, 1H, H-5). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 138.8, 138.6, 138.4, 138.3, 137.7, 128.6(2), 128.5, 
128.4, 128.1(2), 128.0, 127.8(3), 102.8, 84.9, 82.5, 78.1, 75.9, 75.2, 75.1, 73.7, 71.3, 
69.1. 
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  50       51 
Benzyl 2,3,4-tri-O-benzyl-"-D-glucopyranoside (51). Benzyl 2,3,4-tri-O-benzyl-"-D-
glucopyranoside (51) was prepared following the literature procedure.27  Freshly fused 
zinc chloride (1.33 g, 9.76 mmol) was dissolved in 5:1 Ac2O/AcOH (8 mL).  The 
solution was cooled to 0 °C.  A solution of benzyl-2,3,4,6-tetra-O-benzyl-"-D-
glucopyranoside 50 (1.23 g, 1.95 mmol, in 5:1 Ac2O/AcOH (8 mL)) was added dropwise 
to the cold zinc chloride solution.  The reaction mixture was allowed to warm to ambient 
temperature with stirring.  After 1 hour, ice water (60 mL) was added.  The resulting 
white precipitate was washed with water and then filtered.  The solid product was 
dissolved in dichloromethane (100 mL).  The organic solution was washed with water (40 
mL), saturated NaHCO3 solution (50 mL), and brine (50 mL), dried over Na2SO4, and 
concentrated.  The crude 6-O-acetyl product was suspended in methanol (20 mL), and 
sodium metal (50 mg) added.  The mixture was stirred at ambient temperature for 2 
hours, with complete dissolution of the starting material after 30 minutes.  The solvent 
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was evaporated, and the residue partitioned between water (50 mL) and dichloromethane 
(50 mL).  The aqueous layer was extracted with dichloromethane (2 % 50 mL).  The 
combined organic extracts were washed with water and brine, dried over Na2SO4, and 
concentrated.  The residue was purified by flash chromatography on silica gel, using 25% 
ethyl acetate in hexanes as the eluant, to afford a white solid.  The solid was 
recrystallized from chloroform and hexanes to furnish 51 as fine white needles (391 mg, 
0.72 mmol, 37%).  The 1H NMR spectrum was identical to that reported in the 
literature.28 
 
Rf: 0.39 (30% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.38-7.25 (m, 20H, Ar-H), 4.95 (d, 1H, J = 11 Hz, 
PhCH), 4.93 (d, 1H, J = 11 Hz, PhCH), 4.92 (d, 1H, J = 12 Hz, PhCH), 4.86 (d, 1H, J = 
11 Hz, PhCH), 4.81 (d, 1H, J = 11 Hz, PhCH), 4.73 (d, 1H, J = 11 Hz, PhCH), 4.69 (d, 
1H, J = 12 Hz, PhCH), 4.63 (d, 1H, J = 11 Hz, PhCH), 4.57 (d, 1H, J1,2 = 8 Hz, H-1), 
3.90-3.85 (ddd, 1H, J6,6’ = 12 Hz, J5,6 = 2.8 Hz, J6,-OH = 6.4 Hz, H-6), 3.73-3.68 (m, 1H, 
H-6’), 3.67 (t, 1H, J2,3 = J3,4 = 9.2 Hz, H-3), 3.57 (t, 1H, J3,4= J4,5 = 9.2 Hz, H-4), 3.49 (dd, 
1H, J1,2 = 8 Hz, J2,3= 9 Hz, H-2), 3.38-3.34 (m, 1H, H-5), 1.82-1.79 (dd, 1H, J = 6.0 Hz, 
7.6 Hz, -OH). 
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 39   8      52 
Benzyl 3,4,6-tri-O-benzyl-2-O-(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-"-D-
glucopyranoside (52).  Benzyl 3,4,6-tri-O-benzyl-"-D-glucopyranoside (39) (74 mg, 
0.14 mmol) and 2,3,4,6-tetra-O-acetyl-!-D-galactopyranosyl trichloroacetimidate (8) 
(153 mg, 0.31 mmol) were combined in a 25 mL tear drop flask.  Toluene (3 x 3 mL) was 
added to the sugars and the solvent was removed under reduced pressure after each 
addition.  The flask was dried under high vacuum (10-4 torr) for 1 h.  The reactants were 
dissolved in dichloromethane (2.0 mL), and TMSOTf (1 drop from a 1-mL syringe) was 
added.  After stirring at ambient temperature for 30 minutes, the reaction was quenched 
by the addition of triethylamine (0.1 mL) and the solvent removed under reduced 
pressure.  The residue was subjected to flash chromatography, using a gradient elution of 
10-30% ethyl acetate in hexanes, to give the product 52 as a colorless syrup (57 mg, 65 
µmol, 48%). 
 
Rf: 0.71 (50% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.42-7.23 (m 18H), 7.12-7.08 (m, 2H), 5.30 (d, 
1H), 5.25-5.21 (dd, 1H), 5.05-5.01 (d, 1H), 4.99 (d, 1H, J = 8.0 Hz, H-1II), 4.95-4.91 (dd, 
1H), 4.84-4.76 (m, 3H), 4.64-4.60 (d, 2H), 4.57-4.53 (m, 3H), 4.13-4.06 (m, 2H), 3.91-
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3.86 (dd, 1H), 3.80-3.58 (m, 5H), 3.48-3.44 (m, 1H), 2.14 (s, 3H), 1.96 (s, 3H), 1.95 (s, 
3H), 1.80 (s, 3H). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 170.5, 170.4(2), 170.0, 138.6, 138.2, 138.0, 137.9, 
128.6(2), 128.5, 128.1, 128.0(2), 127.9, 127.8, 127.7, 127.3, 101.7, 100.8, 84.6, 81.3, 
78.2, 77.5, 76.0, 75.2, 75.0, 73.7, 71.5, 71.2, 70.8, 70.0, 68.8, 97.2, 61.2, 20.9, 20.8(3).  
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 39   9      53 
Benzyl 3,4,6-tri-O-benzyl-2-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-"-D-
glucopyranoside (53).  Benzyl 3,4,6-tri-O-benzyl-"-D-glucopyranoside (39) (70 mg, 
0.13mmol) and 2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl trichloroacetimidate (9) (144 
mg, 0.29 mmol) were combined in a 25 mL tear drop flask.  Toluene (3 x 3 mL) was 
added to the sugars and the solvent was removed under reduced pressure after each 
addition.  The flask was dried under high vacuum (10-4 torr) for 1 h.  The reactants were 
dissolved in dichloromethane (2.0 mL).  To this solution, TMSOTf (1 drop from a 1-mL 
syringe) was added.  The mixture was stirred at ambient temperature for 30 minutes, then 
quenched by the addition of triethylamine (0.1 mL).   The solvent was evaporated, and 
the residue subjected to flash chromatography, using 30% ethyl acetate in hexanes as 
eluant, to afford 53 as a colorless syrup (98 mg, 0.11 mmol, 88%). 
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Rf: 0.70 (50% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.38-7.22 (m, 18H), 7.12-7.08 (m, 2H), 5.44 (d, 
1H, J = 1.6 Hz, H-1II), 5.34-5.32 (m, 1H), 5.25-5.17 (m, 2H), 5.99 (d, 1H), 4.87 (d, 1H), 
4.81-4.76 (m, 2H), 4.65 (d, 1H), 4.59-4.54 (m, 3H), 4.46 (d, 1H, J = 8.0 Hz, H-1I), 4.17-
4.11 (m, 1H), 3.81-3.68 (m, 6H), 3.59 (t, 1H), 3.48-3.43 (m, 1H), 2.10 (s, 3H), 2.03 (s, 
3H), 1.98 (s, 3H), 1.82 (s, 3H). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 170.9, 170.2, 170.0(2), 138.3, 138.2, 137.8, 137.0, 
128.6, 128.5, 128.2, 128.0(2), 127.7, 127.0, 102.2, 96.9, 83.2, 78.7, 77.5, 75.9, 75.6, 
75.2(2), 73.8, 71.5, 69.5, 69.2, 68.6, 68.3, 65.5, 61.8, 21.1, 21.0, 20.9, 20.8.  
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 44   8      54 
Benzyl 2,4,6-tri-O-benzyl-3-O-(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-"-D-
glucopyranoside (54).  Benzyl 2,4,6-tri-O-benzyl-"-D-glucopyranoside (44) (49 mg, 91 
µmol) and 2,3,4,6-tetra-O-acetyl-!-D-galactopyranosyl trichloroacetimidate (8) (103 mg, 
210 µmol) were combined in a 25 mL round-bottom flask.  Toluene (3 x 3 mL) was 
added to the sugars and the solvent was removed under reduced pressure after each 
addition.  The flask was dried under high vacuum (10-4 torr) for 1 h.  The reactants were 
dissolved in dichloromethane (2.0 mL).  TMSOTf (1 drop from a 1-mL syringe) was 
added to the solution.  The mixture was stirred at ambient temperature for 30 minutes, 
quenched by the addition of triethylamine (0.1 mL), and the solvent removed under 
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reduced pressure.  The residue was purified by flash chromatography on silica gel, using 
a gradient of 10-30% ethyl acetate in hexanes as the eluant, to furnish disaccharide 54 as 
a colorless syrup (48 mg, 55 µmol, 60%). 
 
Rf: 0.65 (50% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.40-7.25 (m, 20H), 5.34 (d, 1H), 5.28-5.23 (dd, 
1H), 5.15 (d, 1H, J = 8.0 Hz, H-1II), 5.02-4.95 (m, 4H), 4.67-4.62 (m, 2H), 4.59-4.55 (m, 
2H), 4.47 (d, 1H, J = 8.0 Hz, H-1I), 4.45-4.42 (d, 1H), 4.16-4.09 (dd, 1H), 4.02 (t, 1H), 
3.98-3.93 (dd, 1H), 3.78-3.69 (m, 3H), 3.57 (t, 1H), 3.49-3.40 (m, 2H), 2.10 (s, 3H), 2.09 
(s, 3H), 2.00 (s, 3H), 1.98 (s, 3H). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 170.5, 170.4, 170.3, 169.5, 138.4, 138.3, 138.0, 
137.4, 128.9, 128.7(2), 128.6, 128.4(2), 128.3, 128.1, 128.0, 127.9, 102.3, 100.5, 83.0, 
80.9, 77.6, 75.8, 75.2, 75.1, 74.7, 73.7, 71.4, 71.2, 70.6, 69.8, 68.9, 67.3, 61.0, 21.2, 
20.8(3).  
 
O
OAc
AcO
AcO
AcO
O CCl3
NH
+
O
AcO
OAc
AcO OAc
O
BnO
O OBn
BnO
BnO
O
BnO
HO
BnO
BnO
OBn
 
 44   9      55 
Benzyl 2,4,6-tri-O-benzyl-3-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-"-D-
glucopyranoside (55).  Benzyl 2,4,6-tri-O-benzyl-"-D-glucopyranoside (44) (42 mg, 78 
µmol) and 2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl trichloroacetimidate (9) (79 mg, 
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160 µmol) were combined in a 25 mL round-bottom flask and dried under high vacuum 
(10-4 torr) for 1 h.  The reactants were dissolved in dichloromethane (2.0 mL).  After the 
addition of TMSOTf (1 drop from a 1-mL syringe), the mixture was stirred at ambient 
temperature for 20 minutes.  The reaction was quenched by the addition of triethylamine 
(0.1 mL), and the solvent removed under reduced pressure.  The residue was purified by 
flash chromatography on silica gel, using a Biotage SP-1 chromatography system 
(Biotage 12M cartridge, 12#50% ethyl acetate in hexanes over 16 column volumes), to 
furnish a white solid.  The solid was recrystallized from hot ethyl acetate and hexanes to 
yield disaccharide 55 as fine white needles (60 mg, 69 µmol, 88%). 
 
Rf: 0.76 (50% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.37-7.21 (m, 18H), 7.12-7.08 (m, 2H), 5.34-5.32 
(m, 1H), 5.32 (br s 1H, H-1II), 5.27-5.24 (dd, 1H), 5.16 (t, 1H), 5.07 (d, 1H), 4.97 (d, 1H), 
4.70-4.64 (m, 2H), 4.61-4.55 (m, 4H), 4.50 (d, 1H, J = 7.6 Hz, H-1I), 4.28-4.24 (m, 1H), 
3.82-3.69 (m, 4H), 3.61 (d, 2H), 3.46-3.41 (m, 2H), 1.98 (s, 3H), 1.97 (s, 3H), 1.96 (s, 
3H), 1.95 (s, 3H). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 170.8, 170.2, 170.0, 169.6, 138.1(2), 137.7, 137.3, 
128.7, 128.6, 128.5, 128.4, 128.3(2), 128.1, 128.0(2), 127.9, 127.8, 127.5, 102.6, 98.0, 
79.6, 79.4, 78.5, 77.5, 74.9, 74.7, 74.6, 73.8, 71.2, 69.6, 69.5, 68.6, 68.2, 65.6, 61.6, 
20.9(4).   
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 49   9      56 
Benzyl 2,3,6-tri-O-benzyl-4-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-"-D-
glucopyranoside (56).  Benzyl 2,3,6-tri-O-benzyl-"-D-glucopyranoside (49) (47 mg, 87 
µmol) and 2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl trichloroacetimidate (9) (91 mg, 
185 µmol) were combined and dried under high vacuum (10-4 torr) for 1 h.  The reactants 
were dissolved in dichloromethane (2.0 mL). TMSOTf (1 drop from a 1-mL syringe) was 
added to the solution.  The mixture was stirred at ambient temperature for 30 minutes, 
then quenched by the addition of triethylamine (0.1 mL), The solvent removed under 
reduced pressure and the residue purified by flash chromatography on silica gel, using a 
gradient of 10#40% ethyl acetate in hexanes as eluant, to yield 56 as a syrup (65 mg, 74 
µmol, 85%). 
 
Rf: 0.57 (50% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.38-7.16 (m, 20H), 5.40 (br s, 1H, H-1
II), 5.26-
5.16 (m, 3H), 5.02-4.92 (m, 3H), 4.71-4.57 (m, 5H), 4.54 (d, 1H, J = 8.0 Hz, H-1I), 4.19-
4.14 (dd, 1H), 3.97-3.94 (m, 1H), 3.89-3.78 (m, 3H), 3.75-3.71 (dd, 1H), 3.66 (t, 1H), 
3.57-3.50 (m, 2H), 2.04 (s, 3H), 2.02 (s, 3H), 1.94 (s, 3H), 1.93 (s, 3H).  
13
C NMR (CDCl3, 101 MHz) $ (ppm) 170.8, 170.2, 169.7(2),  138.3(2), 137.4, 128.6(2), 
128.5, 128.4, 128.3, 128.2, 128.1, 128.0, 127.9, 127.7, 127.5, 127.3, 102.6, 98.8, 84.6, 
82.4, 77.5, 75.6, 75.1, 74.8, 74.4, 73.7, 71.4, 69.5, 96.4, 69.3, 65.9, 62.5, 20.9(2), 20.8(2).  
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 51   8      57 
Benzyl 2,3,4-tri-O-benzyl-6-O-(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-"-D-
glucopyranoside (57).  Benzyl 2,3,4-tri-O-benzyl-"-D-glucopyranoside (51) (77 mg, 143 
µmol) and 2,3,4,6-tetra-O-acetyl-!-D-galactopyranosyl trichloroacetimidate (8) (138 mg, 
280 µmol) were combined and dried under high vacuum (10-4 torr) for 1 h.  The reactants 
were dissolved in dichloromethane (2.0 mL).  TMSOTf (1 drop from a 1-mL syringe) 
was added to the solution, and the mixture stirred at ambient temperature for 20 minutes.   
The reaction was quenched by the addition of triethylamine (0.1 mL), and the solvent 
removed under reduced pressure.  The residue was purified using a Biotage SP-1 
chromatography system (Biotage 12M cartridge, 10#90% ethyl acetate in hexanes over 
12 column volumes).  The first compound to elute was the transacetylated acceptor 
benzyl 6-O-acetyl-2,3,4-tri-O-benzyl-"-D-glucopyranoside27, a white solid (Rf = 0.60 in 
50% EtOAc/hexanes, 25 mg, 43 µmol, 30%).  The second compound to elute was 
disaccharide 57, which was recrystallized from hot ethyl acetate and hexanes to yield fine 
white needles (64 mg, 73 µmol, 51%). 
 
Rf: 0.26 (30% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.40-7.22 (m, 20H), 5.37 (d, 1H), 5.29-5.24 (dd, 
1H), 4.98-4.91 (m, 4H), 4.85 (d, 1H), 4.79-4.68 (m, 3H), 4.58 (d, 1H, J = 8.0 Hz, H-1II), 
 86 
4.55 (d, 1H), 4.50 (d, 1H, J = 7.6 Hz, H-1I), 4.17-4.10 (m, 3H), 3.82 (t, 1H), 3.68-3.62 
(m, 2H), 3.54-3.47 (m, 2H), 3.40 (t, 1H), 2.15 (s, 3H), 2.02 (s, 3H), 1.98 (s, 6H). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 170.6, 170.5, 170.4, 169.4, 138.6, 138.4, 138.1, 
137.5, 128.7, 128.7, 128.4, 128.2, 128.1(2), 128.0, 127.9(2), 102.6, 101.4, 84.8, 82.4, 
78.2, 76.0, 75.1, 75.0, 71.2(2), 70.8, 69.0, 68.6, 67.2, 61.5, 21.0, 20.9(2), 20.8. 
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 51   9      58 
Benzyl 2,3,4-tri-O-benzyl-6-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-"-D-
glucopyranoside (58).  Benzyl 2,3,4-tri-O-benzyl-"-D-glucopyranoside (51) (79 mg, 146 
µmol) and 2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl trichloroacetimidate (9) (141 mg, 
286 µmol) were combined and dried under vacuum (10-4 torr) for 1 hour, then dissolved 
in dichloromethane (2.0 mL).  TMSOTf (1 drop from a 1-mL syringe) was added to the 
solution, and the mixture stirred at ambient temperature for 30 minutes.  The reaction was 
quenched by the addition of triethylamine (0.1 mL), and the solvent evaporated.  The 
residue was purified using a Biotage SP-1 chromatography system (Biotage 12M 
cartridge, 12#50% ethyl acetate in hexanes over 12 column volumes) to provide 
disaccharide 58 as a white foam (95 mg, 109 µmol, 75%). 
 
Rf: 0.68 (50% EtOAc/hexanes) 
 87 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.40-7.25 (m, 20H), 5.40-5.36 (dd, 1H), 5.32-5.26 
(m, 2H), 4.98-4.87 (m, 5H), 4.76 (d, 1H), 4.72 (d, 1H), 4.66 (d, 1H), 4.58 (d, 1H), 4.51 
(d, 1H, J = 7.6 Hz, H-1I), 4.25-4.29 (dd, 1H), 4.10-4.03 (m, 2H), 3.75 (d, 2H), 3.67 (t, 
1H), 3.53-3.41 (m, 3H), 2.16 (s, 3H), 2.08 (s, 3H), 1.99 (s, 3H), 1.92 (s, 3H). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 170.8, 170.2, 170.0, 169.9, 138.6, 138.5, 138.1, 
137.5, 128.7, 128.6(2), 128.4, 128.2, 128.1, 128.0(2), 127.9(2), 102.4, 97.6, 84.9, 82.5, 
78.1, 75.9, 75.1(2), 74.2, 71.2, 69.6, 69.3, 68.7, 66.8, 66.2, 62.5, 21.1, 21.0, 20.9, 20.8. 
 
O
O
BnO
BnO
BnO
OBn
O
AcO
AcO
OAc
AcO
O
O
HO
HO
HO
O
HO
HO
OH
HO
OH
 
   52       59 
2-O-("-D-galactopyranosyl)-D-glucopyranose (59).  Benzyl 3,4,6-tri-O-benzyl-2-O-
(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-"-D-glucopyranoside (52) ( 72 mg, 82 
µmol) was suspended in EtOH (10 mL).  Palladium (10% on carbon, 20 mg) was added, 
and the mixture stirred under an atmosphere of hydrogen at ambient temperature.  After 
14.5 hours, the starting disaccharide had completely dissolved and TLC indicated that 
debenzylation was complete.  The reaction mixture was filtered through Celite, and the 
solvent removed under reduced pressure.  The residue was dissolved in MeOH (5 mL), 
and sodium metal (10 mg) was added.  The mixture was stirred for 4 hours at ambient 
temperature, then neutralized with Dowex 50W X-8 (H+) resin and filtered.  The solvent 
was evaporated under vacuum to furnish disaccharide 59, a mixture of anomers, as a 
syrup (26 mg, 76 µmol, 92%). 
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Rf: 0.63 (2:8 H2O/MeOH) 
1
H NMR (D2O, 400 MHz) $ (ppm) 5.41 (d, 0.6H, J = 3.2Hz), 4.68 (d, 0.4H, J = 8.0 Hz), 
4.52 (d, 0.6H, J = 7.6Hz), 3.90-3.45 (m, 12 H). 
13
C NMR (D2O, 101 MHz) $ (ppm) 105.2, 103.9, 95.4, 92.5, 81.9, 81.4, 76.6, 76.5, 76.0, 
75.7, 73.3, 73.2, 72.4, 72.0, 71.8, 71.7, 70.0, 69.3, 69.2, 61.8, 61.6, 61.3, 61.1. 
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   53      60 
2-O-(!-D-mannopyranosyl)-D-glucopyranose (60).  Benzyl 3,4,6-tri-O-benzyl-2-O-
(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-"-D-glucopyranoside (53) (23 mg, 26 
µmol) was dissolved in EtOH (2 mL).  Palladium (10% on carbon, 10 mg) was added, 
and the mixture stirred under an atmosphere of hydrogen at ambient temperature.  After 
23 hours, the reaction mixture was filtered through a pad of Celite.  The solvent was 
evaporated, and the residue dissolved in MeOH (2 mL).  To this solution, sodium metal 
(10 mg) was added.  The mixture was stirred for 22 hours at ambient temperature, 
neutralized with Dowex 50W X-8 (H+) resin, and filtered.  The solvent was evaporated 
under reduced pressure to furnish disaccharide 60, a mixture of anomers, as a syrup (8.5 
mg, 25 µmol, 96%). 
 
 89 
Rf: 0.60 (2:8 H2O/MeOH) 
1
H NMR (D2O, 400 MHz) $ (ppm) 5.46 (d, 0.5H, J = 3.2 Hz), 5.27 (s, 0.5H), 5.03 (s, 
0.5H), 5.73 (d obscured by solvent peak, J = 8.0 Hz), 4.00-3.36 (m, 12H). 
13
C NMR (D2O, 101 MHz) $ (ppm) 100.4, 97.8, 96.8, 89.7, 79.6, 76.5, 75.5, 75.0, 73.4, 
71.9(2), 71.0, 70.9, 70.3, 70.1, 67.2(2), 61.5, 61.4, 61.2. 
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  54       61 
1,2,4,6-tetra-O-acetyl-3-O-(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-D-
glucopyranose (61).  Benzyl 2,4,6-tri-O-benzyl-3-O-(2,3,4,6-tetra-O-acetyl-"-D-
galactopyranosyl)-"-D-glucopyranoside (54) (68 mg, 78 µmol) was dissolved in EtOH (3 
mL).  Palladium (10% on carbon, 40 mg) was added, and the mixture stirred under an 
atmosphere of hydrogen at ambient temperature.  After 30 hours, the reaction mixture 
was filtered through a pad of Celite and concentrated.  The crude product was acetylated 
with a mixture of acetic anhydride (2 mL) and pyridine (2 mL) at ambient temperature.  
After stirring for 24 hours, the volatiles were evaporated under reduced pressure.  The 
residue was purified by flash chromatography on silica gel, using 50% ethyl acetate in 
hexanes as eluant, to furnish the peracetylated disaccharide 61, a 1:1 mixture of anomers, 
as a white foam (46 mg, 68 µmol, 87%). 
 
Rf: 0.28 (50% EtOAc/hexanes) 
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1
H NMR (CDCl3, 400 MHz) $ (ppm) 6.25 (d, 0.5H, J = 4.0 Hz, H-1
II), 5.62 (d, 0.5H, J = 
8.4 Hz, H-1II), 5.36 (t, 1H), 5.15-5.00 (m, 3H), 4.97-4.92 (m, 1H), 4.60 (d, 0.5H, J = 8.0 
Hz, H-1I), 4.56 (d, 0.5H, J = 8.0 Hz, H-1I), 4.28-3.87 (m, 7H), 3.82-3.78 (m, 0.5H), 2.21 
(s, 1.5H), 2.16 (s, 1.5H), 2.15 (s, 1.5H), 2.11-2.05 (m, 13.5H),  2.03 (s, 1.5H), 1.99 (s, 
1.5H), 1.97 (2 s, 3H). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 171.0, 170.9, 170.7, 170.6, 170.5(2), 170.4(2), 
169.6, 169.5, 169.4, 169.3(2), 169.0(2), 101.4, 101.3, 92.0, 89.4, 78.6, 77.6, 75.9, 73.0, 
72.1, 71.4, 71.2, 70.8, 70.5, 70.1, 69.0, 68.9, 68.0, 67.8, 67.0, 66.9, 62.0, 61.9, 61.1, 60.9, 
21.2, 21.0, 20.9, 20.8, 20.6.  
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  61       62 
3-O-("-D-galactopyranosyl)-D-glucopyranose (62). 1,2,4,6-tetra-O-acetyl-3-O-
(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-D-glucopyranose (61) (11 mg, 16 µmol) 
was dissolved in MeOH (4 mL).  Sodium metal (0.5 mg) was added, and the mixture 
stirred for 90 minutes at room temperature.  The mixture was neutralized with Dowex 
50W X-8 (H+) resin, filtered, and concentrated to give the deprotected disaccharide 62 as 
a syrup (5 mg, 15 µmol, 93%). 
 
Rf: 0.53 (2:8 H2O/MeOH) 
 91 
1
H NMR (D2O, 400 MHz) $ (ppm) 5.24 (d, 0.4H, J = 3.6 Hz), 4.68 (d, 0.6H, J = 8.4 Hz), 
4.64 (d, 0.6H, J = 7.2 Hz), 4.57 (d, 0.2H, J = 8.0 Hz), 3.95-3.41 (m, 11.5H), 3.25-3.15 
(m, 0.5H). 
13
C NMR (D2O, 101 MHz) $ (ppm) 104.1, 104.0, 96.3, 92.6, 85.4, 83.2, 76.2, 76.0, 75.8, 
74.4, 73.2, 71.9(2), 71.8, 71.6, 69.2, 68.9, 61.7, 61.4, 61.2. 
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   55     63 
1,2,4,6-tetra-O-acetyl-3-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-D-
glucopyranose (63).  Benzyl 2,4,6-tri-O-benzyl-3-O-(2,3,4,6-tetra-O-acetyl-!-D-
mannopyranosyl)-"-D-glucopyranoside (55) (120 mg, 138 µmol) was dissolved in EtOH 
(5 mL).  Palladium (10% on carbon, 50 mg) was added.  The mixture was stirred under 
an atmosphere of hydrogen at ambient temperature for 18 hours, then filtered through a 
pad of Celite.  The solvent was evaporated, and the crude product acetylated with a 
mixture of acetic anhydride (2 mL) and pyridine (2 mL) at ambient temperature.  After 
stirring for 12 hours, the volatiles were evaporated under reduced pressure.  The residue 
was purified by flash chromatography on silica gel, using 50% ethyl acetate in hexanes as 
eluant, to furnish the peracetylated disaccharide 63 as a syrup (79 mg, 116 µmol, 84%).  
The product was isolated as a 1:1 mixture of anomers. 
 
 92 
Rf: 0.32 (50% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 6.25 (s, 0.5H, J = 4.0 Hz, H-1
II), 5.71-5.69 (dd, 
0.5H), 5.54 (t, 0.5H), 5.30-5.20 (m, 3H), 5.02-4.96 (m, 3H), 4.46 (t, 1H), 4.26-4.17 (m, 
2H), 4.08-4.03 (m, 2.5H), 3.87 (t, 1H), 3.79-3.74 (m, 0.5H), 2.20-1.98 (m, 24H). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 170.8, 170.7(2), 170.3(2), 170.1(2), 170.0, 169.8, 
169.1(2), 100.1, 100.0, 91.6, 89.2, 77.5(2), 77.4, 74.3, 73.6, 71.3, 70.9, 70.8, 70.1(2), 
70.0, 69.8, 68.6, 68.5, 66.0(2), 62.6, 62.5, 62.3(2), 21.1, 21.0(2), 20.9(2), 20.8(2), 20.7. 
 
O
AcO
OAc
AcO OAc
O
AcO
O
AcO
AcO
OAc
O
HO
OH
OH OH
O
HO
O
HO
HO
OH
 
   63     64 
3-O-(!-D-mannopyranosyl)-D-glucopyranose (64). 1,2,4,6-tetra-O-acetyl-3-O-
(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-D-glucopyranose (63) (14.5 mg, 16.6 
µmol) was dissolved in methanol (2 mL).  Sodium metal (10 mg) was added, and the 
mixture stirred at ambient temperature for 24 hours. The mixture was neutralized with 
Dowex 50W X-8 (H+) resin, filtered, and concentrated to give the deprotected 
disaccharide 64 as a syrup (5.4 mg, 15.8 µmol, 95%). 
 
Rf: 0.55 (2:8 H2O/MeOH) 
1
H NMR (D2O, 400 MHz) $ (ppm) 5.25-5.21 (m, 1H), 4.65 (d, 0.6H, J = 8.0 Hz, H-
1I(")), 4.05-3.25 (m, 12H). 
 93 
13
C NMR (D2O, 101 MHz) $ (ppm) 101.6, 101.5, 96.6, 94.7, 92.9, 82.7, 80.1, 76.3, 73.5, 
73.4, 71.9, 71.0, 70.9, 70.8, 70.7, 67.5, 67.2, 67.1, 61.6, 61.5, 61.3, 61.2, 61.0. 
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   56      65 
4-O-(!-D-mannopyranosyl)-D-glucopyranose (65). Benzyl 2,3,6-tri-O-benzyl-4-O-
(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-D-glucopyranose (56) (53 mg, 78 µmol) 
was dissolved in EtOH (3 mL).  Palladium (10 wt% on carbon) was added.  The mixture 
was stirred at ambient temperature under a hydrogen atmosphere for 48 hours.  The 
mixture was filtered through Celite and the solvent evaporated under reduced pressure.  
The residue was dissolved in MeOH (3 mL).  Sodium metal (10 mg) was added, and the 
mixture stirred at ambient temperature for 3 hours. The mixture was neutralized with 
Dowex 50W X-8 (H+) resin, filtered, and concentrated to give the deprotected 
disaccharide 65 as a syrup (26 mg, 76 µmol, 97%). 
 
Rf: 0.58 (2:8 H2O/MeOH) 
1
H NMR (D2O, 400 MHz) $ (ppm) 5.27 (d, 1H, J = 1.6 Hz, H-1
II), 5.21 (d, 0.5H, J = 3.6 
Hz, H-1I(!)), 4.62 (d, 0.5H, J = 8.0 Hz, H-1I(")),  4.07-4.02 (m, 1H), 3.90-3.51 (m, 
10.5H), 3.25-3.21 (m, 0.5H). 
13
C NMR (D2O, 101 MHz) $ (ppm) 102.1, 102.0, 96.4, 92.5, 77.0, 76.9, 76.8, 75.2, 74.9, 
74.4, 73.9, 72.1, 71.0, 70.9, 70.7, 67.2, 61.5(2), 61.3. 
 94 
 
O
BnO
BnO
O
BnO
OBn
O
AcO
AcO
OAc
AcO
O
HO
HO
O
HO
O
HO
HO
OH
HO
OH
 
   57      66 
6-O-("-D-galactopyranosyl)-D-glucopyranose (66). Benzyl 2,3,4-tri-O-benzyl-6-O-
(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-"-D-glucopyranoside (57) (51 mg, 59 
µmol) was dissolved in EtOH (10 mL).  Palladium (10% on carbon, 20 mg) was added to 
the solution.  The mixture was stirred at ambient temperature under a hydrogen 
atmosphere for 48 hours, then filtered through a pad of Celite.  The solvent was 
evaporated under reduced pressure, and the residue dissolved in MeOH (10 mL).  Sodium 
metal (5 mg) was added, and the mixture stirred at ambient temperature for 1 hour.  The 
mixture was neutralized with Dowex 50W X-8 (H+) resin and filtered.  The solvent was 
evaporated under reduced pressure to yield disaccharide 66 as a syrup (20 mg, 59 µmol, 
99%). 
 
Rf: 0.58 (2:8 H2O/MeOH) 
1
H NMR (D2O, 400 MHz) $ (ppm) 5.22 (d, 0.47H, J = 3.2 Hz, H-1
I(!)), 4.65 (d, 0.53H, 
J = 8.0 Hz), 4.43 (apparent t, 2 overlapping doublets, 1H), 4.22-4.14 (dd, 1H), 4.01-3.43 
(m, 10.4H), 3.27-3.22 (m, 0.6H). 
13
C NMR (D2O, 101 MHz) $ (ppm) 104.0, 96.6(2), 92.8, 76.3, 75.8(2), 75.5, 74.7, 73.3, 
72.1, 71.4, 71.1, 70.1, 70.0, 69.3, 69.2, 61.6. 
 
 95 
O
BnO
BnO
O
BnO
OBn
O
OAc
AcO
AcO
AcO
O
HO
HO
O
HO
O
OH
HO
HO
HO
OH
 
   58      67 
6-O-(!-D-mannopyranosyl)-D-glucopyranose (67). Benzyl 2,3,4-tri-O-benzyl-6-O-
(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-"-D-glucopyranoside (58) (31 mg, 36 
µmol) was dissolved in MeOH (2 mL) and EtOAc (0.5 mL).  Palladium (10% on carbon, 
10 mg) was added to the solution.  After stirring at ambient temperature under a hydrogen 
atmosphere for 48 hours, the mixture was filtered through a pad of Celite.  The solvent 
was evaporated under reduced pressure, and the residue dissolved in MeOH (2 mL).  
Sodium metal (5 mg) was added, and the mixture stirred at ambient temperature for 48 
hours.  The mixture was neutralized with Dowex 50W X-8 (H+) resin and filtered.  The 
solvent was evaporated under reduced pressure to yield disaccharide 67 as a syrup (12 
mg, 35 µmol, 97%). 
 
Rf: 0.19 (1:1:3 H2O/MeOH/EtOAc) 
1
H NMR (D2O, 400 MHz) $ (ppm) 5.07 (d, 0.4H, J = 3.2 Hz), 4.74-4.72 (d, 1H), 4.49 (d, 
0.6H, J = 8.0 Hz), 3.85-3.03 (m, 12H). 
13
C NMR (D2O, 101 MHz) $ (ppm) 100.1(2), 96.6, 92.7, 76.4, 74.6, 74.5, 73.5, 73.2, 
71.9, 71.1, 70.6, 70.4, 70.0, 67.2, 61.4. 
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CHAPTER 3 
Development of Automation Protocols for the Solution-Phase Synthesis of 
Beta-Glucan Fragments 
Abstract 
 Beta-glucans are oligosaccharides composed of repeating D-glucose units 
connected by beta glycosidic linkages.   Found in plants, bacteria, and fungi, the beta-
glucans vary considerably in terms of branching patterns between species.  Beta-glucans 
have been shown to possess a number of interesting biological properties, including 
general stimulation of the innate immune system.  The exact molecular determinants 
responsible for these properties remain unclear.  Access to a library of structurally well-
defined beta-glucan fragments would facilitate the systematic study of the structure-
function relationships of this class of oligosaccharides.  Iterative chemical synthesis 
offers the advantage of providing pure samples of beta-glucan fragments.  Furthermore, 
automation of this chemistry has the potential to provide rapid access to structural 
diversity by assigning the many rote chemical operations involved in iterative synthesis 
to a robotic synthesizer platform.  This chapter describes the development of methods for 
the automated iterative solution-phase synthesis of branched beta-glucan fragments from 
monosaccharide building blocks.  Three new glucose building blocks were synthesized 
and used to construct a 3,6-branched beta-glucan tetrasaccharide.  Through this work, a 
general strategy for the automated synthesis of beta-glucan fragments has been 
established.  This strategy can be applied to the synthesis of a library of other linear and 
branched glucan structures. 
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Introduction 
 Beta-glucans are oligomers of D-glucose residues joined by beta glycosidic 
bonds.  These compounds can be obtained from a number of natural sources, including 
plants, bacteria, and fungi.  The structures and physical properties of beta-glucans vary 
considerably based on the source species.  Beta-glucans have been shown to possess a 
number of biological properties, including cholesterol-lowering effects, anti-
inflammatory properties, and immunomodulatory activity.1  Beta-glucans have emerged 
as a major target for the recognition of pathogens by the innate immune system.  A 
number of beta-glucan receptors have been discovered in vertebrates.2  The 
transmembrane protein Dectin-1, in particular, has been studied extensively in recent 
years.  Dectin-1 recognizes particulate and soluble glucans from plants, fungi, and 
bacteria, and serves as the primary receptor for these carbohydrates on white blood cells.3   
Dectin-1 can induce a number of cellular responses to fungal pathogens, including 
phagocytosis and killing and the induction of cytokines and chemokines.  Further 
research is required to develop a more detailed understanding of the roles Dectin-1 plays 
in antifungal immunity.  Access to a structurally defined library of beta-glucan fragments 
would greatly facilitate the study of the specificity of Dectin-1 with respect to the chain 
length and branching pattern of its beta-glucan ligand.  Although beta-glucans can be 
obtained from natural sources, they are often isolated as heterogeneous mixtures.  
Chemical synthesis offers the advantage of producing pure, structurally well-defined 
samples of beta-glucan fragments. 
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 A number of syntheses of beta-glucan structures have been reported in the 
literature.  Larsson and coworkers prepared tetra- and pentasaccharides related to the 
capsular polysaccharide of S. pneumoniae.4  Kong and coworkers have published several 
syntheses of 3,6-branched "-D-glucose oligosaccharides.5a-e  Similarly, He and coworkers 
synthesized branched glucose tetra-, penta-, and hexasaccharides, relying on a key 3,6-
branched trisaccharide trichloroacetimidate donor for the installation of branch points.6  
These syntheses rely upon convergent approaches using di-, tri- and tetrasaccharide 
building blocks.  In contrast to these convergent approaches, Jamois and coworkers 
reported the synthesis of linear "-(1,3)-glucans by an iterative approach using a single 
monosaccharide building block.7   
The main advantage of the iterative approach to oligosaccharide synthesis is the 
ability to incorporate any desired monosaccharide residue into a growing oligosaccharide 
chain.  By relying on the use of monosaccharide building blocks, chemists can avoid 
using complex synthetic intermediates such as di- and trisaccharide building blocks as 
glycosyl donors.  Since glycosyl donors must be used in excess to ensure high 
glycosylation yields, considerable amounts of these building blocks end up as waste.  
This is especially problematic when the building blocks are extremely costly to prepare, 
as is generally the case with di-, tri-, and higher oligosaccharide donors.  Despite its 
advantages, iterative oligosaccharide synthesis involves multiple cycles of time-
consuming and labor-intensive glycosylation and deprotection steps.  The automation of 
rote, repetitive tasks such as these would greatly reduce the amount of manual labor 
involved in oligosaccharide synthesis. 
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 The automation of peptide and nucleic acid synthesis based on solid-phase 
synthetic methodologies has fueled the development of the fields of proteomics and 
genomics.  Custom-made nucleic acid or peptide sequences can be purchased from a 
number of online vendors.  Unfortunately, commercial custom oligosaccharide synthesis 
is not yet a reality.  Bruce Merrifield’s development of solid-phase peptide synthesis in 
the 1960s provided a means for the rapid synthesis of peptides.8  Shortly thereafter, other 
researchers began to apply this methodology to oligosaccharide synthesis.   The first 
report of solid-phase carbohydrate synthesis was made by Frechet and Schuerch 
presented the first report of solid-phase carbohydrate synthesis in 1971.9  After a 
prolonged lull in activity in this area, Plante and coworkers reported the automated solid-
phase synthesis of oligosaccharides in 2001.10  However, solid-phase synthesis has a 
number of limitations that have prevented its widespread use in oligosaccharide 
synthesis.  For example, large excesses of sugar building blocks (10-20 equivalents per 
coupling cycle) must be used to ensure that high coupling efficiencies are obtained.  
Furthermore, reaction monitoring on the solid phase is often difficult.  The development 
of an alternative phase-switching approach that offers the purification advantages of solid 
phase synthesis with the advantages of solution-phase chemistry and reaction monitoring 
would facilitate the advancement of automated oligosaccharide synthesis. 
 
Results and Discussion 
 The primary goal of this work was to develop a reliable method for the automated 
solution-phase synthesis of branched and linear beta-glucan fragments.  The synthesis of 
3,6-branched beta-glucan structures such as those found on fungal cell walls was of 
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particular importance.  For example, synthetic glucan fragments could be assayed for 
binding with Dectin-1 in order to determine the ligand specificity of this glucan-binding 
protein.  With this in mind, the 3,6-branched tetrasaccharide 18 was chosen as our initial 
synthetic target (Figure 3.1).  The synthesis of compound 18 via an iterative approach 
would require differentiation of O-3 and O-6 of the branch point glucosyl residue to 
allow for subsequent independent chain extension from these positions.  The protocols 
developed for the synthesis of 18 could then be applied to other branched beta-glucan 
structures.  
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Figure 3.1. Initial synthetic target tetrasaccharide 18  
 The first task in the course of this work was the synthesis of a set of suitable 
protected glucose building blocks.  Retrosynthetic analysis shows that three 
monosaccharide building blocks and one fluorocarbon-based aglycon are needed to 
construct "-(1#3)-glucan fragments containing "-(1#6) branches using an iterative 
approach (Figure 3.2).  The alkene-functionalized fluorous tag A provides a handle for 
the purification of intermediates by fluorous solid-phase extraction (FSPE) during the 
synthesis.  The C-C double bond provides a functional handle for the cleavage of the 
fluorous tag from the sugar chain following completion of the synthesis.  The 
monosaccharide building blocks B, C, and D share three common features.  First, they 
possess an anomeric leaving group (LG) that, upon activation, will generate an 
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electrophilic species that can be attacked by a nucleophilic hydroxyl group to form a 
glycosidic bond.  Second, each building block features a protecting group P1 at the O-2 
position.  The use of an ester protecting group at the O-2 position is necessary to provide 
stereochemical control of each newly formed glycosidic linkage through neighboring 
group participation (Figure 3.3).  Third, each building block contains permanent 
protecting groups (R) that will remain in place for the duration of the synthesis.  The 
temporary protecting groups P2, P3, and P4 must be carefully selected.  In particular, the 
groups P2 and P3 must be orthogonal in order to allow for independent chain extension 
from the O-3 and O-6 positions of the branch point glucose unit. 
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Figure 3.2. Retrosynthesis of a branched 1,3-glucan tetrasaccharide fragment.  R = 
permanent protecting group; P1 = semi-permanent group capable of neighboring group
participation during glycosylation reactions; P2, P3, P4 = temporary protecting groups.  
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 Based on the considerations developed from our retrosynthetic plan, the synthesis 
of three monosaccharide building blocks 8, 11, and 15 was carried out (Schemes 1 and 2).  
The requisite ester functionality at the O-2 position of each building block was fulfilled 
using the trimethylacetyl group, commonly referred to as pivaloate (Piv).  The sterically 
bulky pivaloate group was chosen because it is less likely to cause transacylation of the 
glycosyl acceptor, a common side reaction during glycosylation reactions.11  Benzyl 
ethers were chosen as permanent protecting groups, and can be cleaved by catalytic 
hydrogenation or alkali metal reduction at the end of the synthesis.  The selection of 
temporary protecting groups required careful consideration.  Since each building block 
contains a pivaloate group, any ester group we choose as a temporary protecting group 
must be removed under conditions that will not result in the cleavage of the pivaloate 
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group.  One such ester group that has gained popularity in oligosaccharide synthesis in 
recent years is the levulinate (4-oxopentanoate, Lev) group.  The levulinate ester can be 
formed efficiently by reaction of an alcohol with levulinic acid in the presence of the 
coupling reagent N,N’-Dicyclohexylcarbodiimide (DCC).  More importantly, levulinate 
esters are commonly cleaved using hydrazine in pyridine and acetic acid, conditions that 
are compatible with acetate and pivaloate groups.  Lastly, the acetate group was chosen 
as a temporary protecting group on the O-6 position of building block 11.  We 
hypothesized that cleavage of the acetate ester at O-6 using sodium methoxide in 
methanol would occur much more rapidly than the cleavage of a sterically hindered O-2 
pivaloate group. This difference in reaction rate would allow us to selectively deblock the 
O-6 position for incorporation of a second sugar chain from the branch point glucose 
unit.  
 The syntheses of 8 and 11 commenced from the known glucose derivative 1, 
which was prepared in three steps from D-glucose following published procedures.12  
Esterification of the O-3 hydroxyl group with levulinic acid and DCC gave rise to the 
crystalline derivative 2 in 87% yield.  The benzylidene acetal in 2 was cleaved using 
aqueous TFA in dichloromethane to furnish diol 3 in nearly quantitative yield.  The 
conversion of diol 3 to the 4,6-di-O-benzyl derivative 4 proved to be quite challenging. 
Exposure of 3 to strongly basic conditions (BnBr, NaH, DMF) resulted in an intractable 
mixture of products, likely due to ester group migration.  Treatment of 3 with excess 
benzyl trichloroacetimidate and catalytic TfOH13 did result in the formation of 4, but low 
yields and time-consuming chromatographic purification steps prevented this from being 
a viable synthetic option.  Treating 3 with Dudley’s benzylating reagent, N-methyl 2-
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benzyloxypyridinium triflate,14 in toluene gave no reaction, even after prolonged heating.  
Treatment of 3 with excess benzyl bromide and silver (I) oxide in dichloromethane at 
ambient temperature reproducibly gave a mixture of the dibenzyl derivative 4 and 
monobenzyl derivatives 5 and 6.  Flash chromatography was used to separate compound 
4 from the monobenzyl derivatives 5 and 6.  In this manner, the desired dibenzyl 
derivative 4 could be obtained in 35-40% yield.  The monobenzyl derivatives 5 and 6 
were isolated as a mixture, generally in 55-60% yield.  The mixture of 5 and 6 could be 
resubjected to the benzylation conditions to produce additional 4 in low yield.  Attempts 
to facilitate complete conversion of 3 to 4 by using more forcing conditions (Ag2O, BnBr, 
DMF, heat) resulted in significant decomposition of the starting material and were not 
pursued further.  Nevertheless, gram quantities of 4 could be obtained by the mild silver 
oxide-mediated benzylation of 3.  Allyl ether 4 was subjected to iridium-catalyzed olefin 
isomerization15 followed by hydrolysis of the resulting vinyl ether to give the reducing 
sugar 7 in 70% yield.  Lactol 7 was treated with trichloroacetonitrile in the presence of 
Cs2CO3 to generate the trichloroacetimidate 8, solely the ! isomer, in 82% yield. 
 The mixture of mono-O-benzylated derivatives 5 and 6 obtained from the 
benzylation of 3 were difficult to separate chromatographically.  Rather than performing 
this separation, the mixture of 5 and 6 was treated with acetyl chloride and 2,6-lutidine in 
dichloromethane at -78 °C, conditions that selectively acetylate primary alcohols in the 
presence of secondary alcohols.16  Following this reaction, the 6-O-acetyl derivative 9 
was easily separated from the unreacted secondary alcohol 5 by flash chromatography.  
The allyl ether in 9 was cleaved via olefin isomerization and hydrolysis of the resulting 1-
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propenyl ether to furnish reducing sugar 10 in 91% yield.  Lactol 10 was then converted 
to its trichloroacetimidate derivative 11, only the ! anomer, in 84% yield. 
 Next, the capping building block 15 was synthesized.  The known alcohol 1217 
was protected as its pivaloate ester 13 in 86% yield.  The allyl ether was cleaved to give 
lactol 14.  Treatment of 14 with trichloroacetonitrile and Cs2CO3 provided the desired 
trichloroacetimidate 15 in 82% yield. 
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Scheme 1.  Synthesis of linear 1,3-glucan building block 8 and 3,6-branch point 
building block 11. a) Levulinic acid, DCC, DMAP,CH2Cl2, 0 
oC to rt, overnight, 87%; 
b) 60% TFA (aq.), CH2Cl2, 0 
oC to rt, 1.5 h, 97%; c) BnBr, Ag2O, CH2Cl2, rt, 40 h, 
37% (4), 60% (5 & 6); d) [Ir(COD)(PMePh2)2]PF6, H2, THF, rt, then HgCl2, HgO, 
acetone, H2O, rt, 70% for 7, 91% for 10; e) Cl3CCN, Cs2CO3, CH2Cl2, rt, 82% for 8,
84% for 11; f) AcCl, 2,6-lutidine, CH2Cl2, -78 
oC, 1h, 40% (9), 56% (5).  
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Scheme 2.  Synthesis of capping building block 15. a) PivCl, pyr, DMAP, rt, 42 h, 86%;
b) [Ir(COD)(PMePh2)2]PF6, H2, THF, rt, 18 h, then HgCl2, HgO, acetone, H2O, rt, 2 h,
88%; c) Cl3CCN, Cs2CO3, CH2Cl2, rt, 82%.
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 Fluorous tagged monosaccharide 17 was synthesized as an initial glycosyl 
acceptor for further chain elongation on the Chemspeed ASW-1000 synthesizer (Scheme 
3).  The fluorous tag provides a handle for the facile purification of synthetic 
intermediates by fluorous solid-phase extraction (FSPE).  The alkene-containing fluorous 
alcohol 1618 was glycosylated with branch point glucosyl donor 11 in toluene in the 
presence of TMSOTF.  The crude product was directly treated with hydrazine hydrate in 
pyridine and acetic acid to cleave the 3-O-levulinoyl group, and the product purified by 
fluorous solid-phase extraction to provide alcohol 17 in 99% yield over 2 steps.  
HO O
F17C8
1) 11, TMSOTf, Toluene,
    rt, 20 min
16
O
HO
PivO
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BnO
2) Hydrazine hydrate,
    3:2 Pyr/HOAc, CH2Cl2,
    rt, 90 min
    99% over 2 steps
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Scheme 3. Synthesis of fluorous-tagged branch point glucose acceptor 17.  
 With the fluorous-tagged acceptor 17 and the requisite monosaccharide building 
blocks 8 and 15 in hand, we set out to develop an automated synthesis of the branched "-
glucan tetrasaccharide fragment 18 on the Chemspeed ASW-1000 automated synthesis 
workstation (Scheme 4). As shown in Scheme 4, a typical automated synthesis cycle 
consists of three main components: a glycosylation task, a deprotection task, and a 
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fluorous solid-phase extraction (FSPE) task.  In the first glycosylation task, solutions of 
the acceptor and donor are transferred to a reaction vial, followed by the addition of a 
solution of the activating agent, TMSOTf. Following the designated reaction period, the 
reaction is quenched by the addition of triethylamine and the volatiles evaporated.  
Initially, we thought it would be necessary to purify the glycosylation product by FSPE 
prior to the deprotection step.  However, the presence of spent glycosyl donor and any 
salts present in the crude glycosylation product did not affect the deprotection reactions. 
Thus, the crude product following the glycosylation cycle is directly subjected to the 
deprotection reagent, obviating an FSPE purification between the glycosylation and 
deprotection cycles.  Following the deprotection cycle, the crude product is purified by 
FSPE.  The eluate containing the desired fluorous compound is then returned to a 
reaction vial, where the solvent is evaporated prior to the next glycosylation-deprotection 
cycle.  Using the basic synthetic protocols developed by other group members for the 
synthesis of linear mannose and rhamnose oligomers as a starting point, a program was 
developed to perform the synthesis of tetrasaccharide 18. 
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Scheme 4. Automated synthesis of branched tetrasaccharide 18.  
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 The synthesis of 18 was then carried out on the ASW-1000 platform.  To 
complete the synthesis, 2.5 automated cycles were necessary.  In the first glycosylation 
cycle, toluene solutions of acceptor 17 and donor 8 were delivered to a clean reaction 
vial.  The reactor block was cooled to 0 °C.  A solution of TMSOTf in CH2Cl2 was added 
to the reaction mixture, which was vortexed for 40 minutes at 0 °C.  A small aliquot was 
withdrawn from the reaction mixture and dispensed to a 96-well plate for analysis by 
TLC.  The reaction was quenched by the addition of triethylamine, and the solvents were 
evaporated from the reaction mixture.  In order to avoid excessive bumping of the solvent 
during the evaporation cycle, the ASW-1000 was programmed to incrementally reduce 
the pressure over several specified time intervals.  Next, the delevulination cycle was 
carried out.  The initial optimization of the ASW-1000 carried out by other group 
members was done using acetate protecting groups.  As a result, the deprotection cycle 
was modified to reflect the shorter time required for levulinate cleavage as compared to 
that for deacetylation.  In addition, the evaporation temperature was increased from 40 °C 
to 60 °C to facilitate complete evaporation of the less volatile pyridine/acetic acid 
mixture.  A 1.0M solution of hydrazine hydrate in a 3:2 (v/v) mixture of pyridine and 
acetic acid was delivered to the crude glycosylation product, along with CH2Cl2 as a 
cosolvent. The mixture was vortexed for 40 minutes, and a sample of the reaction mixture 
delivered to the 96-well plate for TLC analysis.  The excess hydrazine was destroyed by 
the addition of acetone, and the solvents removed under reduced pressure at 60 °C.  DMF 
was added, and the mixture vortexed to dissolve the crude product.  The solution of the 
product was loaded onto a 2 gram FSPE cartridge located in the SPE rack.  The 
nonfluorous compounds were eluted to waste using 80% aqueous MeOH.  Next, the 
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desired fluorous product was eluted into a vial located directly below the SPE block by 
using 100% MeOH.  Because the ASW-1000 is equipped with a bevel-tipped septum-
piercing needle for solution transfers, we initially experienced problems with incomplete 
transfer of the purified product from the vial below the SPE rack to the next reaction vial.  
By switching from a flat-bottomed SPE collection vial to a conical-bottomed vial, we 
were able to achieve more complete transfer of the purified product to the next reaction 
vial.  Toluene was added to the reaction vial, and the solvents evaporated.  Two 
additional toluene addition/evaporation cycles were carried out to facilitate the azeotropic 
removal of water from monosaccharide acceptor prior to the next glycosylation reaction.   
The second synthetic cycle was carried out in a similar fashion as the first cycle.  
Glucosyl donor 15 was used to install the chain-terminating glucose unit.  During the 
deprotection step, the 6-O-acetyl group on the reducing-end glucose unit was cleaved 
using 0.5M NaOMe in MeOH for 2 hours at room temperature.  No evidence of cleavage 
of the 2-O-pivaloyl groups was observed based on TLC analysis.  Following FSPE and 
evaporation of the solvent, the final glucose monomer was introduced using building 
block 15.  After evaporation of the solvent and a final FSPE purification, the crude 
product was subjected to silica gel flash chromatography to yield tetrasaccharide 18 in 
9.4% overall yield over 5 chemical steps, resulting in an average per step yield of 62%. 
 
Conclusion 
 The automated synthesis of tetrasaccharide 18 described in this chapter provides 
experimental support for a number of hypotheses proposed at the onset of this work.  
First, the C-3 and C-6 hydroxyl groups of branch point glucose unit could be successfully 
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differentiated by using a levulinate protecting group at O-3 and an acetate group at O-6.  
A sugar chain could be extended from the O-3 position of the branch point sugar unit, 
and capped using glucose building block 15.  Second, the 6-O-acetyl group on the branch 
point sugar unit could be selectively cleaved in the presence of several 2-O-pivaloyl 
groups, providing a reactive hydroxyl group for further chain extension.  The synthetic 
utility of the monosaccharide building blocks 8, 11, and 15 was also demonstrated in 
terms of both their reactivity and stereoselectivity as glycosyl donors.  Furthermore, the 
general automation protocols developed during initial optimization of the ASW-1000 
platform proved to be applicable to the synthesis of branched glucan fragments.  Only 
slight modifications of the deprotection cycles were needed to accommodate the 
additional deprotection reagents and conditions needed for the synthesis of branched 
structures.  A single set of conditions for the automated fluorous solid-phase extraction 
cycle could be used regardless of the oligosaccharide being produced, demonstrating that 
fluorous-fluorous interactions are indeed strong enough for reliable phase separation of 
organic and fluorinated compounds. 
 
Experimental Section 
 
General Materials and Methods 
Reaction solvent dichloromethane was obtained from a commercial solvent purification 
tower or distilled from calcium hydride.  Reaction solvents tetrahydrofuran and toluene 
were obtained from a commercial solvent purification tower.  Dowex 50W X-8 (H+) resin 
was washed repeatedly with MeOH prior to use.  Powdered 4Å molecular sieves were 
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purchased from Aldrich Chemical Company and were activated by heating in a furnace at 
250 °C overnight prior to use.  All other reagents were used as received without further 
purification.  Reactions were monitored and the Rf values determined using analytical 
TLC with Sorbent Technologies silica gel plates (60F-254).  Developed TLC plates were 
visualized by immersion in 10% ethanolic sulfuric acid solution, or in acidic p-
anisaldehyde solution, followed by heating on a hot plate.  Moisture-sensitive reactions 
were run in flame- or oven-dried glassware under a nitrogen atmosphere.  Bath 
temperatures were used to record the reaction temperature for reactions performed at 
elevated or sub-ambient temperatures.  All reactions were stirred magnetically at ambient 
temperature unless otherwise indicated.  Manual flash chromatography was performed 
using Sorbent Technologies silica gel (60F-254), and the solvent systems outlined in the 
experimental procedures.  Automated flash chromatography was carried out on a Biotage 
SP-1 chromatography workstation fitted with either a Biotage 12M or 25M silica gel 
cartridge, using ethyl acetate/hexane gradients as outlined in the experimental procedures. 
1H NMR and 13C NMR spectra were obtained with a Bruker DRX400 at 400 MHz and 
101 MHz, respectively.  1H NMR spectra were reported in parts per million ($) relative to 
CDCl3, CD3OD, D2O, or TMS (7.27 ppm, 4.84 ppm, 4.81 ppm, and 0.00 ppm, 
respectively) as internal references.  13C NMR spectra were reported in parts per million 
($) relative to CDCl3 or CD3OD (77.23 ppm or 49.15 ppm, respectively).  For 
13C NMR 
spectra obtained in D2O, chemical shifts are reported relative to acetone as an internal 
standard (215.94 and 30.89 ppm). 
 
Synthetic Procedures 
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Allyl 4,6-O-benzylidene-3-O-levulinoyl-2-O-pivaloyl-!-D-glucopyranoside (2).   
Allyl 4,6-O-benzylidene-2-O-pivaloyl-!-D-glucopyranoside12 (1) (4.083 g, 10.4 mmol) 
was dissolved in dichloromethane (75 mL) and cooled to 0 °C.  N,N’-
dicyclohexylcarbodiimide (2.57 g, 12.48 mmol) and levulinic acid (1.59 mL, 15.6 mmol) 
were added to the solution. The reaction mixture was then allowed to warm to ambient 
temperature. After 2 h, additional N,N’-dicyclohexylcarbodiimide (400 mg, 1.9 mmol) 
and levulinic acid (0.5 mL,  5.0 mmol) were added. The mixture was stirred overnight at 
ambient temperature, then filtered over Celite. The filtrate was diluted with 
dichloromethane and washed successively with NaHCO3, water, and brine, then dried 
over Na2SO4.  The solvent was evaporated under reduced pressure.  The residue was 
subjected to flash chromatography on silica gel (2:8 EtOAc/hexanes) to give the product 
contaminated with a small amount of starting material (4.71 g). Recrystallization from 
1:10 EtOAc/hexanes gave the product 2 as long colorless needles (3.92 g, 77%). The 
mother liquor was concentrated under reduced pressure and recrystallized under the same 
conditions to give a second crop of crystals (508 mg, 10%).  
 
Rf: 0.72 (3:7 EtOAc/hexanes)  
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1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.5-7.3 (m, 5H, Ar-H), 5.88-5.79 (m, 1H, 
CH2=CHCH2O), 5.66 (t, J3,2=J3,4 10.0 Hz, 1H, H-3), 5.51 (s, 1H, PhCH), 5.32 (m, 1H, 
CHaHb=CHCH2O), 5.28 (m, 1H, CHaHb=CHCH2O), 5.10 (d, J1,2 = 4.0 Hz, 1H, H-1), 
4.84-4.80 (dd, J2,1= 3.6, J2,3= 10.0 Hz, 1H, H-2), 4.31-4.27 (dd, J6,6’= 10.0, J6,5= 5.2 Hz, 
1H, H-6), 4.22-4.17 (m, 1H, CH2=CHCHaHbO), 4.00-3.93 (m, 2H, CH2=CHCHaHbO and 
H-5), 3.76 (t, J6’,6=J6’,5 10.0 Hz, 1H, H-6’), 3.65 (t, J4,5=J4,3 10.0 Hz, 1H, H-4), 2.80-2.65 
(m, 2H, CH3COCH2CH2COO), 2.63-2.52 (m, 2H, CH3COCH2CH2COO), 2.13 (s, 3H, 
CH3COCH2CH2COO), 1.19 (s, 9H, t-BuCO). 
13
C NMR (CDCl3, 100 MHz) $ (ppm) 206.2, 178.1, 171.7, 137.2, 133.4, 129.2, 128.4, 
126.4, 118.1, 101.7, 95.8, 79.4, 71.6, 69.3, 69.0, 62.7, 39.0, 38.0, 30.0, 28.0, 27.1. 
HRMS-ESI (m/z): [M+Na]+ Calcd: 513.2101; Found: 513.1945. 
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Allyl 3-O-levulinoyl-2-O-pivaloyl-!-D-glucopyranoside (3).  
Allyl 4,6-O-benzylidene-3-O-levulinoyl-2-O-pivaloyl-!-D-glucopyranoside (2) (1.96 g, 
4.00 mmol) was dissolved in dichloromethane (20 mL) and cooled to 0 °C.  Aqueous 
trifluoroacetic acid (60% v/v, 5.0 mL) was added dropwise, the ice bath removed, and the 
mixture was allowed to warm to ambient temperature with stirring. After 1.5 h, saturated 
aqueous NaHCO3 solution (20 mL) was carefully added.  The layers separated, and the 
organic layer was diluted with dichloromethane, washed successively with saturated 
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NaHCO3 solution, water, and brine, and dried over Na2SO4. The solvent was removed 
under reduced pressure, and the residue subjected to flash chromatography on silica gel 
(30% EtOAc/hexanes#100% EtOAc).  The product 3 was obtained as a colorless syrup 
(1.56 g, 3.88 mmol, 97%).  
 
Rf: 0.46 (100% EtOAc) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 5.88-5.79 (m, 1H, CH2=CHCH2O), 5.47-5.42 (m, 
1H, H-3), 5.32-5.27 (m, 1H, CHaHb=CHCH2O), 5.20-5.16 (m, 1H, CHaHb=CHCH2O), 
5.07 (d, J1,2 = 3.6 Hz, 1H, H-1), 4.76-4.73 (dd, J2,1= 3.6, J2,3= 10.0 Hz, 1H, H-2), 4.21-
4.17 (m, 1H, CH2=CHCHaHbO), 4.00-3.94 (m, 1H, CH2=CHCHaHbO), 3.87 (m, H-6, 2H, 
H-6’) 3.78 (m, 2H, H-4, H-5), 3.30-2.90 (br s, 2H, 2%OH), 2.89-2.70 (m, 2H, 
CH3COCH2CH2COO), 2.65-2.44 (m, 2H, CH3COCH2CH2COO), 2.19 (s, 3H, 
CH3COCH2CH2COO), 1.17 (s, 9H, t-BuCO).  
13
C NMR (CDCl3, 100 MHz) $ (ppm) 208.0, 178.0, 173.0, 133.5, 117.8, 95.1, 73.6, 
71.4, 70.8, 69.6, 68.7, 62.0, 38.9, 38.3, 30.0, 28.2, 27.1.  
HRMS-ESI (m/z): [M+Na]+ calcd: 425.1788; found: 425.1781.  
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Allyl 4,6-di-O-benzyl-3-O-levulinoyl-2-O-pivaloyl-!-D-glucopyranoside (4).  
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Commercial silver (I) oxide (6.00 g, 25.8 mmol) was added to a solution of allyl 3-O-
levulinoyl-2-O-pivaloyl-!-D-glucopyranoside (3) (2.60 g, 6.46 mmol) and benzyl 
bromide (3.07 mL, 25.8 mmol) in dichloromethane (50 mL).  The reaction vessel was 
wrapped in aluminum foil to exclude light, and the mixture was stirred for 40 h at 
ambient temperature. After this reaction period, TLC analysis (30% EtOAc in hexanes) 
showed the presence of the di-O-benzylated derivative 4 (Rf= 0.54) and two mono–O-
benzylated derivatives 5 and 6 (Rf= 0.18 and 0.26, respectively). The reaction mixture 
was filtered over Celite and the solvent removed under reduced pressure. The residue was 
subjected to flash chromatography on silica gel (10% EtOAc/hexanes # 100% EtOAc). 
Unreacted benzyl bromide was eluted first, followed by compound 4 as a colorless syrup 
(1.38 g, 2.36 mmol, 37%). Lastly, a mixture of compounds 5 and 6 was eluted. This 
mixture, a white semisolid (1.91 g, 3.88 mmol, 60%), was carried on to the next step 
without further purification efforts.  
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            4 
Rf: 0.54 (30% EtOAc/hexanes)  
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.38-7.14 (m, 10H, Ar-H), 5.86-5.77 (m, 1H, 
CH2=CHCH2O), 5.61 (t, J3,2=J3,4 9.6 Hz, 1H, H-3), 5.30-5.23 (m, 1H, CHaHb=CHCH2O), 
5.17-5.12 (m, 1H, CHaHb=CHCH2O), 5.08 (d, J1,2 = 3.6 Hz, 1H, H-1), 4.77-4.73 (dd, 
J2,1= 3.6, J2,3= 10.0 Hz, 1H, H-2), 4.70-4.45 (m, 4H, 2%PhCH2), 4.18-4.11 (m, 1H, 
CH2=CHCHaHbO), 3.97-3.90 (m, 1H, CH2=CHCHaHbO), 3.90-3.85 (m, 1H, H-6), 3.81-
3.74 (m, 2H, H-4, H-6’), 3.69-3.64 (dd, J5,4= 11.0, J5,6= 2.0 Hz, 1H, H-5), 2.64-2.60 (m, 
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2H, CH3COCH2CH2COO), 2.46-2.41 (m, 2H, CH3COCH2CH2COO), 2.14 (s, 3H, 
CH3COCH2CH2COO), 1.16 (s, 9H, t-BuCO).  
13
C NMR (CDCl3, 100 MHz) $ (ppm) 206.3, 178.0, 171.8, 138.1, 138.0, 133.6, 128.7, 
128.6, 128.5, 128.2, 128.1, 128.0, 127.9, 127.8, 127.2, 117.7, 95.1, 76.1, 74.6, 73.8, 72.6, 
71.4, 70.3, 68.6, 68.3, 65.5, 38.9, 37.8, 30.1, 28.1, 27.1.  
HRMS-ESI (m/z): calcd: 605.2727; found: 605.2805 [M+Na]+. 
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4,6-di-O-benzyl-3-O-levulinoyl-2-O-pivaloyl-D-glucopyranose (7).   
To a mixture of allyl 4,6-di-O-benzyl-3-O-levulinoyl-2-O-pivaloyl-!-D-glucopyranoside 
(4) (337 mg, 0.58 mmol)  and (1,5-cyclooctadiene)bis(methyldiphenylphosphine) 
iridium(I) hexafluorophosphate (5 mg, 5.8 µmol) was added anhydrous THF (3.0 mL) 
under nitrogen atmosphere. The red suspension was degassed under vacuum, then placed 
under hydrogen atmosphere for a few minutes until the mixture became a colorless, 
homogeneous solution. The solution was degassed under vacuum once more, then stirred 
at room temperature under nitrogen for 24 h.  The solvent was removed in vacuo and the 
crude vinyl ether was dissolved in 10:1 acetone/water (6 mL). Red mercuric oxide (157 
mg, 0.72 mmol) was added, followed by the dropwise addition of a solution of mercuric 
chloride (157 mg, 0.58 mmol, in 2 mL  10:1 acetone/water). The mixture was stirred 
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overnight at ambient temperature, then filtered on Celite. The filtrate was partially 
concentrated under reduced pressure, then diluted with dichloromethane. The solution 
was washed successively with saturated aqueous KI solution (30 mL) and brine (30 mL), 
and dried over Na2SO4. The solvent was removed under reduced pressure. The residue 
was subjected to flash chromatography on silica gel (1:2 EtOAc/hexanes) to provide 7, a 
~6:1 mixture of !- and "-anomers, as a white solid (219 mg, 0.40 mmol, 70% from allyl 
ether).  
 
Rf: 0.30 and 0.25 (30% EtOAc/hexanes)  
1
H NMR (CDCl3, 400 MHz, assignments for the major isomer) $ (ppm) 7.38-7.12 (m, 
10H, Ar-H), 5.61 (t, J3,2=J3,4 10.0 Hz, 1H, H-3), 5.41 (t, J1,2= J1,-OH=3.6 Hz, 1H,  H-1), 
4.78-4.74 (dd, J2,1= 3.2, J2,3= 10.0 Hz, 1H, H-2), 4.69-4.45 (m, 4H, 2%PhCH2), 4.12-4.09 
(m, 1H, H-5), 3.80-3.53 (m, 3H, H-4, H-6, H-6’), 3.10 (d, J1,-OH= 3.2Hz, 1H, -OH), 2.62-
2.56 (m, 2H, CH3COCH2CH2COO), 2.49-2.40 (m, 2H, CH3COCH2CH2COO), 2.14 (s, 
3H, CH3COCH2CH2COO), 1.16 (s, 9H, t-BuCO).  
13
C NMR (CDCl3, 100 MHz) $ (ppm) 206.3, 178.0, 171.8, 138.0, 137.9, 128.7, 128.6, 
128.3, 128.1, 128.0, 127.9, 90.5, 76.3, 74.6, 73.8, 72.2, 71.7, 70.1, 68.5, 38.9, 37.9, 30.1, 
28.3, 27.1.  
HRMS-ESI (m/z):  [M+Na]+ Calcd: 565.2414; Found: 565.2485. 
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4,6-di-O-benzyl-3-O-levulinoyl-2-O-pivaloyl-!-D-glucopyranosyl 
trichloroacetimidate (8). Trichloroacetonitrile (0.38 mL, 3.8 mmol) and cesium 
carbonate (340 mg, 1.05 mmol) were added to a solution of 4,6-di-O-benzyl-3-O-
levulinoyl-2-O-pivaloyl-D-glucopyranose (7) (515 mg, 0.95 mmol) in dichloromethane 
(6 mL). The reaction mixture was stirred at ambient temperature for 21 h, then filtered 
over Celite. The solvent was removed under reduced pressure. The residue was subjected 
to flash chromatography on silica gel (100:30:1 EtOAc/hexanes/Et3N) to give the 
product, almost exclusively the !-anomer, as a light yellow syrup (535 mg, 0.78 mmol, 
82%).  
 
Rf: 0.58 (30% EtOAc/hexanes)  
1
H NMR (CDCl3, 400 MHz) $ (ppm) 8.60 (s, 1H), 7.36-7.17 (m, 10H, Ar-H), 6.54 (d, 
J1,2=3.6 Hz, 1H, H-1), 5.67 (t, J2,3= J3,4= 10.0 Hz, 1H, H-3), 5.07-5.03 (dd, J2,3= 10.0 Hz, 
J1,2= 3.6 Hz, 1H, H-2), 4.66-4.47 (m, 4H, PhCH2 %2), 4.08-4.04 (m, 1H, H-5), 3.94 (t, 
J3,4= J4,5= 9.6 Hz, 1H, H-4), 3.83-3.79 (dd, J6,6’ = 11.2 Hz, J6,5 = 2.8 Hz, 1H, H-6), 3.71-
3.68 (dd, J6,6’ = 11.2 Hz, J6’,5 = 2.0 Hz, 1H, H-6’), 2.65-2.60 (m, 2H, 
CH3COCH2CH2COO), 2.46-2.43 (m, 2H, CH3COCH2CH2COO), 2.16 (s, 3H, 
CH3COCH2CH2COO), 1.12 (s, 9H, t-BuCO).  
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13
C NMR (CDCl3, 100 MHz) $ (ppm) 206.0, 177.6, 171.7, 160.9, 137.8, 128.6, 128.5, 
128.3, 128.2, 128.1, 128.0, 93.5, 75.3, 75.0, 73.7, 73.2, 72.1, 70.2, 67.8, 38.9, 37.7, 30.0, 
27.9, 27.0. 
HRMS-ESI (m/z): [M+Na]+ Calcd: 710.1568; Found: 710.1480. 
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Allyl 6-O-acetyl-4-O-benzyl-3-O-levulinoyl-2-O-pivaloyl-D-glucopyranose (9).   
A mixture of allyl 4-O-benzyl-3-O-levulinoyl-2-O-pivaloyl-!-D-glucopyranoside (6) and 
allyl 6-O-benzyl-3-O-levulinoyl-2-O-pivaloyl-!-D-glucopyranoside (5) (1.91 g, 3.88 
mmol, obtained from the synthesis of 4) was dissolved in dichloromethane (40 mL). 2,6-
Lutidine (0.54 mL, 4.7 mmol) was added, and the mixture cooled to -78 °C. Acetyl 
chloride (0.17 mL, 2.3 mmol) was added, and the reaction mixture stirred at -78 °C.  
After 1h, TLC analysis showed the complete conversion of 6 to the 6-O-acetyl product 9, 
and 5 remained unchanged. The reaction was quenched by the addition of MeOH (1 mL), 
and the reaction mixture allowed to warm to ambient temperature. The solvent was 
removed under reduced pressure, and the residue partitioned between EtOAc (100 mL) 
and water (30 mL). The organic layer was washed successively with aqueous 2N HCl, 
water, saturated aqueous NaHCO3, water, and brine. The organic solution was dried over 
Na2SO4 and concentrated under reduced pressure. The residue was subjected to flash 
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chromatography on silica gel (30#50% EtOAc/hexanes) to give 9 as a colorless syrup 
(832 mg, 1.56 mmol, 40%) and unreacted 5 as a syrup (1.081 g, 2.19 mmol, 56%). 
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Rf: 0.67 (50% EtOAc/hexanes)  
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.36-7.26 (m, 5H, Ar-H), 5.87-5.77 (m, 1H, 
CH2=CHCH2O), 5.65 (dd, J3,2=J3,4 10.0 Hz, 1H, H-3), 5.30-5.25 (m, 1H, 
CHaHb=CHCH2O), 5.19-5.15 (m, 1H, CHaHb=CHCH2O), 5.03 (d, J1,2 = 3.6 Hz, 1H, H-
1), 4.75-4.72 (dd, J2,1 = 3.6 Hz, J2,3 = 10.0 Hz, 1H, H-2), 4.66 (d, J = 11.2 Hz, 1H, 
PhCHaHbO), 4.55 (d, J = 11.2 Hz, 1H, PhCHaHbO), 4.33-4.29 (dd, J6,6’ = 12.0, J6,5 = 2.4 
Hz, 1H,  H-6), 4.27-4.23 (dd, J6,6’ = 12.0, J6,5 = 4.0 Hz, 1H, H-6’) 4.18-4.12 (m, 1H, 
CH2=CHCHaHbO), 3.98-3.91 (m, 2H, CH2=CHCHaHbO and H-5), 3.63 (t, J3,4=J4,5= 9.6 
Hz, 1H, H-4), 2.72-2.59 (m, 2H, CH3COCH2CH2COO), 2.51-2.47 (m, 2H, 
CH3COCH2CH2COO), 2.16 (s, 3H, CH3COCH2CH2COO), 2.07 (s, 3H, CH3COO), 1.17 
(s, 9H, t-BuCO). 
13
C NMR (CDCl3, 100 MHz) $ (ppm) 206.1, 178.0, 171.7, 170.8, 137.6, 133.4, 128.6, 
128.3, 128.2, 117.9, 95.0, 75.9, 74.6, 72.5, 71.2, 68.8, 68.7, 62.8, 38.9, 37.8, 30.0, 28.1, 
27.1, 21.0.  
HRMS-ESI (m/z): [M+Na]+ Calcd: 557.2363; Found: 557.2417. 
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6-O-acetyl-4-O-benzyl-3-O-levulinoyl-2-O-pivaloyl-D-glucopyranose (10).  
To a mixture of allyl 6-O-acetyl-4-O-benzyl-3-O-levulinoyl-2-O-pivaloyl-D-
glucopyranose (9) (564 mg, 1.05 mmol) and (1, 5-cyclooctadiene)bis 
(methyldiphenylphosphine)iridium(I) hexafluorophosphate (9 mg, 10.5 µmol) was added 
anhydrous THF (8.0 mL) under nitrogen atmosphere. The red suspension was degassed 
under vacuum, then placed under hydrogen atmosphere until the mixture became a 
colorless, homogeneous solution (~1 minute). The solution was degassed under vacuum 
once more, then stirred at room temperature under nitrogen for 18 h. The solvent was 
removed in vacuo and the crude vinyl ether was dissolved in 9:1 (v/v) acetone/water (10 
mL). Red mercuric oxide (341 mg, 1.58 mmol) was added, followed by the dropwise 
addition of a solution of mercuric chloride (313 mg, 1.15 mmol, in 3 mL 9:1 (v/v) 
acetone/water). After stirring for 1 h at ambient temperature, additional mercuric chloride 
(35 mg, in 2 mL 9:1 (v/v) acetone/water) was added. The mixture was stirred for an 
additional 1.5 h at ambient temperature, then filtered on Celite The filtrate was partially 
concentrated under reduced pressure, then diluted with dichloromethane (75 mL). The 
solution was washed successively with aqueous KI solution and brine, and dried over 
Na2SO4. The solvent was removed under reduced pressure. The residue was subjected to 
flash chromatography on silica gel (30#50% EtOAc/hexanes) to give the product 10, a 
~2:1 mixture of !- and "-anomers, as a syrup (472 mg, 0.95 mmol, 91% from allyl 
ether).  
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Rf: 0.55 and 0.45 (50% EtOAc/hexanes)  
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.37-7.25 (m, 5H, Ar-H), 5.69-5.64 (t, J2,3= J3,4= 
9.6 Hz, 0.65H, H-3), 5.38-5.33 (m, 1H), 4.79-4.54 (m, 3.35H), 4.35-4.32 (m, 1H), 4.23-
4.14 (m, 1.65H), 3.77 (d, J = 8.4 Hz, 0.35H), 3.67-3.61 (m, 1.35H), 3.39 (br d, J = 3.6 
Hz, 0.65H), 2.72-2.60 (m, 2H, CH3COCH2CH2COO), 2.50-2.46 (m, 2H, 
CH3COCH2CH2COO), 2.16 (s, 3H, CH3COCH2CH2COO), 2.06 (s, 3H, CH3COO), 1.12 
(s, 9H, t-BuCO).  
13
C NMR (CDCl3, 100 MHz) $ (ppm) 206.3, 206.1, 178.1, 171.8, 171.0, 137.6, 137.4, 
128.7, 128.6, 128.3, 128.2, 95.8, 90.3, 75.8(2), 74.7, 74.6, 74.4, 73.6, 73.3, 72.1, 71.5, 
68.5, 62.8, 39.0, 38.9, 37.8, 37.7, 30.0(2), 28.1, 28.0, 27.1, 27.0, 21.0.  
HRMS-ESI (m/z): [M+Na]+ Calcd: 517.2050; Found: 517.2155. 
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6-O-Acetyl-4-O-benzyl-3-O-levulinoyl-2-O-pivaloyl-!-D-glucopyranosyl 
trichloroacetimidate (11). Trichloroacetonitrile (0.43 mL, 4.3 mmol) and cesium 
carbonate (420 mg, 1.29 mmol) were added to a solution of 6-O-acetyl-4-O-benzyl-3-O-
levulinoyl-2-O-pivaloyl-D-glucopyranose (10) (426 mg, 0.86 mmol) in dichloromethane 
(10 mL). The reaction mixture was stirred at ambient temperature for 17 h, then filtered 
on Celite. The solvent was removed under reduced pressure. The residue was subjected to 
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flash chromatography on silica gel (25:75:1 EtOAc/hexanes/Et3N) to give the product 11, 
exclusively the !-anomer, as a colorless syrup that solidified upon standing (459 mg, 
0.72 mmol, 84%).  
 
Rf: 0.39 (30% EtOAc/hexanes)  
1
H NMR (CDCl3, 400 MHz) $ (ppm) 8.63 (s, 1H, N-H), 7.37-7.26 (m, 5H, Ar-H), 6.50 
(d, J1,2 = 3.6 Hz, 1H, H-1), 5.72 (t, J3,2=J3,4=9.6 Hz, 1H, H-3),  5.06-5.03 (dd, J2,1= 3.6, 
J2,3= 10.0 Hz, 1H, H-2), 4.71 (d, J = 11.2 Hz, 1H, PhCHaHbO), 4.58 (d, J = 11.2 Hz, 1H, 
PhCHaHbO), 4.35-4.32 (dd, J6,6’= 12.4, J6,5= 2.0 Hz, 1H, H-6), 4.25-4.21 (dd, J6,6’= 12.4, 
J6,5= 4.0 Hz, 1H, H-6’) 4.15-4.13 (m, 1H, H-5), 3.77 (t, J3,4=J4,5= 9.6 Hz, 1H, H-4), 2.72-
2.61 (m, 2H, CH3COCH2CH2COO), 2.54-2.47 (m, 2H, CH3COCH2CH2COO), 2.17 (s, 
3H, CH3COCH2CH2COO), 2.04 (s, 3H, CH3COO), 1.13 (s, 9H, t-BuCO).  
13
C NMR (CDCl3, 100 MHz) $ (ppm) 206.0, 177.7, 171.7, 170.7, 160.9, 137.3, 128.8, 
128.6, 128.4, 93.1, 75.1, 75.0, 72.2, 71.5, 70.1, 62.3, 39.0, 37.7, 30.0, 28.0, 27.1, 21.0. 
HRMS-ESI (m/z): [M+Na]+ Calcd: 662.1116; Found: 662.1225. 
 
O
BnO
HO
O
BnO
BnO O
BnO
PivO
O
BnO
BnO
 
  12       13 
Allyl 3,4,6-tri-O-benzyl-2-O-pivaloyl-"-D-glucopyranoside (13).  Allyl-3,4,6-tri-O-
benzyl-"-D-glucopyranoside17 (12) (1.69 g, 3.45 mmol), was dissolved in pyridine (15 
mL).  Pivaloyl chloride (0.47 mL, 3.80 mmol) was added, and the mixture stirred for 17 
hours at ambient temperature.  After this period, TLC indicated the reaction was not yet 
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complete. To the mixture, 4-dimethylaminopyridine (DMAP, 20 mg) and pivaloyl 
chloride (0.47 mL) were added.  After another 5.5 h, another aliquot of pivaloyl chloride 
(0.47 mL) was added. The mixture was stirred for an additional 20 h at ambient 
temperature. After this period, TLC indicated that the reaction was complete. The 
reaction was quenched by the addition of MeOH (3 mL). The solvent was removed under 
reduced pressure. The residue was partitioned between EtOAc and water. The organic 
layer was washed with 2N HCl, water, saturated aqueous NaHCO3, water, and brine. The 
organic solution was dried over Na2SO4, and the solvent removed under reduced 
pressure. The residue was purified by flash chromatography on silica gel (20% 
EtOAc/hexanes) to give 13 as a colorless syrup (1.70 g, 2.97 mmol, 86%).  
 
Rf: 0.86 (30% EtOAc/hexanes)  
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.35-7.13 (m, 15H, Ar-H), 5.86-5.80 (m, 1H, 
CH2=CHCH2O), 5.28-5.23 (m, 1H, CHaHb=CHCH2O), 5.17-5.14 (m, 1H, 
CHaHb=CHCH2O), 5.11-5.08 (m, 1H, H-2), 4.78-4.51 (m, 6H, 3%PhCH2) 4.43 (d, J1,2 = 
8.0 Hz, 1H, H-1), 4.37-4.32 (m, 1H, CH2=CHCHaHbO), 4.06-4.01 (m, 1H, 
CH2=CHCHaHbO), 3.77-3.68 (m, 4H, H-3, H-4, H-6, H-6’), 3.52-3.50 (m, 1H, H-5), 1.19 
(s, 9H, t-BuCO).  
13
C NMR (CDCl3, 100 MHz) $ (ppm) 176.9, 138.3, 138.3, 138.1, 133.8, 128.5 (3), 
128.1, 127.9 (2), 127.8, 127.7, 127.6, 117.4, 100.3, 83.4, 78.0, 75.4, 75.1 (2), 73.7, 73.2, 
70.0, 68.9, 39.0, 27.3.  
HRMS-ESI (m/z): [M+Na]+ Calcd: 597.2828; Found: 597.2945. 
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3,4,6-Tri-O-benzyl-2-O-pivaloyl-D-glucopyranose (14).  To a mixture of allyl 3,4,6-tri-
O-benzyl-2-O-pivaloyl-"-D-glucopyranoside (13) (1.65 g, 2.88 mmol)  and (1,5-
cyclooctadiene)bis(methyldiphenylphosphine)iridium(I) hexafluorophosphate (24 mg, 
28.8 µmol) was added anhydrous THF (15.0 mL) under nitrogen atmosphere. The red 
suspension was degassed under vacuum, then placed under hydrogen atmosphere until 
the mixture became a colorless, homogeneous solution (~1 minute). The solution was 
degassed under vacuum once more, and stirred at ambient temperature under nitrogen for 
18 h. The solvent was removed in vacuo, and the residual crude vinyl ether was dissolved 
in 10:1 (v/v) acetone/water (30 mL). Red mercuric oxide (873 mg, 4.03 mmol) was 
added, followed by the dropwise addition of a solution of mercuric chloride (860 mg, 
3.17 mmol, in 10 mL 10:1 (v/v) acetone/water). The mixture was stirred for 2 h at 
ambient temperature, and filtered on Celite. The filtrate was partially concentrated under 
reduced pressure, then diluted with dichloromethane (80 mL). The solution was washed 
successively with aqueous KI solution (15 mL), water (30 mL), saturated sodium 
thiosulfate solution (20 mL), water (30 mL), and brine (30 mL), and dried over Na2SO4.  
The solvent was removed under reduced pressure. The residue was subjected to flash 
chromatography on silica gel (25% EtOAc/hexanes) to give the compond 14, a ~3:1 
mixture of !- and "-anomers, as a semisolid (1.35 g, 2.53 mmol, 88% from allyl ether).  
 
Rf: 0.49 and 0.42 (30% EtOAc/hexanes)  
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1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.32-7.09 (m, 15H, Ar-H), 5.42 (m, 0.75H), 4.83-
4.73 (m, 3.75H), 4.62-4.47 (m, 3.5H), 4.10-4.05 (m, 1.5H), 3.40-3.70 (m, 1.5H), 3.65-
3.59 (m, 2H), 3.55-3.49 (m, 0.25H), 3.41-3.37 (m, 0.75H), 1.21 and 1.20 (2s, 9H total, t-
BuCO).  
13
C NMR (CDCl3, 100 MHz) $ (ppm) 178.0, 138.6, 138.2, 138.0, 137.9, 128.6, 128.5, 
128.1(2), 128.0(2), 127.9(2), 127.8, 127.6, 127.5, 96.3, 90.5, 82.7, 79.8, 77.9, 75.9, 75.5, 
75.4, 75.2, 74.1, 73.7, 73.6, 70.3, 68.9, 68.6, 39.1, 38.9, 27.3(2). 
HRMS-ESI (m/z): [M+Na]+ Calcd: 557.2515; Found: 557.2613. 
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3,4,6-Tri-O-benzyl-2-O-pivaloyl-!-D-glucopyranosyl trichloroacetimidate (15).     
Trichloroacetonitrile (1.24 mL, 12.3 mmol) and cesium carbonate (1.21 g, 3.70 mmol) 
were added to a solution of 3,4,6-tri-O-benzyl-2-O-pivaloyl-D-glucopyranose (14) (1.32 
g, 2.47 mmol) in dichloromethane (20 mL). The reaction mixture was stirred at ambient 
temperature for 17 h, followed by filtration through a pad of Celite. The solvent was 
removed under reduced pressure, and the residue was subjected to flash chromatography 
on silica gel (20:80:1 EtOAc/hexanes/Et3N) to give 15, exclusively the !-anomer, as a 
colorless syrup (1.37 g, 2.02 mmol, 82%).  
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Rf: 0.74 (30% EtOAc/hexanes)  
1
H NMR (CDCl3, 400 MHz) $ (ppm) 8.59 (s, 1H, N-H), 7.33-7.12 (m, 15H, Ar-H), 6.58 
(d, J1,2 = 3.2 Hz, 1H, H-1), 5.14-5.10 (dd, J2,1 = 3.6, J2,3= 10.0 Hz, 1H, H-2), 4.87-4.48 
(m, 6H, 3%PhCH2), 4.14-4.11 (t, J = 9.6 Hz, 1H, H-3), 4.08-4.04 (m, 1H, H-5), 3.92-3.86 
(t, J = 10.0 Hz, 1H, H-4), 3.82-3.78 (dd, J = 11.2 Hz, 2.0Hz, 1H, H-6) 3.71-3.65 (m, 1H, 
H-6’), 1.16 (s, 9H, t-BuCO).  
13
C NMR (CDCl3, 100 MHz) $ (ppm) 177.6, 160.9, 138.3, 138.0, 128.6(2), 128.3, 
128.1(2), 127.9, 127.8, 127.6, 115.5, 93.9, 79.9, 75.6, 73.7, 73.5, 72.5, 68.0, 56.9, 39.0, 
27.3. 
HRMS-ESI (m/z): [M+Na]+ Calcd: 702.1582; Found: 702.1730. 
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Cis-4-(1H,1H,2H,2H,3H,3H-perfluoroundecyloxy)-2-butenyl-6-O-acetyl-4-O-benzyl-
2-O-pivaloyl-"-D-glucopyranoside (17). Cis-4-(1H,1H,2H,2H,3H,3H-
perfluoroundecyloxy)-2-butenyl alcohol (1618) (44.4 mg, 0.081 mmol) and 6-O-acetyl-4-
O-benzyl-3-O-levulinoyl-2-O-pivaloyl-!-D-glucopyranosyl trichloroacetimidate (11) 
(72.0 mg, 0.113 mmol) were combined in a round-bottomed flask.  Toluene (3 x 3 mL) 
was placed in the flask and evaporated under reduced pressure.  The flask was then 
placed under vacuum for 90 min. Anhydrous toluene (3 mL) was then added to the flask, 
which was stirred for 10 min at ambient temperature to allow for complete dissolution of 
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the reagents. TMSOTf (1 drop, approximately 10 µL) was then added to the reaction 
mixture. After 20 min, the reaction was quenched with triethylamine (0.l mL). The 
solvent was evaporated under reduced pressure. The residue was dissolved in 
dichloromethane (1 mL). To this solution, hydrazine hydrate (3.20 mL of a 0.5 M 
solution in 3:2 pyridine/acetic acid, 1.62 mmol) was added. The mixture was stirred for 
90 min at ambient temperature, then quenched by the addition of acetone (1 mL). The 
solvent was removed under reduced pressure. The residue was dissolved in DMF (0.8 
mL) and adsorbed onto a fluorous solid-phase extraction cartridge (5 g). Non-fluorous 
compounds were eluted with 80% MeOH/water (24 mL) and the desired product was 
eluted with 100% MeOH (24 mL). The fraction containing the fluorous product was 
concentrated under reduced pressure to give pure 17 as a colorless syrup (75 mg, 0.080 
mmol, 99%).   
 
Rf:  0.47 (30% EtOAc/hexanes)  
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.37-7.28 (m, 5H), 5.72-5.62 (m, 2H, vinylic H), 
4.86 (d, J = 11.2 Hz, 1H, PhCHaHbO), 4.77-4.72 (dd, J2,1 = 8.0 Hz, J2,3 = 9.6 Hz, 1H, H-
2), 4.68 (d, J = 11.2 Hz, 1H, PhCHaHbO), 4.45 (d, J1,2 = 8.0 Hz, 1H, H-1), 4.40-4.31 (m, 
2H, H-6 and sugar-OCHaHb=CHCH2O-(fluoroalkane)), 4.25-4.16 (m, 2H, H-6’ and 
sugar-OCHaHb=CHCH2O-(fluoroalkane)), 4.02-4.00 (m, 2H, sugar-OCHaHb=CHCH2O-
(fluoroalkane), 3.80 (t, J2,3= J3,4=10.0 Hz, 1H, H-3),  3.68 (t, J4,5= J3,4=9.2 Hz, 1H, H-3), 
3.55-3.49 (m, 4H, H-4, H-5, OCH2CH2CH2CF2), 2.66 (br d, J = 3.2 Hz, O-H), 2.26-2.10 
(m, 2H, OCH2CH2CH2CF2), 2.05 (s, 3H, CH3COO), 1.90-1.83 (m, 2H, 
OCH2CH2CH2CF2), 1.22 (s, 9H, t-BuCO).  
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13
C NMR (CDCl3, 100 MHz) $ (ppm) 178.9, 170.9, 137.9, 130.2, 128.8, 128.5, 128.3(2), 
99.7, 77.9, 76.7, 75.0, 74.4, 73.0, 69.0, 66.6, 64.8, 63.1, 39.1, 27.2, 21.0.  
HRMS-ESI (m/z): [M+Na]+ Calcd: 949.2220; Found: 949.2339. 
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Cis-4-(1H,1H,2H,2H,3H,3H-perfluoroundecyloxy)-2-butenyl-4-O-benzyl-6-O-(3,4,6-
tri-O-benzyl-2-O-pivaloyl-"-D-glucopyranosyl)-3-O-((4,6-di-O-benzyl-3-O-(3,4,6-tri-
O-benzyl-2-O-pivaloyl-"-D-glucopyranosyl)-2-O-pivaloyl-"-D-glucopyranosyl)-"-D-
glucopyranoside (18). The "-glucan fragment tetrasaccharide (18) was synthesized from 
fluorocarbon-tagged glucose monosaccharide acceptor (17) via three coupling and two 
deprotection cycles using the Chemspeed ASW1000 synthesizer. The specific reaction 
conditions are outlined in the table: 
 
Step Task Reagent/Operation Time 
1 Glycosylation 3 eq. donor 8  (150 µmol) in 1.0 mL toluene, 1 eq. 
F-tagged acceptor 17 (50 µmol) in 0.5 mL 
toluene, 0.1 eq. TMSOTf (0.027 M in DCM),  
0 oC 
40 min 
2 TLC Sample 20 µL of crude reaction mixture withdrawn  
3 Quenching 0.5 mL triethylamine  
4 Evaporation 40 oC 45 min 
5 Delevulinoylation 20 eq. Hydrazine hydrate (1.0 M in 3:2 
pyr/HOAc), DCM, rt 
40 min 
6 TLC Sample 20 µL of crude reaction mixture withdrawn  
7 Quenching 0.5 mL acetone  
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8 Evaporation 50 oC 45 min 
9 FSPE Sample 
Preparation 
0.4 mL DMF transferred to reaction vial 
 
 
10 Sample Loading 0.7 mL crude sample transferred to F-SPE 
cartridge 
 
11 Elution 4.7 mL 80% methanol wash  
12 Elution 1.5 mL methanol wash (repeated 3 times)  
13 Transfer 4.7 mL collected sample to clean reaction vial  
14 Transfer/ 
Evaporation 
2 mL toluene added, then evaporated at 50 oC 
(repeated 3%) 
45 min 
% 3 
15 Glycosylation 
 
Donor 15  (150 µmol) in 1.0 mL toluene, 
F-tagged acceptor from cycle 1, 0.1 eq. TMSOTf 
(0.027 M in DCM), 0 oC 
 
40 min 
16 TLC Sample 20 µL of crude reaction mixture withdrawn  
17 Quenching 0.5 mL triethylamine  
18 Evaporation 40 oC 45 min 
19 Deacetylation 0.5 M NaOMe in MeOH, MeOH, rt 2 h 
20 TLC Sample 20 µL of crude reaction mixture withdrawn  
21 Quenching 0.5 M AcOH in MeOH  
22 Evaporation / 
FSPE 
Same as steps 8-14  
23 Glycosylation Donor 15 (150 µmol) in 1.0 mL toluene, 
F-tagged acceptor from cycle 2, TMSOTf (0.027 
M in DCM), 0 oC 
40 min 
24 TLC Sample 20 µL of crude reaction mixture withdrawn  
25 Quenching 0.5 mL triethylamine  
26 Evaporation / 
FSPE 
Same as steps 8-12  
 
Table 3.1. Synthetic procedure for the automated synthesis of tetrasaccharide (18). 
 
Following the final F-SPE procedure, the conical-bottomed extraction vial containing the 
crude tetrasaccharide product was removed from the ASW1000. The solvent was 
removed under reduced pressure. The crude product was purified by flash 
chromatography on silica gel (15#40% EtOAc/hexanes) to yield tetrasaccharide 8 (11.0 
mg, 4.7 µmol, 9.4% overall yield) as a colorless syrup.  
 135 
 
Rf: 0.45 (30% EtOAc/hexanes)  
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.34-7.11 (m, 45H, Ar-H), 5.68-5.63 (m, 1H, 
vinylic H), 5.56-5.51 (m, 1H, vinylic H), 5.10-4.88 (m, 5H), 4.82-4.40 (m, 20H), 4.25-
3.98 (m, 8H), 3.80-3.40 (m, 18H), 3.24 (t, 1H, J = 8.6 Hz), 2.22-2.04 (m, 2H, 
OCH2CH2CH2CF2), 1.86-1.78 (m, 2H, OCH2CH2CH2CF2), 1.25 (s, 9H, (t-BuCO), 1.17 
(s, 9H, t-BuCO), 1.15 (s, 9H, t-BuCO), 1.12 (s, 9H, t-BuCO).  
13
C NMR (CDCl3, 100 MHz) $ (ppm) 177.5, 176.8, 176.6, 176.4, 138.6, 138.5, 138.4, 
138.3, 138.2(2), 138.1, 138.0, 130.6, 128.8, 128.7, 128.6(2), 128.4(2), 128.3, 128.1(2), 
128.0, 127.9, 127.8, 127.7, 101.2 (C-1), 99.6 (C-1), 99.3 (C-1), 99.0 (C-1), 83.6, 83.4, 
78.4, 77.9, 76.5, 76.4, 75.8, 75.7, 75.4, 75.2, 75.1, 74.7, 74.5, 73.9, 73.7, 73.6, 73.5, 73.0, 
69.3, 68.9, 68.8, 68.3, 66.7, 64.3, 39.0(2), 38.9, 38.8, 29.9, 28.2, 27.6, 27.4, 27.3(2). 
HRMS-ESI (m/z): [M+Na]+ Calcd: 2365.9181; Found: 2365.7170. 
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Figure 3.4. Analytical HPLC chromatogram of crude glucan tetramer (18) (1 mL/min flowrate, 20% ethyl 
acetate/hexane, 10 minute run). 
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CHAPTER 4 
Automated Solution-Phase Synthesis of Branched and Linear Beta-Glucan 
Fragments 
Abstract 
 Beta-glucans are oligosaccharides made up of repeating beta-linked D-glucose 
monomer units.  These compounds are found in many living systems, including bacteria, 
plants, and fungi.  A considerable degree of variation is observed in terms of branching 
pattern, molecular weight, solubility, and solution conformation among beta-glucans 
isolated from different species.  The beta-glucans have garnered increasing attention in 
recent years due to their interesting biological properties.  The immune-stimulatory 
properties of beta-glucans have been studied considerably in recent years.  However, the 
lack of availability of homogeneous, structurally well-characterized beta-glucans has 
limited the elucidation of the structure-function relationships of these compounds.  
Iterative chemical synthesis provides a means of generating pure, well-characterized 
samples of beta-glucans for structure-function studies.  By its very nature, iterative 
oligosaccharide synthesis lends itself well to automation, as a computer-controlled robot 
is capable of executing repetitive, rote operations quite successfully.  This chapter 
discusses the automated solution-phase syntheses of branched and linear beta-glucan 
fragments via an iterative approach using solely monosaccharide building blocks.  The 
presence of a single perfluorinated tag provides a handle for the facile purification of 
synthetic intermediates by automated fluorous solid-phase extraction (FSPE).  Three new 
glucosyl trichloroacetimidate building blocks were synthesized in the course of this work.  
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The synthetic utility of each building block was demonstrated by assembling a branched 
glucan trisaccharide and three linear glucan trisaccharides on the Chemspeed ASW1000 
automated synthesis workstation. 
 
Introduction 
 Beta-glucans, oligosaccharides comprised of repeating D-glucose units joined by 
beta-glycosidic linkages, occur naturally in a number of living things, including plants, 
bacteria, yeasts, and fungi.  This structurally diverse class of biomolecules has been 
shown to possess antitumor activity, cholesterol-lowering properties, and the ability to 
stimulate the innate immune system.1  Several beta-glucan receptors have been 
discovered in vertebrates, including the transmembrane protein Dectin-1.2  Dectin-1 is the 
primary glucan receptor present on white blood cells.3  This protein can induce a number 
of cellular responses to fungal pathogens.  Despite the many discoveries made about 
Dectin-1, further research is needed to gain an increased understanding of role this glucan 
receptor plays in the immune response to fungal pathogens.  Chemical synthesis provides 
a means of preparing a library of structurally diverse beta-glucans that can be screened 
for binding with Dectin-1 in order to determine its ligand specificity. 
 Many examples of syntheses of beta-glucan structures have been reported in the 
literature.  For example, Larsson and coworkers prepared tetra- and pentasaccharides 
related to the capsular polysaccharide of S. pneumoniae.4  Kong and coworkers have 
reported a number of syntheses of 3,6-branched "-D-glucose oligosaccharides.5a-e  
Similarly, He and coworkers synthesized branched glucose tetra-, penta-, and 
hexasaccharides, relying on a key 3,6-branched trisaccharide trichloroacetimidate donor 
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for the installation of branch points.6  For the most part, these syntheses rely upon 
convergent approaches for the synthesis of branched glucans.  In contrast, Jamois and 
coworkers published the assembly of linear "-(1,3)-glucans by an iterative approach 
using a single monosaccharide building block.7   
The iterative approach to oligosaccharide synthesis offers the freedom to 
incorporate any desired monosaccharide residue into a growing oligosaccharide chain at 
any point in the synthesis.  Since glycosyl donors must be used in excess to ensure high 
glycosylation yields, considerable amounts of these building blocks end up in the waste 
bin.  This is especially problematic when the building blocks are extremely costly to 
prepare, as is generally the case with di-, tri-, and higher oligosaccharide donors.  Despite 
its advantages, iterative oligosaccharide synthesis involves multiple cycles of time-
consuming and labor-intensive glycosylation and deprotection steps.  By automating 
these rote, repetitive tasks, the amount of manual labor involved in oligosaccharide 
synthesis could be greatly reduced. 
 The fields of proteomics and genomics have progressed significantly as a 
resulting of the automation of peptide and nucleic acid synthesis based on solid-phase 
synthetic methodologies.  Researchers in need of a particular peptide or nucleic acid 
sequence can access the Internet and purchase these compounds from a number of online 
vendors.  However, commercial custom oligosaccharide synthesis is not yet a reality.  
Following Bruce Merrifield’s development of solid-phase peptide synthesis in the 1960s,8 
other researchers began to apply this approach to the synthesis of oligosaccharides. The 
Frechet and Schuerch reported the first example of solid-phase carbohydrate synthesis in 
1971.9  Decades later, Plante and coworkers reported the automated solid-phase synthesis 
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of oligosaccharides using a modified peptide synthesizer.10  However, several key 
limitations have prevented the widespread use of solid-phase oligosaccharide synthesis. 
Large excesses of sugar building blocks (10-20 equivalents per coupling cycle) must be 
used to overcome the kinetic limitations of biphasic glycosylation reactions.  
Furthermore, reaction monitoring on the solid phase and cleavage of the sugar chain from 
the solid support are often difficult.  The development of an alternative phase-switching 
approach that combines the ease of purification associated with solid phase synthesis with 
the advantages of solution-phase kinetics and reaction monitoring would represent a 
significant advancement in automated oligosaccharide synthesis. 
 
Results and Discussion 
 The primary objective of this study was to prepare a small library of branched and 
linear beta-glucan fragments for NMR binding studies with a soluble form of the glucan-
binding protein Dectin-1.  In addition to the 3,6 branched beta-glucans such as those 
found in fungal species, we are also interested in studying the binding affinity of linear 
beta-glucan fragments of varying linkage types.  Our synthetic targets in this work were 
the 3,6-branched trisaccharide 1 and the linear 1,3-, 1,4-, and 1,6-glucans 2, 3, and 4 
(Figure 4.1).  Retrosynthetic analysis of branched glucan 1 shows that this trisaccharide 
can be assembled from the capping building block 5, the branch point building block 6, 
and the alkene-containing fluorous alcohol 711 (Figure 4.2).  The linear glucans 2, 3, and 
4 can be assembled using monosaccharide building blocks 8, 9, and 10, respectively 
(Figure 4.3).  Each glucosyl trichloroacetimidate building block possesses a pivaloate 
ester substituent at O-2 to provide stereochemical control of each newly formed glycosyl 
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linkage through neighboring group participation.  Building blocks 6, 8, and 9 feature 
levulinate esters as temporary masking groups.  The levulinate ester  
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Figure 4.3. Retrosynthesis of Linear Glucans 2, 3, and 4.
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can be cleaved selectively in the presence of other ester groups using hydrazine hydrate 
in pyridine and acetic acid at ambient temperature.  Building block 10 possesses an acetyl 
group at the O-6 position.  We postulated that the rate of cleavage of an acetate ester at 
the O-6 position using sodium methoxide in methanol would be much faster than the rate 
of cleavage of the sterically less accessible pivaloate ester at the O-2 position.  This 
difference in reaction rate would allow us to selectively cleave the acetate ester to 
generate the desired primary alcohol for further extension of the saccharide chain.   
The syntheses of building blocks 5 and 8 were outlined in Chapter 3 of this 
dissertation.  The synthesis of branch point building block 6 commenced from the 6-O-
acetyl derivative 11, a building block intermediate discussed in Chapter 3 (Scheme 1).  
Selective cleavage of the 6-O-acetyl group in 11, followed by esterification of the 
resulting alcohol with levulinic acid in the presence of N,N’-Dicyclohexylcarbodiimide 
(DCC), gave rise to the crystalline 3,6-di-O-levulinoyl derivative 12 in 72% yield over 
two steps.  A two-step, one-pot procedure was used for the cleavage of the allyl ether in 
12.  Compound 12 was converted to the corresponding 1-propenyl ether via iridium-
catalyzed olefin isomerization.12   Water and iodine were added directly to the reaction 
mixture, resulting in hydrolysis of the 1-propenyl ether to give compound 13 in 80% 
yield over two steps.  The reducing sugar 13 was then treated with trichloroacetonitrile in 
the presence of cesium carbonate to generate trichloroacetimidate 6, solely as the !-
anomer, in 77% yield. 
 147 
O
LevO
PivO
LevO
BnO
13
OH
c O
LevO
PivO
LevO
BnO
6
O CCl3
NH
Scheme 1.  Synthesis of 3,6-branch point building block 6. a) NaOMe, MeOH, rt, 2 h,
then levulinic acid, DCC, DMAP,CH2Cl2, rt, 1 h, 72%; b) [Ir(COD)(PMePh2)2]PF6, H2, 
THF, rt, 23 h, then I2, THF, H2O, rt, 40 min, 80%; c) Cl3CCN, Cs2CO3, CH2Cl2, rt, 77%.
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The synthesis of linear 1,4-glucan building block 9 (Scheme 2) began from 
1,2,4,6-tetra-O-acetyl-3-O-benzyl-"-D-glucopyranose 1413, which was prepared in 4 
steps from D-glucose.  Treatment of 14 with allyl alcohol in the presence of BF3
.OEt2 
provided the crude allyl glucoside, which was directly deacetylated using NaOMe in 
MeOH, and subsequently benzylidenated to provide the crystalline derivative 15 in 53% 
yield over three steps.  The hydroxyl group in 15 was protected as its pivaloate ester.  The 
crude product was directly subjected to debenzylidenation using aqueous TFA in CH2Cl2, 
resulting in the formation of 4,6-diol 16.  Diol 16 was subjected to benzylation using 
benzyl bromide (3.0 equiv.) and commercially obtained Ag2O (3.0 equiv.) to generate a 
mixture of the desired 3,6-di-O benzyl derivative 17, 3,4-di-O-benzyl derivative 18, and 
3,4,6-tri-O-benzyl derivative 19.   Compounds 17, 18, and 19 were easily separated by 
flash column chromatography on silica gel.  The use of commercial Ag2O is critical to the 
success of this reaction.  When freshly prepared Ag2O is used, the yield of 17 is reduced 
considerably due to the increased formation of tri-O-benzyl derivative 19.  The C-4 
hydroxyl group in 17 was esterified with levulinic acid and DCC to give the fully 
protected intermediate 20.  The allyl ether in 20 was cleaved using the same one-pot 
procedure described for the synthesis of 13 resulting in the formation of the reducing 
 148 
sugar 21 in 76% yield over two steps.  Finally, lactol 21 was converted to the desired !-
linked trichloracetimidate 9. 
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Scheme 2.  Synthesis of linear 1,4-glucan building block 9. a) allyl alcohol, BF3
.OEt2,
CH2Cl2, 0 
oC, 2.5 h, then NaOMe, MeOH, rt, 16.5 h, then PhCH(OMe)2, CSA, CH3CN,
rt, 1 h, 53%; b) PivCl, DMAP, Et3N, CH2Cl2, rt, 24 h, then 60% TFA (aq.), CH2Cl2, rt, 
40 min, 78% over 2 steps; c) BnBr, Ag2O, CH2Cl2, rt, 3 h, 78% for 17, 6% for 18, 10%
for 19; d) LevOH, DCC, DMAP, CH2Cl2, rt, 1 h, 84%; e) [Ir(COD)(PMePh2)2]PF6, H2, 
THF, rt, 9 h, then I2, H2O, THF, rt, 30 min, 76% over 2 steps; e) Cl3CCN, Cs2CO3, 
CH2Cl2, rt, 2.5 h, 78%.
d
 
 The synthesis of linear 1,6-glucan building block 10 (Scheme 3) began from D-
glucose, which was converted to the penta-O-pivaloate derivative 22 following the 
literature procedure.14  Compound 22 was treated with HBr to yield the corresponding 
crude glycosyl bromide, which was treated with EtOH in the presence of Et3N and TBAB 
to form orthopivaloate 23.  The pivaloate esters in 23 were cleaved, and the resulting 
crude triol treated with BnBr and NaH in DMF to generate the 3,4,6-tri-O-benzyl 
derivative 24.  Orthoester 24 was subjected to acetolysis in the presence of a 
stochiometric amount of ZnCl2, conditions known to selectively acetolyze a 6-O-benzyl 
group.15  As anticipated, acetolysis of the orthoester in 24 also took place under these 
conditions, resulting in the formation of an !/" mixture of anomeric acetates. This crude 
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mixture was treated with hydrazine acetate in DMF to generate lactol 25 in good yield.  
Finally, the reducing sugar 25 was converted to the crystalline !-linked 
trichloroacetimidate 10.  This synthetic route, aided in large part by the tandem benzyl 
ether acetolysis and orthoester cleavage transformation used to convert 24 to 25, provided 
an efficient means of generating gram quantities of building block 10. 
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Scheme 3.  Synthesis of linear 1,6-glucan building block 10. a) PivCl, Et3N, DMAP,
CH2Cl2, 0 
oC to rt, 16 h, 88%; b) 33% HBr in HOAc, CH2Cl2, 0 
oC to rt, then EtOH, TBAB,
Et3N, CH2Cl2, reflux, 18 h, 75% over 2 steps; c) NaOEt, EtOH, rt, 24 h, then BnBr, NaH,
DMF, 0 oC to rt, 17 h, 94% over 2 steps; d) ZnCl2, Ac2O, AcOH, 0 
oC to rt, 3 h, then 
hydrazine acetate, DMF, rt, 20 h, 76% over 2 steps; e) Cl3CCN, Cs2CO3, 
CH2Cl2, rt, 2.5 h, 64%.
O
PivO
PivO
PivO
PivO
OPiv
O
HO
HO
HO
HO
OH
d-Glucose
O
PivO
O
PivO
PivO
O
t-Bu OEt
23
O
BnO
O
BnO
BnO
O
t-Bu OEt
24
e
 
 Having prepared sufficient quantities of the requisite monosaccharide building 
blocks 5, 6, 8, 9, and 10, our efforts were then focused on the synthesis of our target 
trisaccharides 1, 2, 3, and 4 on the Chemspeed ASW-1000 automated synthesis 
workstation.  The ASW-1000 consists of a reactor block that contains sixteen individual 
reaction vials.  The reactor block can be heated or cooled to achieve a desired reaction 
temperature, blanketed with inert gas for air- and moisture-sensitive reactions, and 
vortexed to provide mixing of the reagents.  The reactor block is also connected to a 
vacuum pump to facilitate the evaporation of solvents from reaction mixtures.  A robot 
arm fitted with a septum-piercing needle executes all liquid handling tasks on the 
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workstation.  An SPE rack holds the fluorous solid-phase extraction cartridges that are 
used to purify our synthetic oligosaccharides after each synthetic cycle.  Finally, reagent 
racks, including one blanketed by inert gas, provide storage for the reagent solutions 
needed to carry out the synthesis.  Multiple parameters exist for every operation carried 
out by the ASW-1000, including reactor block temperature, vortexing speed, vacuum, 
volume of reagents transferred, and reaction time.  Each of these parameters require 
careful attention when preparing an automated synthesis program. 
The automated iterative solution-phase synthesis of oligosaccharides can be 
broken down into three basic tasks.  Each cycle consists of a glycosylation task, a 
deprotection task, and a fluorous solid-phase extraction (FSPE) task.  In the glycosylation 
task, the acceptor molecule is combined with a solution of the glycosyl 
trichloroacetimidate donor and vortexed to ensure that the reagents are adequately mixed.  
At this time, the reactor block can be heated or cooled to the desired reaction 
temperature.  A solution of the activating reagent, trimethylsilyl 
trifluoromethanesulfonate (TMSOTf), is a added to initiate the glycosylation reaction.  
After vortexing for the desired reaction time, an aliquot of the reaction mixture is 
dispensed into a 96-well plate for analysis by thin-layer chromatography.  The reaction is 
quenched by the addition of triethylamine, and the solvents evaporated.  At this point, the 
crude glycosylation product could be purified by FSPE prior to the deprotection step.  
However, we have observed that the delevulination and deacetylation steps carried out in 
this study can be performed directly on the crude reaction mixtures present following 
each glycosylation step.  Thus, a solution of the deprotection reagent is added to the 
crude glycosylation product, and the mixture vortexed for the desired reaction time.  By 
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doing so, we can eliminate an FSPE purification step between glycosylation and 
deprotection cycles, thus eliminating unnecessary material transfers and reducing the 
amount of time needed to complete each synthesis.  Following completion of the 
deprotection reaction, an aliquot of the reaction mixture is removed for TLC analysis.  
The appropriate quenching reagent is added to the reaction mixture, and the solvents 
removed by evaporation under reduced pressure.  At this time, a small amount of solvent, 
typically DMF or a mixture of DMF and water, is added to the reaction vial containing 
the crude product.  The reactor block is vortexed to dissolve the crude product, and the 
resulting solution loaded onto a 2-gram FSPE cartridge.  The nonfluorous compounds are 
eluted to waste by washing with 8:2 (v/v) MeOH:H2O, and then the desired fluorous-
tagged product is eluted into a vial located below the FSPE cartridge using a fluorophilic 
solvent such as MeOH or THF.  The eluate containing the fluorous compounds is 
transferred to a clean vessel in the reactor block, where the solvent is evaporated prior to 
the next synthetic cycle.  These synthetic cycles are repeated in an iterative fashion until 
the desired sugar chain length has been achieved. 
By combining the proper number of glycosylation, deprotection, and FSPE tasks, 
programs were written for the synthesis of each target glucan.  First, the synthesis of 
branched glucan trisaccharide 1 was executed (Scheme 4).  In contrast with the 
automated synthesis of the branched glucan tetrasaccharide discussed in Chapter 3, the 
initial glycosylation of fluorous alcohol 7 was carried out on the ASW-1000 platform, 
eliminating several hours of manual benchtop chemistry.  Additionally, we have chosen 
to construct a branched structure by simultaneous extension of sugar chains from the 
hydroxyl groups on C-3 and C-6 of the branch point monomer unit.  To begin the 
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automated synthesis, toluene solutions of the flourous alcohol 7 and 3,6-di-O-levulinoyl 
building block 6 (1.5 equiv.) were delivered to the first reaction vial.  Following addition 
of a stock solution of TMSOTf (0.1 equiv.) in CH2Cl2, the reaction was vortexed for 20 
minutes at 20 °C.  TLC indicated that the glycosylation reaction was complete.  After 
evaporation of the solvents under reduced pressure at 40 °C, the delevulination reagent, 
1.0 M hydrazine hydrate in 3:2 (v/v) pyridine/acetic acid, was added, along with CH2Cl2 
as a cosolvent.  After the fifty-minute reaction period, TLC showed that deprotection was 
complete.  The solvents were removed in vacuo, with the temperature increased to 60 °C 
to facilitate evaporation of the higher-boiling solvents used in the delevulination reaction.  
The crude product was then dissolved in DMF and transferred to the FSPE cartridge for 
purification by automated fluorous solid-phase extraction.  Following FSPE purification, 
the eluate containing the intermediate 3,6-diol monosaccharide was transferred to the 
next reaction vial.  Toluene (0.5 mL) was added, and the solvent evaporated.  Following 
two additional toluene addition-evaporation cycles, the acceptor was ready for the second 
glycosylation cycle.  A toluene solution of the chain-terminating glucose building block 
(3.0 equiv.) was added to the reaction vial, and the mixture vortexed to ensure complete 
dissolution of the acceptor.  The remainder of the second glycosylation cycle was carried 
out in the same way as the first.  Again, TLC revealed that the glycosyl acceptor was 
completely consumed.  Following evaporation of the solvent, a final FSPE cycle was 
carried out.  The crude product was purified by column chromatography to provide the 
desired branched glucan 1 in 18% overall yield using only 4.5 total equivalents of 
monosaccharide building blocks.  The average yield per step was 56%, based on the 
overall yield, and the synthesis was completed in only nine hours of machine time. 
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Scheme 4. Automated synthesis of branched trisaccharide 1.  
 Following the successful synthesis of branched trisaccharide 1, we then set out to 
construct the linear 1,3-glucan trisaccharide 2 (Scheme 5).  The program for this 
synthesis was easily prepared by combining three iterations of the first synthetic cycle 
used for the synthesis of trisaccharide 1, and using the linear 1,3-glucan donor 8 in place 
of donor 6 (Scheme 5).  After three automated glycosylation/delevulination/FSPE cycles, 
the crude product was purified by careful silica gel column chromatography to furnish the 
desired 1,3-linked glucan 2 in 9.5% overall yield.  Based on the overall yield, the 
calculated average step yield was 67%. 
 The program used for the synthesis of 2 was used to synthesize the 1,4-linked 
trisaccharide 3 (Scheme 6).  The only modification was the use of building block 9 
instead of building block 8.  Following completion of the synthesis, TLC analysis showed 
the presence of the desired trisaccharide and a small amount of the corresponding 
disaccharide.  The mixture was purified by column chromatography and preparative TLC 
to furnish the desired trisaccharide 3 in 3.7% overall yield.  
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 Next, the 1,6-linked trisaccharide 4 was synthesized (Scheme 7).  The program 
used to synthesize trisaccharides 3 and 4 was modified to carry out acetate deprotection 
rather than the levulinate deprotection, and to use glycosyl donor 10.  Following three 
synthetic cycles, TLC analysis of the crude product showed the presence of trisaccharide 
4 along with a lesser amount of the corresponding disaccharide.  The compounds were 
separated by preparative TLC to provide the desired trisaccharide 4 in 3.8% overall yield. 
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 Having successfully synthesized each of the target trisaccharides 1, 2, 3, and 4, 
our efforts then focused on the global deprotection of our synthetic glucans to generate 
compounds suitable for NMR binding studies.  We chose to carry out the deprotection of 
branched trisaccharide 1 in order to demonstrate the ability to fully deprotect our 
synthetic glucans (Scheme 8).  The fluorous tag in 1 was cleaved by ozonolysis of the 
alkene and subsequent reduction with sodium borohydride to generate the 2-hydroxyethyl 
glycoside 26 in 40% yield.  The benzyl ethers were cleaved from compound 26 by 
catalytic hydrogenation.  The crude hydrogenation product was treated with NaOMe in 
MeOH to cleave the three pivaloate esters, and generate the fully deprotected 2-
hydroxyethyl glycoside 27 in 95% yield over two steps.  These results clearly 
demonstrated that global deprotection of our synthetic glucans can be carried out in a 
straightforward fashion.  In particular, the sterically bulky pivaloate ester groups could be 
cleaved without complications. 
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Scheme 8. Global deprotection of branched trisaccharide 1. 
a) O3, MeOH, CH2Cl2, -78 
oC, 2 min, then NaBH4, MeOH,
CH2Cl2, -78 
oC to rt, 14 h, 40%; b) H2, Pd/C, EtOH, rt, 5 h,
then NaOMe, MeOH, rt, 21.5 h, 95%.
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Conclusion 
 Through the completion of the research described in the chapter, a number of 
important discoveries have been made.  First, viable synthetic routes to the 
monosaccharide building blocks 6, 9, and 10 were developed.  The automated synthesis 
of branched trisaccharide 1 demonstrated the synthetic utility of building block 6 as a 
precursor to a 3,6-diol glycosyl acceptor for the simultaneous extension of two sugar 
chains from a single glucose residue.  Furthermore, the automated syntheses of 
trisaccharides 3 and 4 demonstrated the synthetic utility of building blocks 9 and 10 in 
terms of both their reactivity and stereoselectivity in glycosylation reactions.  The 
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synthesis of trisaccharide 4 provided support for our hypothesis that an acetate group at 
O-6 of the glucose ring could be selectively cleaved in the presence of an O-2 pivaloate 
group, as no evidence of pivaloate cleavage was observed.  Additionally, only slight 
modifications of a computer program were required to carry out the syntheses of all four 
target trisaccharides.  A single protocol for the automated fluorous solid-phase extraction 
cycle was used for all four syntheses discussed in this chapter, demonstrating that 
fluorous-fluorous interactions are robust enough to provide reliable phase separation of 
organic and fluorous compounds on the automation platform.  Lastly, through the 
preparation of compound 27, we have shown that global deprotection of our synthetic 
glucans can be achieved.  The synthetic strategies presented in this chapter will provide 
access to libraries of larger and more complex branched and linear beta-glucan fragments 
for binding assays other studies that will aid in the determination of the structure-function 
relationships of these compounds. 
 
Experimental Section 
 
General Materials and Methods 
Reaction solvent dichloromethane was obtained from a commercial solvent purification 
tower or distilled from calcium hydride.  Reaction solvents tetrahydrofuran and toluene 
were obtained from a commercial solvent purification tower.  Dowex 50W X-8 (H+) resin 
was washed repeatedly with MeOH prior to use.  Powdered 4Å molecular sieves were 
purchased from Aldrich Chemical Company and were activated by heating in a furnace at 
250 °C overnight prior to use.  All other reagents were used as received without further 
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purification.  Reactions were monitored and the Rf values determined using analytical 
TLC with Sorbent Technologies silica gel plates (60F-254).  Developed TLC plates were 
visualized by immersion in 10% ethanolic sulfuric acid solution, or in acidic p-
anisaldehyde solution, followed by heating on a hot plate.  Moisture-sensitive reactions 
were run in flame- or oven-dried glassware under a nitrogen atmosphere.  Bath 
temperatures were used to record the reaction temperature for reactions performed at 
elevated or sub-ambient temperatures.  All reactions were stirred magnetically at ambient 
temperature unless otherwise indicated.  Manual flash chromatography was performed 
using Sorbent Technologies silica gel (60F-254), and the solvent systems outlined in the 
experimental procedures.  Automated flash chromatography was carried out on a Biotage 
SP-1 chromatography workstation fitted with either a Biotage 12M or 25M silica gel 
cartridge, using ethyl acetate/hexane gradients as outlined in the experimental procedures. 
1H NMR and 13C NMR spectra were obtained with a Bruker DRX400 at 400 MHz and 
101 MHz, respectively.  1H NMR spectra were reported in parts per million ($) relative to 
CDCl3, CD3OD, D2O, or TMS (7.27 ppm, 4.84 ppm, 4.81 ppm, and 0.00 ppm, 
respectively) as internal references.  13C NMR spectra were reported in parts per million 
($) relative to CDCl3 or CD3OD (77.23 ppm or 49.15 ppm, respectively).  For 
13C NMR 
spectra obtained in D2O, chemical shifts are reported relative to acetone as an internal 
standard (215.94 and 30.89 ppm). 
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Synthetic Procedures 
 
O
LevO
PivO
AcO
BnO
OAll
O
LevO
PivO
LevO
BnO
OAll  
   11      12 
Allyl 4-O-benzyl-3,6-di-O-levulinoyl-2-O-pivaloyl-!-D-glucopyranoside (12). Allyl 6-
O-acetyl-4-O-benzyl-3-O-levulinoyl-2-O-pivaloyl-!-D-glucopyranose (11) (2.15 g, 4.02 
mmol) was dissolved in MeOH (50 mL) and CH2Cl2 (50 mL).  A solution of NaOMe 
(0.25M in MeOH) was added until the solution reached a pH of 10 as measured by pH 
paper.  The reaction mixture was stirred for 2 h at ambient temperature, after which TLC 
analysis showed completion conversion of the starting material (Rf 0.68, 1:1 
EtOAc/hexanes) to the deacetylated product (Rf 0.62, 1:1 EtOAc/hexanes).  The reaction 
mixture was neutralized by the addition of Dowex 50W X-8 (H+) resin and filtered.  The 
solvent was evaporated under reduced pressure.  The crude product was dissolved in 
CH2Cl2 (20 mL).  To this solution, N,N-dicyclohexylcarbodiimide (1.66 g, 8.04 mmol), 
levulinic acid (0.933 g, 8.04 mmol), and 4-dimethylaminopyridine (40 mg) were added.  
The resulting mixture was stirred for 1 hour at room temperature.  The mixture was 
diluted with hexanes (20 mL) and filtered through a pad of Celite to remove the 
precipitated dicyclohexylurea byproduct.  The filtrate was diluted with CH2Cl2, washed 
successively with water and brine, and dried over Na2SO4.  The solvent was removed 
under reduced pressure. The residue was dissolved in a 3:7 mixture of EtOAc and 
hexanes (50 mL) and filtered through a pad of silica gel (4 cm deep in a conical glass 
funnel) to remove the residual insoluble dicyclohexylurea.  The solvent was evaporated 
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to give the crude product as a solid, which was recrystallized from EtOH and hexanes to 
afford 12 as colorless needles (1.72 g, 2.91 mmol, 72% over 2 steps). 
 
Rf: 0.81 (7:3 EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.38-7.26 (m, 5H, Ar-H), 5.88-5.77 (m, 1H, 
CH2=CHCH2O), 5.65 (dd, J3,2=J3,4 10.0 Hz, 1H, H-3), 5.30-5.24 (m, 1H, 
CHaHb=CHCH2O), 5.19-5.15 (m, 1H, CHaHb=CHCH2O), 5.04 (d, J1,2 = 3.6 Hz, 1H, H-
1), 4.75-4.70 (dd, J2,1 = 3.6 Hz, J2,3 = 10.0 Hz, 1H, H-2), 4.66 (d, J = 11.2 Hz, 1H, 
PhCHaHbO), 4.57 (d, J = 11.2 Hz, 1H, PhCHaHbO), 4.37-4.31 (dd, J6,6’ = 12.0, J6,5 = 4.0 
Hz, 1H,  H-6), 4.30-4.25 (dd, J6,6’ = 12.0, J6,5 = 2.4 Hz, 1H, H-6’) 4.18-4.12 (m, 1H, 
CH2=CHCHaHbO), 3.98-3.90 (m, 2H, CH2=CHCHaHbO and H-5), 3.64 (t, J3,4=J4,5= 9.6 
Hz, 1H, H-4), 2.80-2.72 (m, 2H, CH3COCH2CH2COO), 2.60-2.48 (m, 4H, 
CH3COCH2CH2COO, CH3COCH2CH2COO), 2.52-2.46 (m, 2H, CH3COCH2CH2COO), 
2.20 (s, 3H, CH3COCH2CH2COO), 2.16 (s, 3H, CH3COCH2CH2COO), 1.16 (s, 9H, t-
BuCO) 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 206.5, 206.2, 178.1, 172.6, 171.7, 137.8, 133.4, 
128.7, 128.3, 128.1, 118.0, 95.0, 76.1, 74.8, 72.5, 71.3, 68.8, 62.9, 38.9, 38.1, 37.8, 30.1, 
28.2, 28.0, 27.1. 
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  12       13 
4-O-benzyl-3,6-di-O-levulinoyl-2-O-pivaloyl-D-glucopyranose (13). Allyl 6-O-acetyl-
3-O-benzyl-4-O-levulinoyl-2-O-pivaloyl-!-D-glucopyranoside (12) (558 mg, 0.94 mmol) 
was dissolved in tetrahydrofuran (10 mL).  To this solution, (1,5-
cyclooctadiene)bis(methyldiphenylphosphine)iridium(I) ( 8 mg,  9.5 µmol) was added.  
The resulting red suspension was degassed by brief exposure of the reaction flask to 
vacuum.  The mixture was then stirred under a balloon of hydrogen until the red 
suspension became a colorless solution (approximately 30 seconds).  The mixture was 
degassed and the flask flushed with nitrogen.  The resulting mixture was stirred for 17 
hours at ambient temperature.  Proton NMR analysis of a small aliquot (~100 µL) of the 
reaction mixture indicated that conversion to the 1-propenyl ether was ~ 70% complete.  
Additional (1,5-cyclooctadiene)bis(methyldiphenylphosphine)iridium(I) (10 mg, 12 
µmol) was added.  The mixture was again stirred under a balloon of hydrogen until the 
red color disappeared, then the flask flushed with nitrogen and stirred for another 6 hours 
at ambient temperature. At this time, proton NMR analysis indicated that conversion to 
the 1-propenyl ether was complete.  To the crude reaction mixture, water ( 1.5 mL) and 
iodine ( 477 mg,  1.88 mmol) were added.  The reaction mixture immediately turned dark 
brown.  After stirring for 40 minutes, saturated sodium thiosulfate solution was added to 
destroy the excess iodine.  The mixture was partitioned between water and 
dichloromethane, and the layers separated.  The aqueous layer was extracted twice with 
dichloromethane.  The combined organic extracts were washed successively with 
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saturated aqueous NaHCO3 solution and brine, dried over Na2SO4, and concentrated 
under reduced pressure.  The crude product was purified by flash chromatography on 
silica gel using 30#60% EtOAc in hexanes as the eluant to afford 13, a ~7:3 mixture of 
!- and "-anomers, as an amber colored syrup (415 mg, 0.75 mmol, 80% over 2 steps).  
 
Rf: 0.29 and 0.19 (1:1 EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.34-7.25 (m, 5 H, Ar-H), 5.65 (t, 0.7H, J3,2=J3,4 
9.6 Hz, H-3), 5.37-5.27 (m, 1H), 4.77-4.54 (m, 3.3H), 4.36-4.30 (m, 1H), 4.27-4.1 (m, 
1.7H), 3.72-3.56 (m, 1.7H), 3.22 (br d, 0.7H, J= 2.4 Hz, -OH),  2.77-2.73 (m, 2H, 
CH3COCH2CH2COO), 2.65-2.54 (m, 4H, CH3COCH2CH2COO, CH3COCH2CH2COO), 
2.48-2.44 (m, 2H, CH3COCH2CH2COO), 2.17 (s, 3H, CH3COCH2CH2COO), 2.13 (s, 
3H, CH3COCH2CH2COO), 1.16 (s, 9H, t-BuCO). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 207.3, 207.0, 206.2, 206.1, 179.1, 178.1, 172.6(2), 
171.8(2), 137.8, 137.6, 128.7(2), 128.3, 128.2, 128.1, 95.8, 90.3, 76.3, 76.0, 74.9, 74.5, 
74.4, 73.7, 73.4, 72.1, 71.6, 68.5, 63.1, 62.8, 39.1, 39.0, 38.3, 38.1, 37.8(2), 30.1, 30.0, 
28.2, 28.1(2), 28.0, 27.1(2). 
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  13       6 
4-O-benzyl-3,6-di-O-levulinoyl-2-O-pivaloyl-!-D-glucopyranosyl 
trichloroacetimidate (6). 4-O-benzyl-3,6-di-O-levulinoyl-2-O-pivaloyl-D-
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glucopyranose (13) (395mg, 0.72 mmol) was dissolved in dichloromethane (10 mL).  
Cesium carbonate (350 mg, 1.07 mmol) and trichloroacetonitrile (0.36 mL, 3.59 mmol) 
were added, and the mixture stirred at ambient temperature for 24 h.  The mixture was 
filtered through a pad of Celite and the solvents removed under reduced pressure.  The 
residue was purified by column chromatography on silica gel, using ethyl 
acetate/hexanes/triethylamine 30:70:1) as the eluant, to afford 6 as a yellow syrup (385 
mg, 0.55 mmol, 77%). 
 
Rf: 0.49 (4:6 EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 8.62 (s, 1H, NH), 7.36-7.24 (m, 5H, Ar-H), 6.51 
(d, 1H, J1,2 = 3.6 Hz, H-1), 5.71 (t, 1H, J2,3 =  J3,4 = 10.0 Hz, H-3), 5.05-5.02 (dd, 1H, J2,3 
= 10.0 Hz, J1,2 = 3.6 Hz, H-2), 4.70 (d, 1H, J  = 11 Hz, PhCHaHbO), 4.61 (d, 1H, J = 11 
Hz, PhCHaHbO), 4.37-4.28 (m, 2H, H-6, H-6’), 4.16-4.11 (m, 1H, H-5), 3.78 (t, 1H, J3,4 =  
J4,5 = 9.6 Hz, H-4), 2.78-2.72 (m, 2H, CH3COCH2CH2COO), 2.70-2.56 (m, 4H, 
CH3COCH2CH2COO, CH3COCH2CH2COO), 2.53-2.47 (m, 2H, CH3COCH2CH2COO), 
2.20 (s, 3H, CH3COCH2CH2COO), 2.17 (s, 3H, CH3COCH2CH2COO), 1.13 (s, 9H, t-
BuCO). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 206.6, 206.0, 177.7, 172.5, 171.7, 160.9, 137.5, 
128.7, 128.5, 128.4, 128.3, 93.2, 91.0, 75.3, 75.1, 72.1, 71.6, 70.1, 62.3, 39.0, 38.0, 37.7, 
30.0(2), 28.0, 27.1. 
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   14      15 
Allyl 3-O-benzyl-4,6-O-benzylidene-"-D-glucopyranoside (15).   A solution of 1,2,4,6-
tetra-O-acetyl-3-O-benzyl-"-D-glucopyranose13 (14) (981 mg, 2.23, mmol) and allyl 
alcohol (0.79 mL, 11.61 mmol) in dichloromethane (10 mL) was cooled to 0°C.  To this 
solution, boron trifluoride diethyl etherate (2.93 mL, 23.2 mmol) was added.  The 
mixture was stirred for 2.5 hours at 0°C, then diluted with ethyl acetate.  The organic 
solution was washed successively with saturated NaHCO3 and brine, and dried over 
Na2SO4.  The solvents were evaporated to give the crude allyl glycoside as a syrup.  An 
additional quantity of the crude allyl glycoside was prepared by treating 14 (5.91 g, 13.48 
mmol) with allyl alcohol (4.6 mL, 67.4 mmol) and boron trifluoride diethyl etherate (17.1 
mL, 134.8 mmol) in dichloromethane (60 mL) at 0°C for 2.5 hours.  Following workup 
as described previously, the two batches of the crude allyl glycoside were combined and 
dissolved in methanol (100 mL).  Sodium metal (200 mg) was added, and the resulting 
mixture stirred for 16.5 hours at ambient temperature.  The solution was neutralized by 
the addition of Dowex-50 (H+) resin and filtered.  The solvent was removed by rotary 
evaporation.  The residual crude triol was dissolved in acetonitrile (30 mL).  To this 
solution, benzaldehyde dimethyl acetal (4.71 mL, 31.4 mmol) and 10-camphorsulfonic 
acid (729 mg, 3.14 mmol) were added.  Following stirring for 1 hour at ambient 
temperature, hexanes (50 mL) and water (50 mL) were added to the reaction mixture, 
resulting in the precipitation of 15 as a white solid.  The liquids were filtered off and the 
solid product dissolved in ethyl acetate.  The solution was washed successively with 
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water and brine, and dried over Na2SO4.  The solvent was removed under reduced 
pressure.  The crude product was recrystallized from ethyl acetate and hexanes to furnish 
15 as fine needles (3.36 g, 8.43 mmol, 53% over three steps). 
 
Rf: 0.57 (3:7 EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.50-7.25 (m, 10H, Ar-H), 5.97-5.89 (m, 1H, 
OCH2CH=CH2), 5.57 (s, 1H, PhCHO2), 5.36-5.31 (m, 1H, OCH2CH=CHaHb), 5.25-5.22 
(m, 1H, OCH2CH=CHaHb), 4.96 (d, 1H, J = 11.6 Hz, PhCHaHbO), 4.80 (d, 1H, J = 11.6 
Hz, PhCHaHbO), 4.45 (d, 1H, J1,2 = 7.6 Hz, H-1), 4.40-4.33 (m, 2H, OCHaHbCH=CH2 
and H-6), 4.18-4.12 (m, 1H, OCHaHbCH=CH2), 3.80 (t, 1H, J5,6 = J6,6’ = 10.2 Hz, H-6’), 
3.73-3.64 (m, 2H, H-3 and H-4), 3.60-3.57 (br dt, 1H, J2,3 &J1,2 = 9.2 Hz, JH-2,OH = 2.4 Hz, 
H-2), 3.47-3.41 (m, 1H, H-5), 2.51 (d, 1H, J = 2.4 Hz, -OH). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 138.5, 138.4, 133.7, 129.2, 128.6, 128.5, 128.2, 
128.0, 126.2, 118.4, 102.4, 101.4, 81.5, 80.4, 74.8, 74.4, 70.7, 68.9, 66.6. 
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   15      16 
Allyl 3-O-benzyl-2-O-pivaloyl-"-D-glucopyranoside (16). A solution of allyl 3-O-
benzyl-4,6-O-benzylidene-"-D-glucopyranoside (15) (2.23 g, 5.60 mmol), 
trimethylacetyl chloride (1.38 mL, 11.2 mmol), 4-dimethylaminopyridine (70 mg), and 
triethylamine (2.34 mL, 16.8 mmol) in dichloromethane (10 mL) was stirred at ambient 
temperature for 24 hours.  The reaction mixture was diluted with dichloromethane and 
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washed successively with water, saturated NaHCO3, and brine, then dried over Na2SO4.  
The solvents were evaporated and the residue dissolved in dichloromethane (20 mL).  An 
aqueous solution of trifluoroacetic acid (60% v/v, 8 mL) was added.  Following stirring 
for 40 minutes at ambient temperature, dichloromethane (50 mL) and saturated NaHCO3 
solution (50 mL) were added.  The mixture was stirred until the evolution of CO2 
subsided.  The mixture was poured into a separatory funnel and the layers separated.  The 
organic layer was washed with water and brine, and dried over Na2SO4.  The solvent was 
removed under reduced pressure.  The residue was purified by flash chromatography on 
silica gel, using a gradient elution of 25% EtOAc in hexanes to 100% EtOAc, to furnish 
diol 16 as a syrup that solidified upon standing (1.72 g, 4.36 mmol, 78% over 2 steps). 
 
Rf: 0.27 (7:3 EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.34-7.25 (m, 5H, -Ph), 5.85-5.78 (m, 1H, 
OCH2CH=CH2), 5.28-5.23 (m, 1H, OCH2CH=CHaHb), 5.18-5.15 (m, 1H, 
OCH2CH=CHaHb), 5.02 (dd, 1H, J1,2 = 8.0 Hz, J2,3 =9.2 Hz, H-2),  4.72 (d, 1H, J  = 11.6 
Hz, PhCHaHbO), 4.64 (d, 1H, J = 11.6 Hz, PhCHaHbO), 4.46 (d, 1H, J1,2 = 8.0 Hz, H-1), 
4.33-4.29 (m, 1H, OCHaHbCH=CH2), 4.05-4.00 (m, 1H, OCHaHbCH=CH2), 3.88-3.85 
(dd, 1H, J6,6’ = 12.0 Hz, J6,5 = 2.8 Hz, H-6), 3.80-3.75 (dd, 1H, J6,6’ = 12.0 Hz, J6’,5 = 4.4 
Hz, H-6’), 3.69 (t, 1H, J3,4 =J4,5 = 9.2 Hz, H-4), 3.55 (t, 1H, J2,3 =J3,4 = 9.2 Hz, H-3), 3.38-
3.32 (m, 1H, H-5), 3.06-2.97 (br s, 1H, -OH), 2.60-2.45 (br s, 1H, -OH), 1.20 (s, 9H, t-
Bu). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 177.1, 138.2, 133.7, 128.7, 128.0, 127.8, 117.7, 
100.5, 82.8, 75.4, 74.6, 72.9, 70.4, 62.4, 39.0, 27.3. 
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 16             17     18          19 
Allyl 3,6-di-O-benzyl-2-O-pivaloyl-"-D-glucopyranoside (17). Allyl 3-O-benzyl-2-O-
pivaloyl-"-D-glucopyranoside (16) (2.21 g, 5.60 mmol) was dissolved in 
dichloromethane (50 mL).  To this solution, commercial silver (I) oxide (Alfa Aesar, 3.89 
g, 16.8 mmol) and benzyl bromide (2.0 mL, 16.8 mmol) were added.  The mixture was 
stirred for 3 hours at ambient temperature, and the solvents evaporated.  The residue was 
purified by flash column chromatography on silica gel using a gradient of 10% to 40% 
ethyl acetate in hexanes to give 17 as a syrup (2.14 g, 4.41 mmol, 78%).  Additionally, 
small amounts of the 3,4-di-O-benzyl derivative 18, a light yellow solid (157 mg, 0.32 
mmol, 6%), and 3,4,6-tri-O-benzyl derivative 19, a syrup (337 mg, 0.59 mmol, 10%), 
were also isolated. 
 
Spectral Data for 17: 
Rf: 0.60 (3:7 EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.36-7.25 (m, 10H, ArH), 5.87-5.79 (m, 1H, 
CH=CH2), 5.28-5.22 (m, 1H, CH=CHaHb), 5.17-5.14 (m, 1H, CH=CHaHb), 5.08-5.04 
(dd, 1H, J1,2 = J2,3 = 8.0 Hz, H-2), 4.74-4.66 (AB dd, 2H, J = 11.6 Hz, PhCH2O), 4.62-
4.55 (AB dd, 2H, J= 12.0 Hz, PhCH2O), 4.52-4.43 (d, 1H, J1,2 = 8.0 Hz, H-1), 4.34-4.30 
(m, 1H, OCHaHbCH=CH2),  4.05-4.00 (m, 1H, OCHaHbCH=CH2), 3.79-3.70 (m, 3H, H-
4, H-6, H-6’), 3.57-3.53 (t, 1H, J2,3 = J3,4 = 9.0 Hz, H-3), 3.50-3.46 (m, 1H, H-5), 2.71 (d, 
1H,  J = 2.4, Hz, -OH), 1.20 (s, 9H, t-BuCO). 
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13
C NMR (CDCl3, 101 MHz) $ (ppm) 177.0, 138.4, 138.0, 133.8, 128.7, 128.6, 128.0, 
127.9, 127.8, 127.2, 117.5, 82.8, 74.5, 74.4, 73.9, 72.7, 72.0, 70.5, 70.1, 39.0, 27.3. 
 
Spectral Data for 18: 
Rf: 0.44 (3:7 EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.38-7.25 (m, 10H, ArH), 5.89-5.80 (m, 1H, 
CH=CH2), 5.28-5.23 (m, 1H, CH=CHaHb), 5.19-5.17 (m, 1H, CH=CHaHb), 5.08-5.04 
(dd, 1H, J1,2 = J2,3 = 8.0 Hz, H-2), 4.83-4.56 (m, 4H, 2%PhCH2O), 4.48 (d, 1H, J1,2 = 8.0 
Hz, H-1), 4.34-4.30 (m, 1H, OCHaHbCH=CH2),  4.07-4.02 (m, 1H, OCHaHbCH=CH2), 
3.90-3.87 (br d, 1H, H-4), 3.76-3.65 (m, 3H, H-3, H-6, H-6’), 3.45-3.38 (m, 1H, H-5), 
2.05-1.80 (br s, 1H, -OH), 1.20 (s, 9H, t-BuCO). 
 
Spectral Data for 19: 
Rf: 0.86 (3:7 EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.35-7.13 (m, 15H, Ar-H), 5.86-5.80 (m, 1H, 
CH2=CHCH2O), 5.28-5.23 (m, 1H, CHaHb=CHCH2O), 5.17-5.14 (m, 1H, 
CHaHb=CHCH2O), 5.11-5.08 (m, 1H, H-2), 4.78-4.51 (m, 6H, 3%PhCH2) 4.43 (d, 1H, J1,2 
= 8.0 Hz, H-1), 4.37-4.32 (m, 1H, CH2=CHCHaHbO), 4.06-4.01 (m, 1H, 
CH2=CHCHaHbO), 3.77-3.68 (m, 4H, H-3, H-4, H-6, H-6’), 3.52-3.50 (m, 1H, H-5), 1.19 
(s, 9H, t-BuCO). 
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13
C NMR (CDCl3, 101 MHz) $ (ppm) 176.9, 138.3, 138.3, 138.1, 133.8, 128.5 (3), 
128.1, 127.9 (2), 127.8, 127.7, 127.6, 117.4, 100.3, 83.4, 78.0, 75.4, 75.1 (2), 73.7, 73.2, 
70.0, 68.9, 39.0, 27.3. 
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  17       20 
Allyl 3,6-di-O-benzyl-4-O-levulinoyl-2-O-pivaloyl-"-D-glucopyranoside (20). Allyl 
3,6-di-O-benzyl-2-O-pivaloyl-"-D-glucopyranoside (17) (2.09 g, 4.30 mmol) was 
dissolved in dichloromethane (30 mL).  To this solution, N,N-dicyclohexylcarbodiimide 
(1.78 g, 8.60 mmol), levulinic acid (1.00 g, 8.60 mmol), and 4-dimethylaminopyridine 
(100 mg) were added.  The resulting mixture was stirred for 1 hour at ambient 
temperature.  The mixture was then filtered on Celite to remove the precipated 
dicyclohexylurea.  The filtrate was diluted with dichloromethane and washed 
successively with saturated aqueous NaHCO3 solution, water, and brine.  The organic 
extract was dried over Na2SO4 and concentrated under reduced pressure.  The residue 
was purified by column chromatography on silica gel using 25% ethyl acetate in hexanes 
to give 20 as a colorless syrup that solidified upon standing (2.09 g, 3.59 mmol, 84%).  
 
Rf: 0.43 (3:7 EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.36-7.21 (m, 10H, ArH), 5.87-5.79 (m, 1H, 
CH=CH2), 5.28-5.22 (m, 1H, CH=CHaHb), 5.18-5.07 (m, 3H, CH=CHaHb, H-2, H-4), 
4.64-4.51 (m, 4H, 2%PhCH2O), 4.49-4.47 (d, 1H, J1,2= 8.0 Hz, H-1), 4.37-4.32 (m, 1H, 
 170 
OCHaHbCH=CH2),  4.07-4.02 (m, 1H, OCHaHbCH=CH2), 3.78-3.73 (t, 1H, J2,3 = J3,4 = 
9.2 Hz, H-3), 3.62-3.58 (m, 3H, H-5, H-6, H-6’), 2.65-2.49 (m, 2H, 
CH3COCH2CH2COO), 2.44-2.25 (m, 2H, CH3COCH2CH2COO), 2.11 (s, 3H, 
CH3COCH2CH2COO), 1.20 (s, 9H, t-BuCO). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 206.4, 176.8, 171.7, 138.2(2), 133.7, 128.5(2), 
128.0, 127.8(2), 127.7(2), 100.2, 80.5, 73.8, 73.7, 73.5, 72.5, 70.9, 70.1, 69.8, 39.0, 37.9, 
30.0, 28.0, 27.3. 
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3,6-di-O-benzyl-4-O-levulinoyl-2-O-pivaloyl-D-glucopyranose (21). Allyl 3,6-di-O-
benzyl-4-O-levulinoyl-2-O-pivaloyl-"-D-glucopyranoside (20) (2.08 g, 3.57 mmol) was 
dissolved in tetrahydrofuran (30 mL).  To this solution, (1,5-
cyclooctadiene)bis(methyldiphenylphosphine)iridium(I) (30 mg, 35.7 µmol) was added.  
The resulting red suspension was degassed by brief exposure of the reaction flask to 
vacuum.  The mixture was then stirred under a balloon of hydrogen until the red 
suspension became a colorless solution (approximately 30 seconds).  The mixture was 
degassed and the flask filled with nitrogen.  The resulting mixture was stirred for 9 hours 
at ambient temperature.  Proton NMR analysis of a small aliquot (~100 µL) of the 
reaction mixture indicated that isomerization of the allyl ether was complete.  To the 
crude reaction mixture, water (2 mL) and iodine (1.36 g, 5.35 mmol) were added.  The 
reaction mixture immediately turned dark brown.  After 30 minutes, saturated sodium 
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thiosulfate solution was added until all traces of brown color disappeared.  The mixture 
was diluted with water and dichloromethane, and the layers separated.  The aqueous layer 
was extracted twice with dichloromethane.  The combined organic extracts were washed 
successively with saturated aqueous NaHCO3 solution and brine.  The organic extract 
was dried over Na2SO4 and concentrated under reduced pressure.  The residue was 
purified by column chromatography on silica gel using a gradient of 30% to 40% ethyl 
acetate in hexanes to give 21, a 1:3 mixture of !- and "-isomers, as a white solid. (1.47 g, 
2.71 mmol, 76% over 2 steps).  
 
Rf: 0.20 and 0.27 (3:7 EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.35-7.23 (m, 10H, Ar-H), 5.49 (t, 0.25H, J = 3.6 
Hz, H-1!), 5.18 (t, 0.75H, J3,4 =  J4,5 = 9.6 Hz, H-4 "), 5.08 (t, 0.25H, J3,4 =  J4,5 = 9.6 Hz, 
H-4 !), 4.94-4.89 (dd, 0.75H, J2,3 = 9.6 Hz, J1,2 = 8.4 Hz, H-2 "), 4.84-4.81 (dd, 0.25H, 
J2,3 = 8.8 Hz, J1,2 = 3.6 Hz, H-2 !), 4.78-4.50 (m, 4.75H, 2% PhCH2O and H-1 "), 4.18-
4.12 (m, 0.25H), 4.08 (t, 0.25H, J2,3 =  J3,4 = 9.6 Hz, H-3 !), 3.79 (t, 0.75H, J2,3 =  J3,4 = 
9.6 Hz, H-3 "), 3.66-3.52 (m, 3.5H), 2.87 (br s, 0.25H, -OH), 2.68-2.48 (m, 2H, 
CH3COCH2CH2COO), 2.43-2.22 (m, 2H, CH3COCH2CH2COO), 2.12(s, 3H, 
CH3COCH2CH2COO), 1.23 (s, 9H, t-BuCO). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 206.5, 206.4, 179.2, 177.9, 171.7(2), 138.5, 138.1, 
138.0(2), 128.6, 128.5, 128.3, 127.9(2), 127.8(2), 96.3, 90.3, 80.0, 75.4, 75.0, 74.4, 73.9, 
73.8(2), 73.7, 70.9(2), 69.3, 69.2, 69.0, 39.1, 38.9, 38.0(2), 30.0, 28.0(2), 27.3(2). 
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     9        21 
3,6-di-O-benzyl-4-O-levulinoyl-2-O-pivaloyl-!-D-glucopyranosyl 
trichloroacetimidate (9). 3,6-di-O-benzyl-4-O-levulinoyl-2-O-pivaloyl-D-
glucopyranose (21) (1.46 g, 2.69 mmol) was dissolved in dichloromethane (25 mL).  
Cesium carbonate (1.31 g, 4.03 mmol) and trichloroacetonitrile (1.94 g, 1.34 mL, 13.45 
mmol) were added, and the resulting mixture stirred at ambient temperature for 2.5 h.  
The mixture was filtered through a pad of Celite and the solvents removed under reduced 
pressure.  The residue was purified by column chromatography on silica gel, using ethyl 
acetate/hexanes/triethylamine (25:75:1) as the eluant, to afford 9 as a colorless syrup 
(1.44 g, 2.09 mmol, 78%). 
 
Rf: 0.52 (3:7 EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 8.64 (s, 1H, NH), 7.33-7.24 (m, 10H, Ar-H), 6.59 
(d, 1H, J1,2 = 3.6 Hz, H-1), 5.30 (t, 1H, J3,4 =  J4,5 = 10.0 Hz, H-4), 5.13-5.10 (dd, 1H, J2,3 
= 10.0 Hz, J1,2 = 3.6 Hz, H-2), 4.73 (d, 1H, J  = 11.6 Hz, PhCHaHbO), 4.63 (d, 1H, J = 
11.6 Hz, PhCHaHbO), 4.53-4.46 (2 d, 2H, J = 11.6 Hz, PhCH2O), 4.16-4.10 (m, 2H, H-3, 
H-5), 3.62-3.58 (dd, 1H, J6,6’ = 11.2 Hz, J6,5 = 3.2 Hz, H-6), 3.56-3.52 (dd, 1H, J6,6’ = 11.2 
Hz, J6’,5 = 4.4 Hz, H-6’), 2.65-2.50 (m, 2H, CH3COCH2CH2COO), 2.44-2.25 (m, 2H, 
CH3COCH2CH2COO), 2.11 (s, 3H, CH3COCH2CH2COO), 1.17 (s, 9H, t-BuCO).
13
C 
NMR (CDCl3, 101 MHz) $ (ppm) 206.4, 177.4, 171.5, 160.7, 138.1, 138.0, 128.5, 128.4, 
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128.1, 127.9, 127.8, 93.5, 91.2, 77.0, 74.7, 73.7, 72.1, 72.0, 70.0, 68.5, 39.0, 37.9, 30.0, 
28.0, 27.3.  
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!-D-Glucose pentapivaloate (22).  A solution of triethylamine (18.6 mL, 133.2 mmol), 
4-dimethylaminopyridine (150 mg), and trimethylacetyl chloride (16.5 mL, 133.2 mmol) 
in dichloromethane (60 mL) was cooled to 0°C.  To this solution, D-glucose (3.00 g, 16.7 
mmol) was added in small portions over 30 minutes.  The ice bath was then removed and 
the mixture slowly warmed to room temperature.  After 16 h, the mixture was diluted 
with dichloromethane and washed successively with 2N HCl, water, NaHCO3, water, and 
brine.  Following drying over Na2SO4, the solvent was evaporated under reduced 
pressure.  The residue was subjected to flash chromatography on silica gel (1:9 
EtOAc/hexanes) to give the product 22 as a white solid (8.86 g, 14.74 mmol, 88%).  
 
Rf: 0.32 (1:9 EtOAc/hexanes)
 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 6.32 (d, 1H, J1,2 = 3.6 Hz, H-1), 5.54 (t, 1H, J2,3 = 
J3,4 =  10.0 Hz, H-3), 5.19 (t, 1H, J3,4 = J4,5 =  10.0 Hz, H-4), 5.14-5.10 (dd, 1H, J1,2 = 3.6 
Hz, J2,3 = 10.0 Hz, H-2), 4.16-4.08 (m, 3H, H-5, H-6, H-6’), 1.28 (s, 9H, t-Bu), 1.21 (s, 
9H, t-Bu), 1.18 (s, 9H, t-Bu), 1.13 (s, 9H, t-Bu), 1.12 (s, 9H, t-Bu). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 178.2, 177.3, 177.2, 176.7, 176.1, 88.8, 70.5, 
69.8, 69.6, 67.5, 61.8, 39.4, 39.1, 39.0 (2), 38.9, 27.4, 27.3 (3). 
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        22            23 
1,2-O-(1-ethoxy-2,2,2-trimethylethylidene)-3,4,6-tri-O-pivaloyl-!-D-glucopyranose 
(23).   A solution of !-D-Glucose pentapivaloate (22) (4.45 g, 7.40 mmol) in 
dichloromethane (50 mL) was cooled to 0°C.  To this solution, 20 mL of a 33% (w/w) 
solution of HBr in acetic acid was added via syringe.  The mixture was stirred overnight 
and allowed to warm to room temperature.  The mixture was poured into ice water and 
extracted with dichloromethane.  The organic extracts were washed successively with 
saturated NaHCO3 and brine, then dried over Na2SO4.  The solvent was evaporated under 
reduced pressure to give the crude glucosyl bromide as a white solid.  This solid was 
dissolved in dichloromethane (40 mL).  To this solution, ethanol (0.47 mL, 8.14 mmol), 
tetrabutylammonium bromide (1.19 g, 3.70 mmol), and triethylamine (3.1 mL, 22.2 
mmol) were added.  The mixture was heated to reflux for 18 h, then cooled to room 
temperature.  The mixture was diluted with dichloromethane, washed successively with 
water and brine, and dried over Na2SO4.  The solvent was removed under reduced 
pressure, and the residue purified by flash chromatography on silica gel using 1:9:0.1 
EtOAc/hexanes/Et3N as eluant to give the product 23 as a white solid (3.03 g, 5.56 mmol, 
75%). 
 
Rf: 0.41 (1:9 EtOAc/hexanes)
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1
H NMR (CDCl3, 400 MHz) $ (ppm) 5.78 (d, 1H, J 1,2 = 5.6 Hz, H-1), 5.23 (dd, 1H, J 2,3 
= 3.6 Hz, J 3,4 = 6.0 Hz, H-3), 4.98 (dd, 1H, J 4,3 = 6.0 Hz, J 4,5 = 9.6 Hz, H-4), 4.29 (dd, 
1H, J 2,1 = 3.6 Hz, J 2,3 = 5.6 Hz, H-2), 4.28-4.10 (m, 3H, H-5, H-6, H-6’), 3.59 (m, 2H, 
OCH2CH3), 1.22 (s, 9H, t-Bu), 1.20 (s, 9H, t-Bu), 1.18 (s, 9H, t-Bu), 1.17 (t, 3H, J = 7.2 
Hz, OCH2CH3), 1.11 (s, 9H, t-Bu). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 178.2, 177.0, 176.9, 125.1, 97.6, 76.1, 72.2, 68.9, 
67.2, 62.8, 60.3, 39.5, 39.0, 38.9, 38.8, 27.3, 27.2 (2), 25.8, 15.5. 
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1,2-O-(1-ethoxy-2,2,2-trimethylethylidene)-3,4,6-tri-O-benzyl-!-D-glucopyranose 
(24).   A solution of 1,2-O-(1-ethoxy-2,2,2-trimethylethylidene)-3,4,6-tri-O-pivaloyl-!-
D-glucopyranose (23) (4.03 g, 7.39 mmol) was suspended in absolute ethanol (100 mL).  
To this suspension sodium metal (60 mg) was added.  The mixture was stirred at room 
temperature.  The starting material slowly dissolved as the reaction proceeded.  After ~20 
h, additional sodium metal (50 mg) was added to the reaction mixture.  Following stirring 
for an additional 4 h, the solvents were evaporated under reduced pressure.  The resulting 
crude triol was dissolved in DMF (40 mL).  Benzyl bromide (3.96 mL, 33.3 mmol) was 
added, and the mixture cooled to 0°C.  Sodium hydride (1.33 g of a 60% dispersion in 
mineral oil) was added, and the mixture allowed to slowly warm to room temperature 
while stirring.  After 17 h, the excess sodium hydride was destroyed by the addition of 
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methanol (2 mL).  The reaction mixture was partitioned between ethyl acetate (100 mL) 
and water (60 mL).  The layers separated and the aqueous layer was extracted with ethyl 
acetate (100 mL).  The combined organic extracts were washed with brine and dried over 
Na2SO4.  After removal of solvents under reduced pressure, the residue was purified by 
flash chromatography on silica gel using a gradient elution of 5-10% ethyl acetate in 
hexanes to give tribenzyl orthoester 24 as a light yellow syrup (3.91 g, 6.94 mmol, 94%). 
 
Rf: 0.63 (2:8 EtOAc/hexanes)
 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.41-7.19 (m, 15H, Ar-H), 5.89 (d, 1H, J 1,2 = 5.2 
Hz, H-1) 4.86, 4.80, 4.70, 4.52, 4.48, 4.41 (6 d, each 1H, J = 12.0 Hz, 3%PhCHaHbO), 
4.36 (t, 1H, J 2,3 = J 1,2 = 5.2 Hz, H-2), 3.89-3.73 (m, 3H, H-3, H-4, H-5), 3.66 (dd, 1H, J 
6,6’ = 10.4 Hz, J 6,5 = 1.6 Hz, H-6), 3.59 (dd, 1H, J 6’,6 = 10.4 Hz, J 6’,5 = 2.8 Hz, H-6’),  
3.51 (q, 2H, J = 7.2 Hz, OCH2CH3), 1.18 (t, 3H, J = 7.2 Hz, OCH2CH3), 1.05 (s, 9H, t-
Bu). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 138.4, 138.3, 138.2, 128.6, 128.5, 128.3, 128.2, 
128.0 (2), 127.9 (2), 126.7, 98.3, 82.1, 81.5, 74.5, 74.3, 73.6, 73.5, 72.5, 69.8, 58.7, 39.1, 
25.7, 15.4. 
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6-O-acetyl-3,4-di-O-benzyl-2-O-pivaloyl-D-glucopyranose (25).   A solution of freshly 
fused zinc chloride (4.66 g, 34.2 mmol) was dissolved in 24 mL of 5:1 acetic 
anhydride/acetic acid (v/v) and cooled to 0°C.  A solution of orthoester (24) (3.85 g, 6.84 
mmol) in 24 mL of 5:1 acetic anhydride:acetic acid (v/v) was added dropwise to the 
cooled zinc chloride solution.  The ice bath was removed and the reaction warmed to 
room temperature.  After 3 h, the mixture was poured into water (100 mL) and extracted 
with dichloromethane (3%80 mL).  The combined organic extracts were washed 
successively with saturated NaHCO3 (2%100 mL) and brine (100 mL), and dried over 
Na2SO4.  The solvents were removed under reduced pressure.  The resulting residue was 
dissolved in DMF (20 mL).  To this solution, hydrazine acetate (755 mg, 8.21 mmol) was 
added and the mixture stirred at room temperature.  After 20 h, the mixture was diluted 
with water (60 mL) and extracted with dichloromethane (4%80 mL).  The combined 
organic extracts were washed with brine, dried over Na2SO4, and concentrated under 
reduced pressure.  The residue was purified by flash chromatography on silica gel using 
1:3 EtOAc/hexanes as eluant to furnish the product 25, a 7:3 mixture of !- and "-
anomers, as a light yellow syrup (2.52 g, 5.18 mmol, 76% over 2 steps). 
 
Rf: 0.28 and 0.39 (3:7 EtOAc/Hexanes)
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1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.35-7.23 (m, 10H, Ar-H), 5.42 (d, 0.7H, J1,2 = 3.6 
Hz, H-1!), 4.87-4.79 (m, 4H), 4.62-4.55 (m, 1.3H), 4.35-4.32 (m, 1H), 4.25-4.21 (m, 
1H), 4.14-4.09 (m, 1.3H), 3.79 (t, 0.3H, J = 9.6 Hz), 3.62-3.56 (m, 1.3 H), 2.05 (s, 3H, 
CH3CO), 1.22 (br s, 9H, t-BuCO). 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 179.4, 178.2, 171.1, 171.0, 138.3, 138.0, 137.9, 
137.6, 128.7 (2), 128.6, 128.3, 128.1, 128.0, 127.9, 127.7, 127.6, 96.2, 90.4, 82.8, 79.8, 
75.8, 75.6, 75.5, 75.2, 74.0, 73.4, 68.8, 63.0, 39.1, 39.0, 27.3, 27.2, 21.1. 
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6-O-acetyl-3,4-di-O-benzyl-2-O-pivaloyl-!-D-glucopyranosyl trichloroacetimidate 
(10).   To a solution of lactol (25) (2.52 g, 5.18 mmol) in dichloromethane (50 mL) was 
added cesium carbonate (2.53 g, 7.77 mmol) and trichloroacetonitrile (3.73 g, 2.6 mL, 
25.9 mmol).  The mixture was stirred at room temperature for 18 h, then filtered on Celite 
an concentrated under reduced pressure.  The residue was purified by flash 
chromatography on silica gel using a gradient elution of 10-70% ethyl acetate in hexanes 
to give trichloroacetimidate 10 as a white crystalline solid (2.08 g, 3.29 mmol, 64%). 
 
Rf: 0.73 (3:7 EtOAc/hexanes)
 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 8.62 (s, 1H, NH), 7.36-7.24 (m, 10H, Ar-H), 6.52 
(d, 1H, J1,2 = 3.2 Hz, H-1), 5.10 (dd, 1H, J2,1 = 3.2 Hz, J2,3 = 10.0 Hz, H-2), 4.86-4.83 (m, 
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3H, PhCHaHb, PhCHa’Hb’), 4.58 (d, 1H, J = 10.8 Hz, PhCHa’Hb’), 4.32 (dd, 1H, J6,6’ = 
12.0 Hz, J6,5 = 2.0 Hz, H-6), 4.24 (dd, 1H, J6’,6 = 12.0 Hz, J6’,5 = 4.0 Hz, H-6’), 4.16 (t, 
1H, J3,2 = J3,4  = 9.6 Hz, H-3), 4.09 (ddd, 1H, J5,6 = 2.0 Hz, J5,6’ = 4.0 Hz, J5,4 = 10.0 Hz, 
H-5), 3.71 (t, 1H, J4,3 = J4,5  = 9.6 Hz, H-4), 2.02 (s, 3H, CH3CO), 1.17 (s, 9H, t-BuCO). 
 
13
C NMR (CDCl3, 101 MHz) $ (ppm) 177.7, 170.8, 160.9, 138.1, 137.5, 128.8, 128.7, 
128.6, 128.4, 128.0, 127.6, 93.6, 91.2, 80.0, 76.7, 75.7, 75.5, 72.4, 71.7, 62.5, 39.0, 27.3, 
21.0. 
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     7       1 
Cis-4-(1H,1H,2H,2H,3H,3H-perfluoroundecyloxy)-2-butenyl 4-O-benzyl-3,6-di-O-
(3,4,6-tri-O-benzyl-2-O-pivaloyl-"-D-glucopyranosyl)-2-O-pivaloyl-"-D-
glucopyranoside (1). 
The branched "-glucan trisaccharide 1 was synthesized from fluorocarbon-tagged alcohol 
7 via 1.5 automated synthesis cycles using the Chemspeed ASW1000 synthesizer. The 
specific reaction conditions are outlined in the table below: 
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Step Task Reagent/Operation Time 
1 Glycosylation 1.5 eq. donor 6 (112 µmol) in 1.5 mL 
toluene, 1 eq. F-tagged acceptor 7 (75 
µmol) in 0.5 mL toluene, 0.1 eq. TMSOTf 
(0.1 M in DCM), 20 oC 
20 min 
2 TLC Sample 40 µL of crude reaction mixture 
withdrawn 
 
3 Quenching 0.2 mL triethylamine  
4 Evaporation 40 oC 45 min 
5 Delevulinoylation 10 eq. Hydrazine hydrate (1.0 M in 3:2 
pyr/HOAc), DCM, rt 
50 min 
6 TLC Sample 40 µL of crude reaction mixture 
withdrawn 
 
7 Quenching 0.5 mL acetone  
8 Evaporation 60 oC 45 min 
9 FSPE Sample Preparation 0.8 mL DMF transferred to reaction vial  
10 Sample loading crude sample transferred to F-SPE 
cartridge 
 
11 Elution 4.7 mL 80% methanol wash  
12 Elution 1.5 mL THF wash (repeated 3 times)  
13 Transfer 4.7 mL collected sample to clean reaction 
vial 
 
14 Transfer / Evaporation 0.5 mL toluene added, then evaporated at 
40 oC (repeated 3%) 
45 min 
% 3 
15 Glycosylation Donor 5  (225 µmol) in 1.5 mL toluene, 
F-tagged acceptor from cycle 1, 0.1 eq. 
TMSOTf  
(0.1 M in DCM), 20 oC 
 
16 TLC Sample 40 µL of crude reaction mixture 
withdrawn 
 
17 Quenching 0.2 mL triethylamine  
18 Evaporation 40 oC 45 min 
19 FSPE Same as steps 9-12  
 
Table 4.1. Synthetic procedure for the automated synthesis of trisaccharide (1). 
  
Following the final F-SPE procedure, the conical-bottomed extraction vial containing the 
crude trisaccharide product was removed from the ASW1000. The solvent was removed 
under reduced pressure. The crude product was purified by flash chromatography on 
 181 
silica gel (0#20% EtOAc/hexanes) to yield trisaccharide 1 (25.4 mg, 13.2 µmol, 18% 
overall yield) as a colorless syrup.  
 
Rf: 0.49 (20% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.34-7.11 (m, 35H, Ar-H), 5.68-5.63 (m, 1H, 
vinylic H), 5.57-5.51 (m, 1H, vinylic H), 5.10-4.97 (m, 3H), 4.87 (t, 1H, J = 9 Hz), 4.80-
4.62 (m, 8H), 4.60-4.43 (m, 8H), 4.41 (d, 1H, J = 8.0 Hz, H-1), 4.26-4.18 (m, 3H), 4.17-
4.00 (m, 4H), 3.80-3.40 (m, 16H), 3.30 (t, 1H, J = 8.8 Hz), 2.22-2.08 (m, 2H, 
OCH2CH2CH2CF2), 1.86-1.78 (m, 2H, OCH2CH2CH2CF2), 1.21 (s, 9H, (t-BuCO), 1.19 
(s, 9H, t-BuCO), 1.16 (s, 9H, t-BuCO). 
13
C NMR (CDCl3, 100 MHz) $ (ppm) 177.5, 176.8, 176.2, 138.5(2), 138.3(2), 138.2, 
128.7(2), 128.6, 128.5, 128.4, 128.3, 128.2, 128.1, 128.0, 127.9, 127.8(2), 127.7(2), 
127.5(2), 101.3, 99.6, 99.4, 83.6, 83.5, 78.5, 78.0, 76.2, 75.8, 75.5, 75.4, 75.2, 75.1, 74.8, 
73.8, 73.7, 73.4, 73.1, 69.0(2), 68.9, 68.4, 66.7, 64.3, 39.0, 38.9(2), 29.9, 28.2, 28.0, 
27.4(2), 27.3, 21.0. 
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Figure 4.4. Analytical HPLC chromatogram of crude 1 obtained from the Chemspeed ASW-1000 
workstation.  T = 1.9, 2.2 min: decomposed donor; T = 3.4 min; trisaccharide 1. (Flow rate 1 mL/min, 20% 
EtOAc in hexanes)  
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 7           2 
Cis-4-(1H,1H,2H,2H,3H,3H-perfluoroundecyloxy)-2-butenyl 4,6-di-O-benzyl-3-O-
(4,6-di-O-benzyl-3-O-(4,6-di-O-benzyl-2-O-pivaloyl-"-D-glucopyranosyl)-2-O-
pivaloyl-"-D-glucopyranosyl)-2-O-pivaloyl-"-D-glucopyranoside (2). 
The linear 1,3-linked "-glucan trisaccharide 2 was synthesized from fluorocarbon-tagged 
alcohol 7 and glucosyl donor 8 via three automated synthesis cycles using the Chemspeed 
ASW1000 synthesizer. The specific reaction conditions are given in the table below: 
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Step Task Reagent/Operation Time 
1 Glycosylation 1.5 eq. donor 8 (112 µmol) in 1.5 mL toluene, 
1 eq. F-tagged acceptor 7 (75 µmol) in 0.5 
mL toluene, 0.1 eq. TMSOTf (0.1 M in 
DCM), 20 oC 
20 
min 
2 TLC Sample 40 µL of crude reaction mixture withdrawn  
3 Quenching 0.2 mL triethylamine  
4 Evaporation 40 oC 
 
45 
min 
5 Delevulinoylation 10 eq. Hydrazine hydrate (1.0 M in 3:2 
pyr/HOAc), DCM, rt 
50 
min 
6 TLC Sample 40 µL of crude reaction mixture withdrawn  
7 Quenching 0.5 mL acetone  
8 Evaporation 60 oC 45 
min 
9 FSPE Sample Preparation 0.8 mL DMF transferred to reaction vial  
10 Sample loading crude sample transferred to F-SPE cartridge  
11 Elution 4.7 mL 80% methanol wash  
12 Elution 1.5 mL THF wash (repeated 3 times)  
13 Transfer 4.7 mL collected sample to clean reaction vial  
14 Transfer / Evaporation 0.5 mL toluene added, then evaporated at 40 
oC (repeated 3%) 
45 
min 
% 3 
15 Glycosylation Donor 8  (225 µmol) in 1.5 mL toluene, 
F-tagged acceptor from cycle 1, 0.1 eq. 
TMSOTf (0.1 M in DCM), 20 oC 
 
16 TLC / Delevulinoylation  
Evaporation / FSPE 
Same as steps 2-12 
 
 
17 Transfer / Evaporation Same as steps 13-14  
18 Glycosylation / 
Delevulinoylation / FSPE 
Same as steps 15-16 
 
 
19 FSPE Same as steps 9-12  
 
Table 4.2. Synthetic procedure for the automated synthesis of trisaccharide (2). 
 
Following the final automated FSPE cycle, the conical-bottomed extraction vial 
containing the crude trisaccharide product was removed from the ASW1000. The solvent 
was removed under reduced pressure. The crude product (30 mg) was purified by flash 
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chromatography on silica gel (1 cm % 15 cm column, 0#20% EtOAc/hexanes) only 
partially separated trisaccharide 2 from a small amount of the corresponding disaccharide 
product.  Careful column chromatography of the mixed fractions (1 cm % 20 cm column, 
10#20% EtOAc/hexanes) gave additional pure 2.  (total yield 13.0 mg, 7.11 µmol, 9.5% 
overall yield) as a colorless syrup.  
 
Rf: 0.31 (20% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.34-7.18 (m, 30H, Ar-H), 5.68-5.60 (m, 1H, 
vinylic H), 5.59-5.53 (m, 1H, vinylic H), 4.99-4.90 (m, 3H), 4.87-4.72 (m, 4H), 4.64-4.60 
(m, 2H), 4.53-4.40 (m, 8H), 4.28-4.06 (m, 5H), 3.94 (d, 2H, J= 5.6 Hz, allylic CH2), 
3.78-3.72 (m, 2H), 3.70-3.40 (m, 11H), 3.57 (t, 2H, J = 5.6 Hz, OCH2CH2CH2CF2), 2.46 
(br d, 1H, J = 4.0 Hz, -OH), 2.20-2.02 (m, 2H, OCH2CH2CH2CF2), 1.84-1.76 (m, 2H, 
OCH2CH2CH2CF2), 1.22 (s, 9H, (t-BuCO), 1.19 (s, 9H, t-BuCO), 1.11 (s, 9H, t-BuCO). 
13
C NMR (CDCl3, 100 MHz) $ (ppm) 179.3, 176.6, 176.4, 138.7(2), 138.4, 138.3, 138.1, 
130.1, 128.8, 128.7(2), 128.6, 128.5(2), 128.4(2), 128.3, 128.2, 128.0, 99.6, 99.3, 98.9, 
78.9, 78.0, 76.6(2), 76.0, 75.7, 75.5, 75.3, 75.2, 75.0, 74.7, 74.5, 74.0, 73.7, 73.6, 39.2, 
39.0, 38.8, 29.9, 28.2, 27.6, 27.3(2), 21.0. 
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 7          3 
Cis-4-(1H,1H,2H,2H,3H,3H-perfluoroundecyloxy)-2-butenyl 3,6-di-O-benzyl-4-O-
(3,6-di-O-benzyl-4-O-(3,6-di-O-benzyl-2-O-pivaloyl-"-D-glucopyranosyl)-2-O-
pivaloyl-"-D-glucopyranosyl)-2-O-pivaloyl-"-D-glucopyranoside (3). 
The linear 1,4-linked "-glucan trisaccharide 3 was synthesized from fluorocarbon-tagged 
alcohol 7 and glucosyl donor 9 via three automated synthesis cycles using the Chemspeed 
ASW1000 synthesizer.   The specific reaction conditions are outlined in the table below: 
 
Step Task Reagent/Operation Time 
1 Glycosylation 1.5 eq. donor 9 (112 µmol) in 1.5 mL toluene, 
1 eq. F-tagged acceptor 7 (75 µmol) in 0.5 
mL toluene, 0.1 eq. TMSOTf (0.1 M in 
DCM), 20 oC 
20 
min 
2 TLC Sample 40 µL of crude reaction mixture withdrawn  
3 Quenching 0.2 mL triethylamine  
4 Evaporation 40 oC 
 
45 
min 
5 Delevulinoylation 10 eq. Hydrazine hydrate (1.0 M in 3:2 
pyr/HOAc), DCM, rt 
50 
min 
6 TLC Sample 40 µL of crude reaction mixture withdrawn  
7 Quenching 0.5 mL acetone  
8 Evaporation 60 oC 45 
min 
9 FSPE Sample Preparation 0.8 mL DMF transferred to reaction vial  
10 Sample loading crude sample transferred to F-SPE cartridge  
11 Elution 4.7 mL 80% methanol wash  
12 Elution 1.5 mL THF wash (repeated 3 times)  
13 Transfer 4.7 mL collected sample to clean reaction vial  
14 Transfer / Evaporation 0.5 mL toluene added, then evaporated at 40 
oC (repeated 3%) 
45 
min 
% 3 
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15 Glycosylation Donor 9  (225 µmol) in 1.5 mL toluene, 
F-tagged acceptor from cycle 1, 0.1 eq. 
TMSOTf (0.1 M in DCM), 20 oC 
 
16 TLC / Delevulinoylation  
Evaporation / FSPE 
Same as steps 2-12 
 
 
17 Transfer / Evaporation Same as steps 13-14  
18 Glycosylation / 
Delevulinoylation / FSPE 
Same as steps 15-16 
 
 
19 FSPE Same as steps 9-12  
 
Table 4.3. Synthetic procedure for the automated synthesis of trisaccharide (3). 
 
Following the final automated FSPE cycle, the conical-bottomed extraction vial 
containing the crude trisaccharide product was removed from the ASW1000. The solvent 
was removed under reduced pressure. The crude product (27 mg) was purified by column 
chromatography on silica gel (1 cm % 20 cm column, 10#30% EtOAc/hexanes), 
followed by a second silica gel column (1 cm % 20 cm column, 10#24% 
EtOAc/hexanes).  However, these chromatographic steps failed to remove the presumed 
disaccharide impurity present.  The remaining mixed product (8.0 mg) was further 
purified by preparative TLC (10 cm % 20 cm plate, eluted once with 30% EtOAc in 
hexanes), to provide pure 3 as a colorless syrup (5.1 mg, 2.8 µmol, 3.7% overall yield). 
 
Rf: 0.59 (30% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.34-7.12 (m, 30H, Ar-H), 5.64-5.57 (m, 2H, 
vinylic H), 5.12-4.90 (m, 5H), 4.77 (apparent t, 2H, J = 12.8 Hz), 4.58 (d, 1H, J = 11.2 
Hz), 4.50 (d, 1H, J = 11.6 Hz), 4.44-4.38 (m, 2H), 4.38-4.28 (m, 4H), 4.25 (d, 2H, J = 6.0 
Hz, allylic CH2), 4.18-4.12 (dd, 1H), 4.07-3.72 (m, 6H), 3.80-3.52 (m, 6H), 3.43-4.34 (m, 
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4H), 3.30-3.12 (m, 5H), 2.96 (s, 1H, -OH), 2.22-2.06 (m, 2H, OCH2CH2CH2CF2), 1.86-
1.77 (m, 2H, OCH2CH2CH2CF2), 1.11 (s, 9H, (t-BuCO), 1.08 (s, 9H, t-BuCO), 1.07 (s, 
9H, t-BuCO). 
13
C NMR (CDCl3, 100 MHz) $ (ppm)  
HO O
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 7        4 
Cis-4-(1H,1H,2H,2H,3H,3H-perfluoroundecyloxy)-2-butenyl 3,4-di-O-benzyl-6-O-
(3,4-di-O-benzyl-6-O-(3,4-di-O-benzyl-2-O-pivaloyl-"-D-glucopyranosyl)-2-O-
pivaloyl-"-D-glucopyranosyl)-2-O-pivaloyl-"-D-glucopyranoside (4). 
The linear 1,6-linked "-glucan trisaccharide 4 was synthesized from fluorocarbon-tagged 
alcohol 7 and glucosyl donor 10 via three automated synthesis cycles using the 
Chemspeed ASW1000 synthesizer.  The specific reaction conditions are outlined in the 
table below: 
Step Task Reagent/Operation Time 
1 Glycosylation 1.5 eq. donor 10 (112 µmol) in 1.5 mL 
toluene, 1 eq. F-tagged acceptor 7 (75 µmol) 
in 0.5 mL toluene, 0.1 eq. TMSOTf (0.1 M in 
DCM), 20 oC 
20 
min 
2 TLC Sample 40 µL of crude reaction mixture withdrawn  
3 Quenching 0.2 mL triethylamine  
4 Evaporation 40 oC 
 
45 
min 
5 Deacetylation 0.25 M NaOMe in MeOH, rt 2 h  
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6 TLC Sample 40 µL of crude reaction mixture withdrawn  
7 Quenching 0.5 M AcOH in MeOH  
8 Evaporation 40 oC 45 
min 
9 FSPE Sample Preparation 0.8 mL DMF transferred to reaction vial  
10 Sample loading crude sample transferred to F-SPE cartridge  
11 Elution 4.7 mL 80% methanol wash  
12 Elution 1.5 mL THF wash (repeated 3 times)  
13 Transfer 4.7 mL collected sample to clean reaction vial  
14 Transfer / Evaporation 0.5 mL toluene added, then evaporated at 40 
oC (repeated 3%) 
45 
min 
% 3 
15 Glycosylation Donor 10  (225 µmol) in 1.5 mL toluene, 
F-tagged acceptor from cycle 1, 0.1 eq. 
TMSOTf (0.1 M in DCM), 20 oC 
 
16 TLC / Deacetylation  
Evaporation / FSPE 
Same as steps 2-12 
 
 
17 Transfer / Evaporation Same as steps 13-14  
18 Glycosylation / 
Deacetylation / FSPE 
Same as steps 15-16 
 
 
19 FSPE Same as steps 9-12  
 
Table 4.4. Synthetic procedure for the automated synthesis of trisaccharide (4). 
 
Following the final automated FSPE cycle, the conical-bottomed extraction vial 
containing the crude trisaccharide product was removed from the ASW1000. The solvent 
was removed under reduced pressure. TLC of the crude product showed the presence of 
two products, the desired trisaccharide (Rf = 0.55, 3:7 EtOAc/hexanes) and some 
unreacted disaccharide acceptor (Rf = 0.43, 3:7 EtOAc/hexanes).  The ratio of 
trisaccharide to disaccharide was approximately 3:1 based on TLC.  The crude product 
(16.5 mg) was purified by preparative TLC (20 cm % 20 cm plate, eluted once with 30% 
EtOAc in hexanes), to provide pure 4 as a colorless syrup (5.2 mg, 2.8 µmol, 3.8% 
overall yield). 
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Rf: 0.55 (30% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.35-7.13 (m, 30H, Ar-H), 5.70-5.56 (m, 2H, 
vinylic H), 5.06-4.97 (m, 3H), 4.80-4.55 (m, 13H), 4.39 (d, 2H, J = 7.6 Hz), 4.32-4.15 
(m, 1H), 4.18-4.10 (m, 1H), 4.10 (d, 2H, allylic CH2), 3.90-3.53 (m, 14H), 3.50-3.40 (m, 
3H), 3.37-3.30 (m, 1H), 2.22-2.00 (m, 2H, OCH2CH2CH2CF2), 1.88-1.77 (m, 2H, 
OCH2CH2CH2CF2), 1.16 (s, 9H, (t-BuCO), 1.15 (s, 9H, t-BuCO), 1.14 (s, 9H, t-BuCO). 
13
C NMR (CDCl3, 100 MHz) $ (ppm) 177.4, 176.8, 176.7, 138.3(2), 138.2, 138.1, 138.0, 
130.0, 128.7, 128.6, 128.5, 128.4, 128.3, 128.2(2), 128.1, 127.9, 127.8, 127.6, 127.5(2), 
102.2, 101.5, 100.0, 83.4(2), 83.2, 76.0, 75.1(2), 75.0, 73.3, 73.1, 73.0, 69.0, 66.8, 64.7, 
62.0, 39.0(2), 29.9, 27.4(2), 27.3. 
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         1         26 
2-hydroxyethyl 4-O-benzyl-3,6-di-O-(3,4,6-tri-O-benzyl-2-O-pivaloyl-"-D-
glucopyranosyl)-2-O-pivaloyl-"-D-glucopyranoside (26).  A solution of branched 
trisaccharide 1 (20.0 mg, 10.4 µmol) was dissolved in MeOH (2 mL) and CH2Cl2 (1 mL).  
The solution was cooled to -78 °C.  Ozone was bubbled through the solution until a pale 
blue color persisted (~ 2 minutes).  Nitrogen was then bubbled through the solution until 
it became colorless.  To this solution, NaBH4 (12 mg, 313 µmol) was added, and the 
mixture allowed to warm to ambient temperature.  After 9 hours, additional NaBH4 (4 
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mg, 106 µmol) was added, and the mixture stirred at ambient temperature for an 
additional 5 hours.  The solvents were evaporated using a stream of nitrogen.  The 
residue was partitioned between CH2Cl2 (10 mL) and saturated aqueous NH4Cl.  The 
aqueous layer was extracted with CH2Cl2 (5 mL).  The combined organic extracts were 
washed successively with water (5 mL) and brine (5 mL), and dried over Na2SO4.  The 
solvent was evaporated under reduced pressure.  Silica gel flash chromatography of the 
residue gave a white, waxy syrup (12.2 mg), but proton NMR showed the presence of the 
cleaved fluorous alcohol compound, which wasn’t visible upon staining the TLC plate.  
The product was then loaded onto a 2-gram fluorous solid-phase extraction cartridge with 
MeOH (0.2 mL).  The desired product was eluted using 80% aqueous MeOH.  However, 
some of the desired product was retained on the FSPE column until the fluorophilic 
solvent, MeOH, was eluted through the cartridge.   The fraction containing the 
fluorophilic eluant was concentrated under reduced pressure.  The resulting residue was 
dissolved in dichloromethane (0.2 mL) and loaded onto a 2-gram FSPE cartridge.  This 
time, the desired product was completely eluted by the fluorophobic solvent.  The 
combined fluorophobic eluate from the two FSPE purifications was concentrated under 
reduced pressure to provide 26 as a colorless syrup (5.9 mg, 4.12 µmol, 40%). 
 
Rf: 0.69 (50% EtOAc/hexanes) 
1
H NMR (CDCl3, 400 MHz) $ (ppm) 7.35-7.10 (m, 35H, Ar-H), 5.08-5.02 (m, 2H), 4.97 
(d, 1H, J = 11.2 Hz), 4.86 (t, 1H, J = 8.8 Hz), 4.78-4.62 (m, 7H), 4.58-4.42 (m, 8H), 4.24 
(2, 1H, J = 8.0 Hz, H-1), 4.16 (t, 1H, J = 8.8 Hz), 4.01 (d, 1H, J = 10 Hz), 3.78-3.44 (m, 
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16H), 3.30 (t, 1H, J = 8.0 Hz), 3.14-3.08 (m, 1H), 2.40-2.30 (br s, 1H, -OH),  (1.21 (s, 
9H, (t-BuCO), 1.17 (s, 9H, t-BuCO), 1.14 (s, 9H, t-BuCO). 
13
C NMR (CDCl3, 100 MHz) $ (ppm) 177.4, 177.0, 176.6, 138.5, 138.4, 138.3(2), 
138.2(2), 137.9, 128.7, 128.6(2), 128.4(2), 128.2, 128.1, 128.0, 127.9, 127.8(2), 127.7 
(2), 127.5(2), 101.3, 101.1, 99.7, 83.5, 83.4, 78.5, 78.0, 77.5, 76.0, 75.9, 75.4, 75.3, 75.1, 
75.0, 74.8, 74.2, 73.7, 73.6, 73.4, 73.0, 72.0, 69.0, 68.9, 68.0, 62.0, 46.2, 39.1, 39.0, 29.9, 
27.4(3). 
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    26              27 
2-hydroxyethyl 3,6-di-O-("-D-glucopyranosyl)-"-D-glucopyranoside (27).  A solution 
of the 2-hydroxyethyl glycoside 26 (5.5 mg, 3.8 µmol) was dissolved in EtOH (1 mL)  To 
this solution, palladium (10 wt.% on activated carbon, 10 mg) was added.  The reaction 
flask was evacuated and purged with hydrogen gas three times, then stirred under an 
atmosphere of hydrogen for 5 hours at ambient temperature.  The reaction mixture was 
filtered through a pad of Celite, and the solvents evaporated.  The residue was dissolved 
in MeOH (0.5 mL).  To this solution, a 0.25M solution of NaOMe in MeOH was added 
until the pH of the reaction mixture was ~10 as measured by pH paper.  After stirring at 
ambient temperature for 22.5 hours, the mixture was neutralized with Dowex 50W X-8 
(H+) resin and filtered.  The solvent was evaporated to yield the deprotected trisaccharide 
27 as a colorless syrup. 
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1
H NMR (CD3OD, 400 MHz) $ (ppm) 4.57 (d, 1H, J = 8.0 Hz), 4.34 (d, 2H, J = 8.0 Hz), 
4.26-4.19 (m, 1H), 3.90-3.10 (m, 21H). 
13
C NMR (CD3OD, 100 MHz) $ (ppm) 105.3, 105.1, 104.3, 87.7, 78.3, 78.1(2), 78.0, 
76.9, 75.7, 75.3, 74.7, 73.2, 71.7, 70.2, 70.1, 62.9, 62.8, 62.6. 
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CHAPTER 5 
Conclusions and Future Directions 
 
 In this dissertation, two libraries of mass-identical disaccharides varying in 
linkage position and the identity of the reducing-end monosaccharide residue were 
synthesized.  The initial results obtained from the MS-MS spectra of the initial test group 
of nine synthetic disaccharides bearing a propyl group at the reducing end revealed subtle 
differences in fragmentation that were used to generate classification functions.  These 
classification functions could be used to correctly assign the linkage position and non-
reducing end monosaccharide residue of each disaccharide.  However, the method must 
be carried out on larger and more complex oligosaccharides to show its true potential.  
Since only a limited number of simple trisaccharides are commercially available, a 
library of synthetic trisaccharides is needed to provide additional standards for analysis 
by mass spectrometry.  The Chemspeed ASW1000 automated synthesis workstation 
provides an excellent platform for parallel oligosaccharide synthesis, and early efforts are 
underway to prepare a library of trisaccharides using this approach. 
 Secondly, we demonstrated that branched and linear beta-glucans can be rapidly 
synthesized using an automated solution-phase approach.  Synthetic routes to several new 
glucosyl trichloroacetimidate building blocks were developed.  These building blocks 
reliably generate the desired 1,2-trans linkage during each coupling reaction. Fluorous 
solid-phase extraction provides a robust means of purifying intermediates during the 
course of each synthesis.  This study culminated in the syntheses of two branched glucans 
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and three linear glucans.  To fully exploit the utility of the automation protocols 
developed in this work, larger and more elaborate beat-glucans can be synthesized.  
Additionally, each synthetic glucan will be subjected to global deprotection in 
preparation for NMR binding studies with the glucan-binding protein Dectin-1. 
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1
H NMR Spectrum of Allyl 2,3-di-O-benzyl-4,6-O-benzylidene-!-D-glucopyranoside (4). 
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1
H NMR Spectrum of Allyl 2,3-di-O-benzyl-!-D-glucopyranoside (5). 
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1
H NMR Spectrum of Allyl-2,3,6-tri-O-benzyl-!-D-glucopyranoside (6).  
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1
H and 
13
C NMR Spectra of Allyl 3,4,6-tri-O-benzyl-2-O-(2,3,4,6-tetra-O-acetyl-"-D-glucopyranosyl)-"-D-
glucopyranoside (10). 
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1
H and 
13
C NMR Spectra of Allyl 3,4,6-tri-O-benzyl-2-O-(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-"-D-
glucopyranoside (11). 
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1
H and 
13
C NMR Spectra of Allyl 3,4,6-tri-O-benzyl-2-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-"-D-
glucopyranoside (12). 
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1
H and 
13
C NMR Spectra of Allyl 4,6-O-benzylidene-2-O-pivaloyl-3-O-(2,3,4,6-tetra-O-acetyl-"-D-
glucopyranosyl)-!-D-glucopyranoside (13). 
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1
H and 
13
C NMR Spectra of Allyl 4,6-O-benzylidene-2-O-pivaloyl-3-O-(2,3,4,6-tetra-O-acetyl-"-D-
galactopyranosyl)-!-D-glucopyranoside (14). 
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1
H and 
13
C NMR Spectra of Allyl 4,6-O-benzylidene-2-O-pivaloyl-3-O-(2,3,4,6-tetra-O-acetyl-!-D-
mannopyranosyl)-!-D-glucopyranoside (15). 
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1
H and 
13
C NMR Spectra of Propyl 2,3,6-tri-O-acetyl-4-O-(2,3,4,6-tetra-O-acetyl-"-D-glucopyranosyl)- "-D-
glucopyranoside (17). 
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1
H and 
13
C NMR Spectra of Propyl 2,3,6-tri-O-acetyl-4-O-(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)- "-D-
glucopyranoside (19). 
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1
H NMR Spectrum of Allyl 2,3,6-tri-O-benzyl-4-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-!-D-
glucopyranoside (20). 
 212 
O
BnO
BnO
O
HO
OAll
O
AcO
AcO
AcO
AcO
 
 
 
1
H and 
13
C NMR Spectra of Allyl 2,3-di-O-benzyl-6-O-(2,3,4,6-tetra-O-acetyl-"-D-glucopyranosyl)-!-D-
glucopyranoside (21). 
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1
H and 
13
C NMR Spectra of Allyl 2,3-di-O-benzyl-6-O-(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-!-D-
glucopyranoside (22). 
 214 
O
BnO
BnO
O
HO
OAll
O
OAc
AcO
AcO
AcO
 
 
 
1
H and 
13
C NMR Spectra of Allyl 2,3-di-O-benzyl-6-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-!-D-
glucopyranoside (23). 
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1
H and 
13
C NMR Spectra of Propyl 2-O-("-D-glucopyranosyl)-"-D-glucopyranoside (24). 
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1
H and 
13
C NMR Spectra of Propyl 3,4,6-tri-O-acetyl-2-O-(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-"-D-
glucopyranoside (25). 
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1
H and 
13
C NMR Spectra of Propyl 2-O-("-D-galactopyranosyl)-"-D-glucopyranoside (26). 
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1
H and 
13
C NMR Spectra of Propyl 3,4,6-tri-O-acetyl-2-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-"-D-
glucopyranoside (27). 
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1
H and 
13
C NMR Spectra of Propyl 2-O-(!-D-mannopyranosyl)-"-D-glucopyranose (28). 
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1
H and 
13
C NMR Spectra of Propyl 3-O-("-D-glucopyranosyl)-!-D-glucopyranose (29). 
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1
H and 
13
C NMR Spectra of Propyl 3-O-("-D-galactopyranosyl)-!-D-galactopyranose (30). 
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1
H and 
13
C NMR Spectra of Propyl 3-O-(!-D-mannopyranosyl)-!-D-glucopyranose (31). 
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1
H and 
13
C NMR Spectra of Propyl 4-O-("-D-glucopyranosyl)-"-D-glucopyranoside (32). 
 224 
O
HO
HO
HO
O
OPr
O
HO
HO
OH
HO
 
 
 
1
H and 
13
C NMR Spectra of Propyl 4-O-("-D-galactopyranosyl)-"-D-glucopyranoside (33). 
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1
H and 
13
C NMR Spectra of Propyl 4-O-(!-D-mannopyranosyl)-!-D-glucopyranoside (34). 
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1
H and 
13
C NMR Spectra of Propyl 6-O-("-D-glucopyranosyl)-!-D-glucopyranoside (35). 
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1
H and 
13
C NMR Spectra of Propyl 6-O-("-D-galactopyranosyl)-!-D-glucopyranoside (36). 
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1
H NMR Spectrum of Propyl 6-O-(!-D-mannopyranosyl)-!-D-glucopyranoside (37). 
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1
H and 
13
C NMR Spectra of Benzyl 3,4,6-tri-O-benzyl-"-D-glucopyranoside (39). 
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1
H NMR Spectrum of 3-O-allyl-1,2-5,6-di-O-isopropylidene-D-glucofuranose (41). 
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1
H NMR Spectrum of 3-O-allyl-"-D-glucopyranose (42). 
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1
H and 
13
C NMR Spectra of Benzyl 3-O-allyl-2,4,6-tri-O-benzyl-"-D-glucopyranoside (43). 
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1
H and 
13
C NMR Spectra of Benzyl 2,4,6-tri-O-benzyl-"-D-glucopyranoside (44). 
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1
H NMR Spectrum of Benzyl 2,3-di-O-benzyl-4,6-O-benzylidene-"-D-glucopyranoside (48). 
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1
H NMR Spectrum of Benzyl 2,3,6-tri-O-benzyl-"-D-glucopyranoside (49). 
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1
H and 
13
C NMR Spectra of Benzyl 2,3,4,6-tetra-O-benzyl-"-D-glucopyranoside (50). 
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1
H NMR Spectrum of Benzyl 2,3,4-tri-O-benzyl-"-D-glucopyranoside (51). 
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1
H and 
13
C NMR Spectra of Benzyl 3,4,6-tri-O-benzyl-2-O-(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-"-D-
glucopyranoside (52). 
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1
H and 
13
C NMR Spectra of Benzyl 3,4,6-tri-O-benzyl-2-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-"-D-
glucopyranoside (53). 
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1
H and 
13
C NMR Spectra of Benzyl 2,4,6-tri-O-benzyl-3-O-(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-"-D-
glucopyranoside (54). 
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1
H and 
13
C NMR Spectra of Benzyl 2,4,6-tri-O-benzyl-3-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-"-D-
glucopyranoside (55). 
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1
H and 
13
C NMR Spectra of Benzyl 2,3,6-tri-O-benzyl-4-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-"-D-
glucopyranoside (56). 
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1
H and 
13
C NMR Spectra of Benzyl 2,3,4-tri-O-benzyl-6-O-(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-"-
D-glucopyranoside (57). 
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1
H and 
13
C NMR Spectra of Benzyl 2,3,4-tri-O-benzyl-6-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-"-D-
glucopyranoside (58). 
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1
H and 
13
C NMR Spectra of 2-O-("-D-galactopyranosyl)-D-glucopyranose (59). 
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1
H and 
13
C NMR Spectra of 2-O-(!-D-mannopyranosyl)-D-glucopyranose (60). 
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1
H and 
13
C NMR Spectra of 1,2,4,6-tetra-O-acetyl-3-O-(2,3,4,6-tetra-O-acetyl-"-D-galactopyranosyl)-D-
glucopyranose (61). 
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1
H and 
13
C NMR Spectra of 3-O-("-D-galactopyranosyl)-D-glucopyranose (62). 
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1
H and 
13
C NMR Spectra of 1,2,4,6-tetra-O-acetyl-3-O-(2,3,4,6-tetra-O-acetyl-!-D-mannopyranosyl)-D-
glucopyranose (63). 
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1
H and 
13
C NMR Spectra of 3-O-(!-D-mannopyranosyl)-D-glucopyranose (64). 
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1
H and 
13
C NMR Spectra of 4-O-(!-D-mannopyranosyl)-D-glucopyranose (65). 
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1
H and 
13
C NMR Spectra of 6-O-("-D-galactopyranosyl)-D-glucopyranose (66). 
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1
H and 
13
C NMR Spectra of 6-O-(!-D-mannopyranosyl)-D-glucopyranose (67). 
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H and 
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H and 
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C NMR Spectra of 4-O-benzyl-3,6-di-O-levulinoyl-2-O-pivaloyl-!-D-glucopyranosyl 
trichloroacetimidate (6). 
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H and 
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C NMR Spectra of Allyl 3-O-benzyl-4,6-O-benzylidene-"-D-glucopyranoside (15). 
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H and 
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C NMR Spectra of Allyl 3-O-benzyl-2-O-pivaloyl-"-D-glucopyranoside (16). 
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1
H and 
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C NMR Spectra of trisaccharide (1). 
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C NMR Spectra of trisaccharide (2). 
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1
H NMR Spectrum of trisaccharide (3). 
 288 
O
BnO
PivO
O
BnO
O
BnO
PivO
O
BnO
O O
F17C8
O
BnO
PivO
OH
BnO
 
 
 
1
H and 
13
C NMR Spectra of trisaccharide (4). 
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1
H and 
13
C NMR Spectra of trisaccharide (26). 
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1
H and 
13
C NMR Spectra of trisaccharide (27). 
